<SEC-DOCUMENT>0001047469-17-001969.txt : 20170324
<SEC-HEADER>0001047469-17-001969.hdr.sgml : 20170324
<ACCEPTANCE-DATETIME>20170324121801
ACCESSION NUMBER:		0001047469-17-001969
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20170503
FILED AS OF DATE:		20170324
DATE AS OF CHANGE:		20170324
EFFECTIVENESS DATE:		20170324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		17711873

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2231431zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<P><FONT SIZE=3 >
Use these links to rapidly review the document<BR>
<A HREF="#bg14905_table_of_contents">  TABLE OF CONTENTS</A><BR></font>
</P>

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B> SCHEDULE 14A</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Proxy
Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2> Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Soliciting Material under &sect;240.14a-12<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> USANA Health Sciences,&nbsp;Inc.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><BR>
Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=2>Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.<BR> </B></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=515550,FOLIO='blank',FILE='DISK135:[17ZAA5.17ZAA14905]BA14905A.;4',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g429027.jpg" ALT="LOGO" WIDTH="102" HEIGHT="135">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3838 West Parkway Boulevard<BR>
Salt Lake City, Utah 84120-6336<BR>
(801)&nbsp;954-7100 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>March&nbsp;24,
2017 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Dear
Shareholders, </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
cordially invite you to attend the 2017 Annual Meeting of Shareholders of USANA Health Sciences,&nbsp;Inc. to be held at 11&nbsp;a.m. Mountain Daylight Time on Wednesday,
May&nbsp;3, 2017, at our offices at 3838 West Parkway Boulevard, Salt Lake City, Utah. Details regarding the meeting, the business to be conducted, and information about the Company that you should
consider when you vote your shares are described in the following pages, which contain the formal Notice of Annual Meeting and the Proxy Statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the Annual Meeting, you will be asked to elect our Board of Directors, ratify the selection of our independent registered public accounting firm, and vote on an advisory basis on
executive compensation and the frequency of future advisory votes on executive compensation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
will receive or have access to a Notice of Annual Meeting and Proxy Statement. The Proxy Statement describes the business we will conduct at the Annual Meeting and provides
information about the Company that you should consider when you vote your shares. The Proxy Statement includes a section highlighting the Company's corporate governance practices. The Company and its
Board of Directors have a longstanding commitment to good governance, and the Board reviews its governance practices on an ongoing basis to ensure that they promote shareholder value. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
hope you will be able to attend the Annual Meeting. You may vote over the Internet as well as by telephone. In addition, if you requested to receive printed proxy materials, you may
vote by completing, signing, dating and returning your proxy card by mail. We urge you to vote promptly in accordance with the instructions set forth in the Notice of Internet Availability of Proxy
Materials or on your proxy card. Regardless of whether or not you can attend the Annual Meeting, we encourage you to vote by proxy so that your shares will be represented and voted at the meeting. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thank
you for your continued support of USANA. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="50%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="50%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Sincerely,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g263414.jpg" ALT="GRAPHIC" WIDTH="162" HEIGHT="58">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Kevin Guest<BR></FONT> <FONT SIZE=2><I>Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=737642,FOLIO='blank',FILE='DISK135:[17ZAA5.17ZAA14905]BC14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->




<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->





<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g429027.jpg" ALT="LOGO" WIDTH="102" HEIGHT="135">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3838 West Parkway Boulevard<BR>
Salt Lake City, Utah 84120-6336<BR>
(801)&nbsp;954-7100 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS<BR>
TO BE HELD MAY 3, 2017</B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="111pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="13pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>DATE:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2>Wednesday, May&nbsp;3, 2017</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>TIME:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>11&nbsp;a.m. Mountain Daylight Time</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>PLACE:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>USANA Health Sciences,&nbsp;Inc.<BR>
3838 West Parkway Boulevard<BR>
Salt Lake City, Utah 84120</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>RECORD DATE:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>March&nbsp;1, 2017</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2>PURPOSES:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>1.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Elect the seven directors named in the Proxy Statement;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>2.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Ratify the selection of KPMG&nbsp;LLP as the Company's independent registered public accounting firm for the fiscal year 2017;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>3.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Approve on an advisory basis the Company's executive compensation, commonly referred to as a "Say on Pay" proposal;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>4.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Consider a non-binding advisory vote regarding the frequency of submission to shareholders of such advisory "Say on Pay" proposals; and</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><BR><FONT SIZE=2>5.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Such other business as may properly come before the meeting or at any postponement or adjournment thereof.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
foregoing items of business are more fully described in the Proxy Statement accompanying this Notice of Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
or about March&nbsp;24, 2017, we began sending a Notice of Internet Availability of Proxy Materials to all shareholders entitled to vote at the Annual Meeting. All shareholders are
cordially invited to attend the Annual Meeting in person. Your vote is important. We encourage you to vote by proxy even if you plan to attend the meeting. You may vote your proxy via the Internet or
by telephone by following the instructions included on your Notice of Internet Availability or, if you received a printed copy of the proxy materials, on your proxy card. Voting now will not limit
your right to change your vote or to attend the Annual Meeting. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g725724.jpg" ALT="GRAPHIC" WIDTH="150" HEIGHT="54">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>James H. Bramble</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><I> Chief Legal Officer, General Counsel and Corporate Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Salt
Lake City, Utah<BR>
March&nbsp;24, 2017 </FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=765294,FOLIO='blank',FILE='DISK135:[17ZAA5.17ZAA14905]BE14905A.;13',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_bf14905_1_2"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="bf14905_important_notice_regarding_the__imp04344"> </A>
<A NAME="toc_bf14905_1"> </A>
<BR></FONT><FONT SIZE=2><B>  IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR<BR>  THE SHAREHOLDER MEETING TO BE HELD ON MAY 3, 2017    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>This Proxy Statement and our annual report to shareholders for the fiscal year ended December&nbsp;31, 2016, along
with our proxy card, are available for viewing, printing, and downloading free of charge at </B></FONT><FONT SIZE=2><B><I>www.proxyvote.com</I></B></FONT><FONT SIZE=2><B>.</B></FONT><FONT SIZE=2> To view these
materials please have your 12-digit control number available that appears on your Notice of Internet Availability of Proxy Materials or proxy card. On this website, you can also elect to receive
future distributions of our proxy statements and annual reports to shareholders by electronic delivery. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally,
you can find a copy of our Annual Report on Form&nbsp;10-K, which includes our financial statements for the fiscal year ended December&nbsp;31, 2016, on the website of
the Securities and Exchange Commission at www.sec.gov, or on the "Investor Relations" section of our website at www.usanahealthsciences.com. You may also obtain a printed copy of our Annual Report on
Form&nbsp;10-K,
including our financial statements, free of charge, from us by sending a written request to: Corporate Secretary, USANA Health Sciences,&nbsp;Inc., 3838 West Parkway Boulevard, Salt Lake City, Utah
84120. Exhibits will be provided upon written request and payment of an appropriate processing fee. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>ii</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=1039850,FOLIO='ii',FILE='DISK135:[17ZAA5.17ZAA14905]BF14905A.;5',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><A
NAME="BG14905A_main_toc"></A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="bg14905_usana_health_sciences,_inc._an__usa02900"> </A>
<BR></FONT><FONT SIZE=2><B>  USANA HEALTH SCIENCES,&nbsp;INC.<BR>  ANNUAL MEETING OF SHAREHOLDERS<BR>  PROXY STATEMENT    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="bg14905_table_of_contents"> </A></FONT> <FONT SIZE=2><B>  TABLE OF CONTENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>
<A NAME="BG14905_TOC"></A> </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->
<!-- COMMAND=ADD_START_LINKTABLE -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#PRXYQUSANS"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND PROXY STATEMENT</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#PRXYQUSANS"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#PRXYQUSANS"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>QUESTIONS AND ANSWERS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#PRXYQUSANS"><FONT SIZE=2>1</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_board_of_directors_and_corporate_governance"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_board_of_directors_and_corporate_governance"><FONT SIZE=2>7</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_board_leadership_structure"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Board Leadership Structure</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_board_leadership_structure"><FONT SIZE=2>7</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_director_independence"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Director Independence</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_director_independence"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_executive_sessions_of_non-management_directors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Executive Sessions of Non-Management Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_executive_sessions_of_non-management_directors"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_communications_with_directors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Communications with Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_communications_with_directors"><FONT SIZE=2>8</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_committees_of_the_board_of_directors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Committees of the Board of Directors</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_committees_of_the_board_of_directors"><FONT SIZE=2>9</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_risk_oversight_and_management"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Risk Oversight and Management</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_risk_oversight_and_management"><FONT SIZE=2>10</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_compensation_risk_analysis"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Risk Analysis</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_compensation_risk_analysis"><FONT SIZE=2>11</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_board_committee_charters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Board Committee Charters</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_board_committee_charters"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_corporate_governance_guidelines"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Corporate Governance Guidelines</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_corporate_governance_guidelines"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_code_of_ethics"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Code of Ethics</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_code_of_ethics"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_compensation_committee__dc102478"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_compensation_committee__dc102478"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dc14905_section_16(a)_benefici__dc102025"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dc14905_section_16(a)_benefici__dc102025"><FONT SIZE=2>12</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de14905_executive_officers"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXECUTIVE OFFICERS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de14905_executive_officers"><FONT SIZE=2>13</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de1"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #1: ELECTION OF DIRECTORS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de1"><FONT SIZE=2>15</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#de14905_compensation_of_directors"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>COMPENSATION OF DIRECTORS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#de14905_compensation_of_directors"><FONT SIZE=2>18</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#PRO2"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #2: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#PRO2"><FONT SIZE=2>19</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_report_of_the_audit_committee"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>REPORT OF THE AUDIT COMMITTEE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_report_of_the_audit_committee"><FONT SIZE=2>20</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_policy_on_pre-approval_of_audi__pol02605"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Policy on Pre-Approval of Audit and Permissible Non-Audit
Services</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_policy_on_pre-approval_of_audi__pol02605"><FONT SIZE=2>20</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_independence"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Independence</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_independence"><FONT SIZE=2>21</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_services"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Services</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_services"><FONT SIZE=2>21</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_executive_compensation"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EXECUTIVE COMPENSATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_executive_compensation"><FONT SIZE=2>21</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_compensation_discussion_and_analysis"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Discussion and Analysis</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_compensation_discussion_and_analysis"><FONT SIZE=2>21</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_compensation_philosophy_and_objectives"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Philosophy and Objectives</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_compensation_philosophy_and_objectives"><FONT SIZE=2>23</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_role_of_compensation_committee"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Role of Compensation Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_role_of_compensation_committee"><FONT SIZE=2>23</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_role_of_corporate_leadership_i__rol02643"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Role of Corporate Leadership in Assisting Compensation
Committee</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_role_of_corporate_leadership_i__rol02643"><FONT SIZE=2>23</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_compensation_consultant"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Consultants</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_compensation_consultant"><FONT SIZE=2>24</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_2016_compensation_determinations"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Compensation Determinations</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_2016_compensation_determinations"><FONT SIZE=2>25</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dg14905_components_of_compensation"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Components of Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dg14905_components_of_compensation"><FONT SIZE=2>25</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#OTHER"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Other Compensation</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#OTHER"><FONT SIZE=2>28</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#di14905_section_162(m)_treatment_regar__sec02348"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>&#151;Section&nbsp;162(m) Treatment Regarding Performance-Based Equity
Awards</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di14905_section_162(m)_treatment_regar__sec02348"><FONT SIZE=2>29</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#di14905_report_of_the_compensation_committee"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>REPORT OF THE COMPENSATION COMMITTEE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di14905_report_of_the_compensation_committee"><FONT SIZE=2>29</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#di14905_summary_compensation_table"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SUMMARY COMPENSATION TABLE</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#di14905_summary_compensation_table"><FONT SIZE=2>30</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk14905_grants_of_plan-based_awards"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>GRANTS OF PLAN-BASED AWARDS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk14905_grants_of_plan-based_awards"><FONT SIZE=2>32</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#OUTEND"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#OUTEND"><FONT SIZE=2>33</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk14905_option_exercises_and_stock_vested"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OPTION EXERCISES AND STOCK VESTED</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk14905_option_exercises_and_stock_vested"><FONT SIZE=2>34</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk14905_equity_compensation_plan_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EQUITY COMPENSATION PLAN INFORMATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk14905_equity_compensation_plan_information"><FONT SIZE=2>34</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dk14905_employment_contracts_and_other_arrangements"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>EMPLOYMENT CONTRACTS AND OTHER ARRANGEMENTS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dk14905_employment_contracts_and_other_arrangements"><FONT SIZE=2>34</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#PRO3"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #3 ADVISORY VOTE ON EXECUTIVE COMPENSATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#PRO3"><FONT SIZE=2>35</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#PRO4"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PROPOSAL #4 FREQUENCY OF ADVISORY VOTE ON EXECUTIVE COMPENSATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#PRO4"><FONT SIZE=2>36</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dm14905_security_ownership_of_certain___sec02525"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm14905_security_ownership_of_certain___sec02525"><FONT SIZE=2>37</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dm14905_certain_relationships_and_related_transactions"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm14905_certain_relationships_and_related_transactions"><FONT SIZE=2>39</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dm14905_other_matters"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>OTHER MATTERS</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm14905_other_matters"><FONT SIZE=2>40</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dm14905_annual_report"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>ANNUAL REPORT</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm14905_annual_report"><FONT SIZE=2>40</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><A HREF="#dm14905_further_information"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FURTHER INFORMATION</FONT></A></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><A HREF="#dm14905_further_information"><FONT SIZE=2>40</FONT></A></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
<!-- COMMAND=ADD_END_LINKTABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=5,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=742625,FOLIO='blank',FILE='DISK135:[17ZAA5.17ZAA14905]BG14905A.;7',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_da14905_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g429027.jpg" ALT="LOGO" WIDTH="102" HEIGHT="135">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=3><B><A NAME="PRXYQUSANS"></A>PROXY STATEMENT FOR<BR>
THE ANNUAL MEETING OF SHAREHOLDERS<BR>
TO BE HELD MAY 3, 2017  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of USANA Health Sciences,&nbsp;Inc. ("We," "USANA," or the "Company") is soliciting the accompanying proxy to be used at
our 2017 Annual Meeting of Shareholders (the "Annual
Meeting") to be held on Wednesday, May&nbsp;3, 2017, at 11&nbsp;a.m., Mountain Daylight Time, or at any adjournments thereof for the purposes set forth in this Proxy Statement and in the
accompanying Notice of the meeting. This Proxy Statement is dated March&nbsp;24, 2017 and on or about March&nbsp;24, 2017, we began sending the Notice of Internet Availability of Proxy Materials,
or Notice of Availability, to all shareholders entitled to vote at the Annual Meeting. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="da14905_important_information_about_the_meeting"> </A>
<A NAME="toc_da14905_1"> </A>
<BR></FONT><FONT SIZE=2><B>  IMPORTANT INFORMATION ABOUT THE MEETING    <BR>    </B></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_why_is_the_company_soliciting_my_proxy_"> </A>
<A NAME="toc_da14905_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Why is the Company soliciting my proxy?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of USANA is soliciting your proxy to vote at the Annual Meeting to be held at our offices, 3838 West Parkway Boulevard,
Salt Lake City, Utah, on Wednesday, May&nbsp;3, 2017, at 11:00&nbsp;a.m. MDT and any adjournments of the meeting. The Proxy Statement along with the accompanying Notice of Annual Meeting of
Shareholders summarizes the purposes of the meeting and the information you need to know to vote at the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have sent you the Notice of Availability because you owned shares of USANA common stock on the record date, which is March&nbsp;1, 2017. We have also delivered printed versions of
these materials to certain shareholders by mail. The Company commenced distribution of the Notice of Availability and the proxy materials to shareholders on or about March&nbsp;24, 2017. Our Notice
of Availability will instruct you on how to access and review our Proxy Statement for the Annual Meeting and our Annual Report for the fiscal year ended December&nbsp;31, 2016 ("Annual Report"). It
will instruct you on how you may vote your proxy via the Internet, or how you can request a full set of printed proxy materials, including a proxy card to return by mail. If you would like to receive
printed proxy materials, you should follow the instructions contained in our Notice of Availability. Unless requested, you will not receive printed proxy materials by mail. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Properly
delivered proxies will be voted in accordance with the specifications made and where no specifications are given, such proxies will be voted FOR the proposal to elect the seven
nominees to the Board of Directors of the Company to serve until their respective successors are elected and qualified, FOR the proposal to ratify the appointment of KPMG&nbsp;LLP as our independent
registered public accounting firm for the fiscal year ending December&nbsp;30, 2017, FOR approval of the compensation of our named executive officers, and FOR the recommendation that an advisory
vote on executive compensation be held every year. In the discretion of the proxy holders, the proxies will also be voted FOR or AGAINST such other matters as may properly come before the Annual
Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
management is not aware of any other matters that are to be presented for action at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, the
persons named in your proxies will vote in accordance with their best judgment. Although it is intended that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=6,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=620795,FOLIO='1',FILE='DISK135:[17ZAA5.17ZAA14905]DA14905A.;16',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_da14905_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>the
proxies will be voted for the nominees named herein, the holders of the proxies reserve discretion to cast votes for individuals other than such nominees in the event of the unavailability of any
such nominee. We have no reason to believe that any of the nominees will become unavailable for election. The proxies may not be voted for a greater number of persons than the number of nominees
named. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials?</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
permitted by the rules of the U.S. Securities and Exchange Commission, or the SEC, we have elected to furnish our proxy materials to our shareholders by providing access to such
documents on the Internet, rather than mailing printed copies of these materials to each shareholder. Most shareholders will not receive printed copies of the proxy materials unless they request them.
We believe that this process should expedite shareholders' receipt of proxy materials, lower the costs of the annual meeting and help to conserve natural resources. If you received a Notice of
Availability by mail or electronically, you will not receive a printed or email copy of the proxy materials, unless you request one by following the instructions included in the Notice of
Availability. Instead, the Notice of Availability will instruct you how you may access and review all of the proxy materials and submit your proxy on the Internet. If you requested a paper copy of the
proxy materials, you may authorize the voting of your shares by following the instructions on the enclosed proxy card, in addition to the other methods of voting described in this Proxy Statement. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_who_can_vote_"> </A>
<A NAME="toc_da14905_3"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who can vote?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only shareholders who owned USANA common stock at the close of business on March&nbsp;1, 2017, or the record date, are entitled to vote at the
Annual Meeting. On this record date, there were 24,504,413 shares of our common stock outstanding and entitled to vote. Common stock is our only class of voting stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
do not need to attend the Annual Meeting in person to vote your shares. Shares represented by valid proxies, received in time for the meeting and not revoked prior to the meeting,
will be voted at the meeting. For instructions on how to change or revoke your proxy, see "May I Change or Revoke My Proxy?" below. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_how_many_votes_do_i_have_"> </A>
<A NAME="toc_da14905_4"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How many votes do I have?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each share of USANA common stock that you own as of the record date entitles you to one vote. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_how_do_i_vote_"> </A>
<A NAME="toc_da14905_5"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How do I vote?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether you plan to attend the Annual Meeting or not, we urge you to vote by proxy. All shares represented by valid proxies that we receive
through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the proxy card or as instructed via Internet or telephone. You may specify whether your
shares should be voted for or withheld for each nominee for director, and whether your shares should be voted for, against or abstain with respect to any other proposal. If you properly submit a proxy
without giving specific voting instructions, your shares will be voted in accordance with the Board's recommendations as noted below. Voting by proxy will not affect your right to attend the Annual
Meeting. If your shares are registered directly in your name through our stock transfer agent, American Stock Transfer and Trust Company, or you have stock certificates registered in your name, you
may vote:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> By Internet or by telephone. Follow the instructions included in the Notice of Availability or, if you received printed materials, in the proxy
card, to vote by Internet or telephone. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=7,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=473465,FOLIO='2',FILE='DISK135:[17ZAA5.17ZAA14905]DA14905A.;16',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_da14905_1_3"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> By mail. If you received your proxy materials by mail, you can vote by mail by completing, signing, dating and returning the proxy card as
instructed on the card. If you sign the proxy card but do not specify how you want your shares voted, they will be voted in accordance with the Board's recommendations as noted below. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> In person at the meeting. If you attend the meeting, you may deliver a completed proxy card in person or you may vote by completing a ballot,
which will be available at the meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Telephone
and Internet voting facilities for shareholders of record will be available 24-hours a day and will close at 11:59&nbsp;p.m. Eastern Daylight Time on May&nbsp;2, 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
your shares are held in "street name" (held in the name of a bank, broker or other holder of record or nominee), you will receive instructions from the holder of record. You must
follow the instructions of the nominee in order for your shares to be voted. Telephone and Internet voting also will be offered to shareholders owning shares through certain banks and brokers. If your
shares are not registered in your own name and you plan to vote your shares in person at the Annual Meeting, you should contact your broker or agent to obtain a legal proxy or broker's proxy card and
bring it to the Annual Meeting in order to vote. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_how_does_the_board_of_director__how02885"> </A>
<A NAME="toc_da14905_6"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How does the Board of Directors recommend that I vote on the proposals?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors recommends that you vote as follows:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "FOR" the election of the seven nominees for director; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "FOR" the ratification of the selection of KPMG&nbsp;LLP as our independent registered public accounting firm for our 2017 fiscal year; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "FOR" the approval of the compensation paid to our named executive officers (the "Say on Pay" proposal); and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> "FOR" recommendation of the Board of Directors that a shareholder advisory vote on "Say on Pay" proposals be held every year. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
do not expect any other business to come before the meeting. If any other matter is presented, your proxy provides that your shares will be voted by the proxy holder listed in the
proxy in accordance with his or her best judgment. At the time this Proxy Statement was first made available, we knew of no matters that needed to be acted on at the Annual Meeting, other than those
discussed in this Proxy Statement. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_may_i_change_or_revoke_my_proxy_"> </A>
<A NAME="toc_da14905_7"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


May I change or revoke my proxy?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you give us your proxy, you may change or revoke it at any time before the meeting. You may change or revoke your proxy in any one of the
following ways:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> by re-voting by Internet or by telephone as instructed above; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> if you received printed proxy materials, by signing a new proxy card with a date later than your previously delivered proxy and submitting it
as instructed above; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> by notifying our Corporate Secretary in writing before the Annual Meeting that you have revoked your proxy; or </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> by attending the meeting in person and voting in person. Attending the meeting in person will not in and of itself revoke a previously
submitted proxy unless you specifically request it. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
most current vote, whether by telephone, Internet or proxy card, is the one that will be counted. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=8,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=115712,FOLIO='3',FILE='DISK135:[17ZAA5.17ZAA14905]DA14905A.;16',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_da14905_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<UL>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_what_if_i_receive_more_than_on__wha02764"> </A>
<A NAME="toc_da14905_8"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What if I receive more than one Notice of Availability or proxy card?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may receive more than one Notice of Availability or proxy card if you hold shares of our common stock in more than one account, which may be
in registered form or held in street name. Please vote in the manner described under "How do I vote?" for each account to ensure that all of your shares are voted. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_what_are__broker_non-votes__"> </A>
<A NAME="toc_da14905_9"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What are "broker non-votes"?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your shares are held in street name through a bank or broker and you do not provide voting instructions before the Annual Meeting, your bank
or broker may vote your shares under certain circumstances in accordance with New York Stock Exchange ("NYSE") rules that govern banks and brokers. These circumstances include "routine matters," such
as the ratification of the appointment of our independent registered public accounting firm described in this Proxy Statement. If you do not vote your shares with respect to these matters, your bank
or broker may vote your shares on your behalf or leave your shares unvoted. "Broker non-votes" are shares represented by proxies, received from a bank or broker that are not voted on a matter because
the bank or broker did not receive voting instructions from you. Broker non-votes will be treated the same as abstentions, which means they will be present at the Annual Meeting and counted toward the
quorum, but they will not be counted as votes cast. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_will_my_shares_be_voted_if_i_do_not_vote_them_"> </A>
<A NAME="toc_da14905_10"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Will my shares be voted if I do not vote them?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If your shares are registered in your name, they will not be voted if you do not vote as described above under "How do I vote?" If your shares
are held in street name by a bank, broker or other holder of record (nominee) and you do not provide voting instructions to the nominee that holds your shares as described above, the nominee has the
authority to vote your unvoted shares only on the ratification of our independent registered public accounting firm (Proposal #2), unless the nominee receives instructions from you. Therefore, we
encourage you to provide voting instructions. This ensures your shares will be voted at the meeting and in the manner you desire. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_what_vote_is_required_to_appro__wha02998"> </A>
<A NAME="toc_da14905_11"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What vote is required to approve each proposal and how are votes counted?    <BR>  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 </UL>
 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="23%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="23%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="70pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Proposal

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Vote Required </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Voting Options </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effect of<BR>
Abstentions </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Broker<BR>
Discretionary<BR>
Voting<BR>
Allowed? </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Effect of<BR>
Broker<BR>
Non-Votes </B></FONT></TH>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Election of Directors (Proposal #1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>Plurality of the votes cast at the Annual Meeting.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>FOR, AGAINST or ABSTAIN</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>No effect&#151;not treated as a "vote cast"</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>No</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>No effect&#151;not treated as a "vote cast"</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Ratification of Auditor Appointment (Proposal&nbsp;2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Majority of shares with voting power present in person or represented by proxy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>FOR, AGAINST or ABSTAIN</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Treated as a vote AGAINST the proposal</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Yes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Not applicable</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Non-Binding Advisory Vote on Executive Compensation (Say on Pay) (Proposal&nbsp;3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Majority of shares with voting power present in person or represented by proxy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>FOR, AGAINST or ABSTAIN</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>No effect&#151;not treated as a "vote cast</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>No</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>No effect&#151;not entitled to vote</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Non-Binding Advisory Vote on Frequency of Submission to Shareholders of "Say on Pay" Proposals (Proposal 4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Majority of shares with voting power present in person or represented by proxy</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>ONE YEAR, TWO YEARS or THREE YEARS</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>No effect&#151;not treated as a "vote cast"</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>No</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>No effect&#151;not entitled to vote</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
cumulative voting rights are authorized, and dissenters' rights are not applicable to the matters being voted on. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>

<!-- ZEQ.=4,SEQ=9,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=260350,FOLIO='4',FILE='DISK135:[17ZAA5.17ZAA14905]DA14905A.;16',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_da14905_1_5"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_is_voting_confidential_"> </A>
<A NAME="toc_da14905_12"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Is voting confidential?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will keep all the proxies, ballots and voting tabulations private. We only let our Inspector of Elections examine these documents.
Management, other than the Inspector of Elections, will not know how you voted on a specific proposal unless it is necessary to meet legal requirements. We will, however, forward to management any
written comments you make, on the proxy card or elsewhere. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_who_will_count_the_votes_"> </A>
<A NAME="toc_da14905_13"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who will count the votes?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Broadridge Investor Communications Services will tabulate the votes that are received prior to the Annual Meeting. Representatives of USANA will
act as the Inspectors of Election and will tabulate the votes, if any, that are cast in person at the Annual Meeting. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_where_can_i_find_the_v__da102361"> </A>
<A NAME="toc_da14905_14"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Where can I find the voting results of the Annual Meeting?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The preliminary voting results will be announced at the Annual Meeting, and we will publish preliminary, or final results if available, in a
Current Report on Form&nbsp;8-K within four business days of the Annual Meeting. If final results are unavailable at the time we file the Form&nbsp;8-K, then we will file an amended report on
Form&nbsp;8-K to disclose the final voting results within four business days after the final voting results are known. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_who_pays_the_costs_of_soliciting_these_proxies_"> </A>
<A NAME="toc_da14905_15"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who pays the costs of soliciting these proxies?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These proxies are solicited by our Board of Directors and we will pay all of the costs of soliciting these proxies. Our directors and employees
may solicit proxies in person or by telephone, fax or email. We will pay these employees and directors no additional compensation for these services. We will ask banks, brokers and other institutions,
nominees and fiduciaries to forward these proxy materials to their principals and to obtain authority to deliver proxies. We will then reimburse them for their expenses. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_what_constitutes_a_quorum_for_the_annual_meeting_"> </A>
<A NAME="toc_da14905_16"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What constitutes a quorum for the Annual Meeting?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The presence, in person or by proxy, of the holders of a majority of the voting power of our common stock outstanding on the record date is
necessary to constitute a quorum at the meeting. For the purpose of determining whether the shareholders have approved matters other than the election of directors, abstentions are treated as shares
present or represented and voting, so abstaining has the same effect as a negative vote. Shares held by brokers who do not have discretionary authority to vote on a particular matter and who have not
received voting instructions from their customers are counted for determining the presence or absence of a quorum for conducting business but are not counted or deemed to be present or represented for
the purpose of determining whether shareholders have approved that matter. As of the close of business on the record date, there were 24,504,413 shares of our common stock outstanding. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>How do I submit and what are the deadlines for submitting a shareholder proposal for next year's annual meeting?</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders
are entitled to present proposals for consideration at the next annual meeting of shareholders, provided that they comply with the proxy rules promulgated by the SEC and our
Bylaws. Any shareholder who intends to submit a proposal for consideration at the 2018 Annual Meeting of Shareholders must deliver such proposal to the Corporate Secretary, c/o USANA Health
Sciences,&nbsp;Inc., 3838 West Parkway Blvd., Salt Lake City, Utah 84120, not later than 120&nbsp;days prior to the one-year anniversary of the date on which this Proxy Statement is first mailed,
which date is November&nbsp;24, 2017, if the proposal is submitted for inclusion in our proxy materials for that meeting pursuant to Rule&nbsp;14a-8 under the Securities Exchange Act of 1934
("Exchange Act"). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=10,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=72759,FOLIO='5',FILE='DISK135:[17ZAA5.17ZAA14905]DA14905A.;16',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_da14905_1_6"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_who_should_i_call_if_i_have_questions_"> </A>
<A NAME="toc_da14905_17"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who should I call if I have questions?    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you have questions about the proposals or the Annual Meeting, you may call Joshua Foukas, USANA Executive Vice President of Legal, at
(801)&nbsp;954-7100. You may also send an e-mail to </FONT><FONT SIZE=2><I>investor.relations@us.usana.com.</I></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_attending_the_annual_meeting"> </A>
<A NAME="toc_da14905_18"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Attending the Annual Meeting    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Annual Meeting will be held at 11:00&nbsp;a.m. local time on Wednesday, May&nbsp;3, 2017, at our offices at 3838 West Parkway Boulevard,
Salt Lake City, Utah. Please note that attendance at the meeting is limited to our shareholders or their named representatives. Proof of ownership of our common stock as of the record date and photo
identification will be required for admittance to the Annual Meeting. If you are a registered shareholder, the top portion of your proxy card may serve as proof of ownership. If you are attending on
behalf of an entity that is a shareholder, evidence of your employment or association with that entity also will be required. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
obtain directions to attend the Annual Meeting, please contact our Investor Relations Department at (801)&nbsp;954-7100. When you arrive at our offices, our personnel will direct
you to the appropriate meeting room. You need not attend the Annual Meeting in person to vote. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_householding_of_annual_disclosure_documents"> </A>
<A NAME="toc_da14905_19"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Householding of Annual Disclosure Documents    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SEC rules concerning the delivery of annual disclosure documents allow us or your broker to send a single Notice of Availability or, if
applicable, a single set of our proxy materials to any household at which two or more of our shareholders reside, if we or your broker believe that the shareholders are members of the same family.
This practice, referred to as "householding," benefits both you and us. It reduces the volume of duplicate information received at your household and helps to reduce our expenses. The rule applies to
our notices, annual reports, proxy statements and information statements. Once you receive notice from your broker or from us that communications to your address will be "householded," the practice
will continue until you are otherwise notified or until you revoke your consent to the practice. Shareholders who participate in householding will continue to have access to and utilize separate proxy
voting instructions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
your household received a single notice or, if applicable, set of proxy materials this year, but you would prefer to receive your own copy, please contact Broadridge, by calling their
toll free number&nbsp;1-800-542-1061. If you do not wish to participate in "householding" and would like to receive your own Notice of Availability or, if applicable, set of proxy materials in
future years, follow the instructions described below. Conversely, if you share an address with another USANA shareholder and together both of you would like to receive only a single Notice of
Availability or, if applicable, set of proxy materials, follow these instructions:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> If your USANA shares are registered in your own name, please contact Broadridge and inform them of your request by calling them at
1-800-542-1061 or writing them at Broadridge Householding Department, 51 Mercedes Way, Edgewood, NY 11717. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> If a broker or other nominee holds your USANA shares, please contact the broker or other nominee directly and inform them of your request. Be
sure to include your name, the name of your brokerage firm and your account number. </FONT></DD></DL>
</UL>
<UL>
<BR>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="da14905_electronic_delivery_of__da102387"> </A>
<A NAME="toc_da14905_20"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Electronic Delivery of Company Shareholder Communications    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Most shareholders can elect to receive notices of the availability of future proxy materials by email instead of receiving a paper copy in the
mail. You can choose this option and save us the cost of producing and mailing these documents by following the instructions provided on your Notice of Availability or proxy card or following the
instructions provided when you vote over the Internet at www.proxyvote.com. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=11,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=355234,FOLIO='6',FILE='DISK135:[17ZAA5.17ZAA14905]DA14905A.;16',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dc14905_1_7"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc14905_board_of_directors_and_corporate_governance"> </A>
<A NAME="toc_dc14905_1"> </A>
<BR></FONT><FONT SIZE=2><B>  BOARD OF DIRECTORS AND CORPORATE GOVERNANCE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors is elected by and is accountable to the shareholders of the Company. The Board establishes policy and provides strategic
direction, oversight, and control of the Company. The Board met 12 times during fiscal year 2016 and each director attended at least 75% of all meetings of the Board of Directors and each committee on
which he served. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Williams
was appointed to the Board of Directors in March 2016, and Messrs.&nbsp;Peng and Winssinger were elected to the Board of Directors in May 2016, at which time they
also joined their respective committees. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_board_leadership_structure"> </A>
<A NAME="toc_dc14905_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Leadership Structure    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our founder, Dr.&nbsp;Myron Wentz, is the Chairman of our Board of Directors and Kevin Guest is our CEO and reports directly to the Board.
Historically, we have utilized a corporate governance structure where the Chairman of the Board and the CEO have been separate offices held by separate individuals. Notwithstanding the foregoing, the
board has not adopted a specific policy on whether the same person should serve as both the CEO and chairman of the Board or, if the roles are separate, whether the chairman should be selected from
the non-employee directors or should be an employee. The Board believes it is most appropriate to retain the discretion and flexibility to make these determinations at any given point in time in the
way that it believes best to provide appropriate leadership for the Company at that time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe it is currently appropriate to separate the roles of CEO and Chairman of the Board as a result of the demands of and differences between each role. Our CEO is responsible for
setting the strategic direction for the Company, with guidance from the Board. The CEO is also responsible for the day-to-day leadership and performance of the Company, while the Chairman of the Board
provides guidance to the CEO and sets the agenda for Board meetings and presides over meetings of the full Board. Although Dr.&nbsp;Wentz is not independent under the rules of the NYSE, the Board
believes the experience, leadership and vision he provides as Chairman of the Board is essential to the short-and-long-term success of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board maintains a number of governance practices to ensure effective independent oversight of Board decisions, including (i)&nbsp;the appointment of strong, independent directors
who constitute a majority of the Board and intimately understand the Company's business and industry; (ii)&nbsp;executive sessions of the independent directors in connection with every Board
meeting; and (iii)&nbsp;annual evaluations of the performance of the Board, carried out by the independent directors. Because the Board also believes that strong, independent board leadership is an
important aspect of corporate governance, the Board has historically utilized a Lead Director. The Lead Director is an independent director elected for a one year term by the independent directors.
The Lead Director chairs the Board meetings during all executive sessions and when the Chairman is unable to participate in Board meetings, and is a contact person for shareholders and third parties
who may desire to contact the Board independently of the Chairman. With the transition of Board members in 2016, the Board did not expressly appoint a Lead Director in 2016, but Mr.&nbsp;Fuller
fulfilled the role of Lead Director during executive sessions and at other necessary times. For 2017, Mr.&nbsp;Fuller was appointed Lead Director and will serve in this capacity until the Board's
initial meeting in 2018, after which the independent directors will again elect a Lead Director. Additional responsibilities of the Lead Director include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Setting the agenda for and leading regularly-held independent director sessions and briefing the Chairman on those sessions; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Coordinating the activities of the independent directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Presiding at meetings of the Board at which the Chairman is not present, including executive sessions of the independent directors; </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=12,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=784010,FOLIO='7',FILE='DISK135:[17ZAA5.17ZAA14905]DC14905A.;10',USER='C902278',CD='21-MAR-2017;14:33' -->
<A NAME="page_dc14905_1_8"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Acting as a liaison of the independent directors to the Chairman and CEO for the views and any concerns and issues of the independent
directors; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Performing other duties that the Board may from time to time delegate to assist the Board in the fulfillment of its responsibilities. </FONT></DD></DL>
</UL>
<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_director_independence"> </A>
<A NAME="toc_dc14905_3"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Independence    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NYSE listing standards relating to corporate governance matters (the NYSE Standards) generally require listed companies to have a board of
directors with a majority of independent directors. The Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley Act) and rules of the SEC require that the Audit Committee be comprised solely of independent
directors. The NYSE Standards
further require that our Compensation Committee and Governance, Risk and Nominating Committee also be comprised solely of independent directors. Our Board of Directors has affirmatively determined
that Gilbert A. Fuller, Feng Peng, D. Richard Williams and Frederic Winssinger had no material relationship with the Company other than their relationship as members of our Board of Directors and were
independent within the meaning of the Sarbanes-Oxley Act and the NYSE Standards. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
assist the Board in making its determination regarding director independence, the Board has adopted independence standards that conform to the independence requirements of the NYSE
Standards. In addition to evaluating each director's independence, the Board considers all relevant facts and circumstances in making its independence determination. We assess director independence on
an annual basis. In making these determinations, our Governance, Risk and Nominating Committee, with assistance from our Executive Vice President of Legal, evaluate responses to an independence and
qualification questionnaire completed annually by each director and follow-up inquiries made to certain directors. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_executive_sessions_of_non-management_directors"> </A>
<A NAME="toc_dc14905_4"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Sessions of Non-Management Directors    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with the NYSE Standards, our Board of Directors typically holds an executive session of non-management, independent directors as a
part of every regularly scheduled meeting of our Board of Directors. These executive sessions are chaired by the Lead Director. In the event that the Lead Director cannot preside at an executive
session, the session will be chaired by the chairs of the Audit, Compensation and Governance, Risk and Nominating Committees of our Board of Directors on a rotating basis. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_communications_with_directors"> </A>
<A NAME="toc_dc14905_5"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Communications with Directors    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our shareholders or other interested parties wishing to communicate with the Board of Directors, the non-management directors as a group, or any
individual director may do so in writing by addressing the correspondence to that individual or group, c/o James H. Bramble, General Counsel and Corporate Secretary, USANA Health
Sciences,&nbsp;Inc., 3838 West Parkway Boulevard, Salt Lake City, Utah 84120. All such communications will be initially received and processed by our Corporate Secretary. Accounting, audit, internal
accounting controls and other financial matters will be referred to our Audit Committee chair. Other matters will be referred to the Board of Directors, the non-management directors, or individual
directors as appropriate. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Directors
are encouraged by the Company to attend the Annual Meeting of Shareholders if their schedules permit. All directors who served in 2016 were present at the Company's Annual
Meeting of the Shareholders that was held in May 2016. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=13,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=153286,FOLIO='8',FILE='DISK135:[17ZAA5.17ZAA14905]DC14905A.;10',USER='C902278',CD='21-MAR-2017;14:33' -->
<A NAME="page_dc14905_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_committees_of_the_board_of_directors"> </A>
<A NAME="toc_dc14905_6"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Committees of the Board of Directors    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has three standing committees: the Governance, Risk and Nominating Committee, the Audit Committee, and the Compensation
Committee. Information about the composition and responsibilities of each committee is provided below. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT><FONT SIZE=2>G</FONT><FONT SIZE=2><I>overnance, Risk and Nominating Committee.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Governance, Risk and Nominating Committee
of the Board
of Directors (the "Governance Committee") was established in February 2004. The Governance Committee met eight times during 2016. Gilbert A. Fuller is the Chair and the other members are D. Richard
Williams, Feng Peng, and Frederic Winssinger. Each member of the Governance Committee meets the definition of "independent" set forth in the NYSE Standards. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance Committee's responsibilities include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Overseeing corporate governance matters, including, without limitation: (i)&nbsp;developing and recommending to the Board a set of corporate
governance guidelines applicable to the Company; and (ii)&nbsp;ensuring that the Company maintains effective corporate governance policies and procedures; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Overseeing the Company's risk management programs and processes for governance and ethics matters; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Overseeing the evaluation of the Board and management; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Identifying and evaluating individuals qualified to become members of the Board, consistent with criteria approved by the Board; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Selecting and nominating director nominees for election to the Board of Directors. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board has delegated much of its responsibility for risk oversight and management to the Governance Committee. The Governance Committee conducts these risk oversight and management
functions as part of its corporate governance oversight and reports its findings with respect to risk oversight and management to the entire Board. More information about the Board of Directors and
Governance Committee's risk oversight and management practices is provided below under the caption "Risk Oversight and Management". </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance Committee believes, among other things, that the Company's Board of Directors should be composed of directors with varied, complementary backgrounds, which reflect a
diversity of viewpoints, backgrounds, experience and other factors. The Governance Committee also believes that directors should, at a minimum, (i)&nbsp;have expertise that may be useful to the
Company, (ii)&nbsp;possess the highest personal and professional ethics, and (iii)&nbsp;be willing and able to devote the required amount of time to the Company's business. In light of these
beliefs, the Governance Committee considers many factors in evaluating the suitability of candidates for Board membership, and also determining whether a director should be retained and stand for
re-election, including: whether the candidate meets the requirements for independence; the candidate's background and experience, particularly in the Company's industry; the candidate's personal
qualities, accomplishments, character and reputation in the business community; and the fit of the candidate's individual skills and personality with those of the Company's other directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance Committee may from time to time consider qualified nominees who are recommended by shareholders. The Governance Committee does not have different standards for evaluating
nominees based on whether they have been suggested by our shareholders or by our directors. Shareholders who
wish to make such a recommendation may do so by sending a written notice, as described under the heading "How do I submit a shareholder proposal for next year's annual meeting?" in the section of this
Proxy Statement titled "Important Information About the Meeting." </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=14,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=211525,FOLIO='9',FILE='DISK135:[17ZAA5.17ZAA14905]DC14905A.;10',USER='C902278',CD='21-MAR-2017;14:33' -->
<A NAME="page_dc14905_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit Committee.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee has been established as required by Section&nbsp;3(a) of the Exchange Act and the rules of the
NYSE. Our Audit
Committee provides assistance to our Board of Directors in fulfilling its responsibilities related to accounting, auditing and public reporting practices of the Company, the quality and integrity of
our financial reports, and our internal controls over finance, accounting and financial reporting, legal compliance, risk management and ethics established by management and our Board of Directors.
The Audit Committee also oversees and approves certain related party transactions and other matters that may involve conflicts of interest. In fulfilling these functions, our Audit Committee reviews
and makes recommendations to our Board of Directors with respect to certain financial and accounting matters. Our Audit Committee also engages and sets compensation for our independent auditors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee met five times during 2016. Members of the Audit Committee at the date of this Proxy Statement are Gilbert A. Fuller, Chair, D. Richard Williams, Feng Peng, and
Frederic Winssinger, each of whom meets the independence standards set forth above. The Board has also determined that Mr.&nbsp;Williams, Mr.&nbsp;Fuller and Mr.&nbsp;Winssinger are "audit
committee financial experts," as defined by the applicable regulations promulgated by the SEC under the Exchange Act and that each member of the Audit Committee meets the NYSE composition
requirements, including the requirements regarding financial literacy. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation Committee.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Members of the Compensation Committee at the date of this Proxy Statement are D. Richard Williams, Chairman,
Feng Peng, and
Frederic Winssinger, each of whom meets the definition of "independent" set forth in the rules of the NYSE. In addition, all members of the Compensation Committee are outside directors as defined by
Rule&nbsp;162(m) of the Internal Revenue Code and are non-employee directors as defined by the applicable regulations promulgated by the SEC under the Exchange Act. The Compensation Committee met
five times during 2016. The Compensation Committee's responsibilities include: (i)&nbsp;reviewing and recommending to the Board of Directors the salaries, bonuses, and other forms of compensation
and benefit plans for management and (ii)&nbsp;administering our equity and long-term incentive compensation plans. The duties of the Compensation Committee as the administrator of those plans
include, but are not limited to, determining those persons who are eligible to receive awards, establishing terms of all awards, authorizing officers of the Company to execute grants of awards, and
interpreting the provisions of the equity compensation plans and grants that are made under those plans. The Compensation Committee
is also responsible for reviewing and approving the Compensation Discussion and Analysis included in this Proxy Statement. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_risk_oversight_and_management"> </A>
<A NAME="toc_dc14905_7"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Risk Oversight and Management    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board of Directors is actively involved in the oversight and management of the material risks that could affect the Company. Historically,
our Board of Directors has carried out its risk oversight and management responsibilities by both monitoring risk directly as a full board and, where appropriate, through Board committees. Effective
risk oversight is a priority of our Board of Directors. Both the full Board of Directors and its committees oversee the various risks we face. Management is responsible for the day-to-day management
of our risks and provides periodic reports to the Board of Directors and its committees relating to those risks and risk-mitigation efforts. All committees report on the risk categories they oversee
to the full Board of Directors on an as needed basis. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Board of Directors has delegated primary responsibility for overseeing our risk management process to the Audit Committee. The Audit Committee oversees our risk identification and
mitigation processes and specifically oversees management of our financial, legal and fraud policies, as well as our regulatory compliance risks. This includes regular evaluation of risks related to
the Company's financial statements, including internal controls over financial reporting, and risks relating to liquidity, capital structure and investments, including land acquisition and
development. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=15,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=480154,FOLIO='10',FILE='DISK135:[17ZAA5.17ZAA14905]DC14905A.;10',USER='C902278',CD='21-MAR-2017;14:33' -->
<A NAME="page_dc14905_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee, as well as the Board of Directors as a whole, reviews our long-term strategic plans, annual budget, capital commitments, cash needs and funding plans. As with other
risks, management is responsible for the day-to-day management of the risks relating to liquidity and investments, as well as land acquisition and development, while our Board of Directors takes an
oversight role with respect to those risks. Members of our management, including our Chief Financial Officer, Executive Vice President of Legal, and Director of Internal Audit, report to the Audit
Committee on a quarterly basis regarding the on-going risk management activities. The Audit Committee also oversees the internal audit function and our independent auditors, and meets separately on at
least a quarterly basis with the Chief Financial Officer, Director of Internal Audit and representatives of our independent registered public accounting firm and our in-house and outside legal counsel
as part of this oversight responsibility. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee oversees our risks related to compensation programs and philosophy. The Compensation Committee ensures that our compensation programs, including those
applicable to our executives, do not encourage excessive risk taking. The Compensation Committee works periodically with its independent compensation consultant to structure executive compensation
plans that are appropriately balanced and incentivize management to act in the best interest of our shareholders. The Compensation Committee is responsible for the oversight of risk relating to the
Company's compensation and benefits programs. To satisfy these oversight responsibilities, the Compensation Committee regularly meets with and receives reports from our Chief Executive Officer and
Chief Financial Officer to understand the financial, human resources and shareholder implications of compensation and benefits decisions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance, Risk and Nominating Committee reviews, monitors and assesses our risks relating to governance matters and also oversees our ethics program, including implementation of
our Code of Ethics, and compliance by directors and management with the corporate governance and ethics standards of the Company. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_compensation_risk_analysis"> </A>
<A NAME="toc_dc14905_8"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Risk Analysis    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Compensation Committee considers the risk to the Company associated with each component of our executive compensation program, namely base
salary, executive bonuses, and short-and-long term incentive compensation. In considering these risks, the Compensation Committee believes that the following factors, among others, reduce the
likelihood of excessive risk taking in connection with executive compensation at USANA:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our compensation components provide a balanced mix of (i)&nbsp;cash and equity compensation, (ii)&nbsp;short-term and long-term incentive
compensation, and (iii)&nbsp;financial and non-financial performance metrics; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our executives generally all participate in the same short-term incentive program with similar performance metrics; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Maximum pay-out levels for short-term incentive compensation are generally capped at 100% of an executive's base salary; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our equity awards generally vest over several years and are only valuable if the Company performs well financially and our stock price
increases over time; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We maintain strict internal controls over the determination and pay-out of each component of executive compensation; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We do not typically enter into employment or other management agreements with any of our executive officers that contain post-termination or
change-in-control payments; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> We generally do not provide significant perquisites or personal benefits to our executive officers. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=16,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=87521,FOLIO='11',FILE='DISK135:[17ZAA5.17ZAA14905]DC14905A.;10',USER='C902278',CD='21-MAR-2017;14:33' -->
<A NAME="page_dc14905_1_12"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the Compensation Committee's review of these factors and others, the Committee does not believe that the Company's executive compensation program creates risks that are
reasonably likely to have a material adverse effect on the Company. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_board_committee_charters"> </A>
<A NAME="toc_dc14905_9"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Board Committee Charters    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board of Directors has adopted charters for our Audit, Compensation and Governance, Risk and Nominating Committees designed to comply with
the NYSE Standards and applicable provisions of the Sarbanes-Oxley Act and the rules of the SEC. The current version of each of these charters has been posted and is available for public viewing on
our web site at </FONT><FONT SIZE=2><I>www.usanahealthsciences.com</I></FONT><FONT SIZE=2> under the "Corporate Governance" tab. The information contained on the website is not incorporated by
reference in, or considered part of, this Proxy Statement. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_corporate_governance_guidelines"> </A>
<A NAME="toc_dc14905_10"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Governance Guidelines    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has adopted Corporate Governance Guidelines that outline the Company's corporate governance policies and principles. The Company's
Corporate Governance Guidelines are available, free of charge, on the Company's website at </FONT><FONT SIZE=2><I>www.usanahealthsciences.com</I></FONT><FONT SIZE=2> under the "Corporate Governance"
tab. The information contained on the website is not incorporated by reference in, or considered part of, this Proxy Statement. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dc14905_code_of_ethics"> </A>
<A NAME="toc_dc14905_11"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Code of Ethics    <BR>  </B></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a code of ethics that applies to all of our directors, officers (including our Chief Executive Officer and Chief Financial
Officer), and employees. We require that all of our directors, officers and employees certify on an annual basis that they are in compliance with the code. A copy of the Code of Ethics for Directors
and Employees is available on our web site at </FONT><FONT SIZE=2><I>www.usanahealthsciences.com</I></FONT><FONT SIZE=2> under the "Corporate Governance" tab. In the event we make any amendment to,
or grant any waivers of, a provision of our Code of Ethics that applies to our principal executive officer, principal financial officer or principal accounting officer that requires disclosure under
applicable SEC rules, we intend to disclose such amendment or waiver and the reasons therefor on a Current Report on Form&nbsp;8-K or on its next periodic report filed under the Exchange Act. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc14905_compensation_committee__dc102478"> </A>
<A NAME="toc_dc14905_12"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee during fiscal 2016 was composed of D. Richard Williams, Chair, Feng Peng and Frederic Winssinger. All members of the
Compensation Committee are independent directors. None of the members of our Compensation Committee has ever been an officer or employee of the Company or any of our subsidiaries. None of the members
of our Compensation Committee had any relationship requiring disclosure under "Transactions with Related Persons." During fiscal year 2016, none of our executive officers served as a director or
member of the compensation committee (or other committee of the board of directors performing equivalent functions) of another entity that had an executive officer serving on our Board of Directors. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dc14905_section_16(a)_benefici__dc102025"> </A>
<A NAME="toc_dc14905_13"> </A>
<BR></FONT><FONT SIZE=2><B>  SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16(a) of the Exchange Act requires our officers, directors, and persons who beneficially own more than 10% of our common stock to
file reports of ownership and changes in ownership with the SEC. These parties are also required by the SEC to furnish us with copies of all Section&nbsp;16(a) forms that they file. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
solely upon a review of these forms that were furnished to us, and based on representations made by certain persons who were subject to this obligation that such filings were not
required to be made, the Company believes that all reports that are required to be filed by these individuals and persons under Section&nbsp;16(a) were filed on time in fiscal year 2016, except that
one filing on Form&nbsp;4 for Gilbert A. Fuller was filed late. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=17,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=312211,FOLIO='12',FILE='DISK135:[17ZAA5.17ZAA14905]DC14905A.;10',USER='C902278',CD='21-MAR-2017;14:33' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de14905_1_13"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de14905_executive_officers"> </A>
<A NAME="toc_de14905_1"> </A>
<BR></FONT><FONT SIZE=2><B>  EXECUTIVE OFFICERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The executive officers of USANA at December&nbsp;31, 2016, and as of the date of this Proxy Statement were: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="187pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="378pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Position </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Kevin G. Guest</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Executive Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Jim Brown</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>President and Chief Operating Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Paul A. Jones</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Financial Officer and Chief Leadership Development Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>James H. Bramble</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Legal Officer and Corporate Secretary</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Daniel A. Macuga</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Communications Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Robert Sinnott</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Scientific Officer</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Walter Noot</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Information Officer</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>David Mulham</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Chief Field Development Officer</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following information is provided to us by our executive officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Kevin G. Guest,</B></FONT><FONT SIZE=2> 54, Chief Executive Officer. Mr.&nbsp;Guest joined USANA on a part-time basis in April 2003, as Executive Director of
Media and Events. Following the Company's acquisition of FMG Productions, a media, video, and event productions company that was founded by Mr.&nbsp;Guest, he became a full-time employee of the
Company and was promoted to Vice President of Media and Events in February 2004. In January 2006, he was appointed as the Company's Executive Vice President of Marketing and served in that role until
July 2008, when he was appointed Chief Marketing Officer. Mr.&nbsp;Guest served in this role until May 2011, when he was appointed as President of North America. In October 2012, he was appointed as
President of the Americas, Europe and South Pacific. In August 2014, Mr.&nbsp;Guest was appointed President of the Company and served in this role until August 2015, when he was appointed Co-Chief
Executive Officer. He served in this role until November 2016 when he was appointed Chief Executive Officer. Prior to joining USANA full-time, from 1992 to February 2004, Mr.&nbsp;Guest served as
the Managing Partner of FMG Productions. Mr.&nbsp;Guest earned a B.A. in Communications from Brigham Young University. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Jim Brown</B></FONT><FONT SIZE=2>, 48, President and Chief Operating Officer. Mr.&nbsp;Brown joined USANA in 2006 as Vice President of Operations. In July 2011,
he was appointed Vice President of Global Operations and served in that role until July 2012, when he was appointed Chief Production Officer. He served in that role until November 2013 when he was
appointed Chief Operating Officer. He served in that role until November 2016 when he was appointed President and Chief Operating Officer. Prior to joining USANA, Mr.&nbsp;Brown was employed at
Sonoco as a plant manager where he was responsible for safety, quality, finance, production, and maintenance. Mr.&nbsp;Brown received a bachelor's degree with a double major in computer science and
math as well as an M.B.A. from Francis Marion University in Florence, South Carolina. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Paul A. Jones,</B></FONT><FONT SIZE=2> 53, Chief Financial Officer and Chief Leadership Development Officer. Mr.&nbsp;Jones joined USANA in 2005 as Vice
President of Human Resources and served in this role until June 2007, when he left to complete a three year service mission. Mr.&nbsp;Jones returned to USANA as Vice President of Human Resources in
July 2010 and served in this role until December 2012, when he was appointed Chief Financial Officer. In August 2015, Mr.&nbsp;Jones was also appointed Chief Leadership Development Officer. Prior to
joining USANA, Mr.&nbsp;Jones was employed as Vice President of Human Resources and later as Vice President of Operations for Associated Food Stores,&nbsp;Inc. Mr.&nbsp;Jones received a B.S. in
finance from Utah State University and a master of arts in organizational management from the University of Phoenix. Mr.&nbsp;Jones is also a Certified Management Accountant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>James H. Bramble</B></FONT><FONT SIZE=2>, 47, Chief Legal Officer and Corporate Secretary. Mr.&nbsp;Bramble joined USANA in March 1998 to manage the Compliance
and Legal Departments. In April 2006 he was appointed Vice President and General Counsel. In July 2008, Mr.&nbsp;Bramble was also appointed Corporate </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=18,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=792890,FOLIO='13',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_de14905_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Secretary,
and served in these roles until May 2011, when he was appointed Chief Legal Officer and Corporate Secretary. Prior to joining USANA, Mr.&nbsp;Bramble was employed with Novus Services.
Mr.&nbsp;Bramble received a B.S. in political science with a minor in Spanish from the University of Utah in Salt Lake City, Utah. He received his J.D. from the S.J. Quinney College of Law at the
University of Utah. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Daniel A. Macuga, Jr.</B></FONT><FONT SIZE=2>, 46, Chief Communications Officer. Mr.&nbsp;Macuga joined USANA in 2007 as Vice President of Network Development
and Public Relations. In July 2008, he was appointed as Vice President of Marketing, Public Relations and Social Media and served in that role until December 2011, when he was appointed Chief
Communications Officer. He served in that role until February 2014 when he was appointed Chief Communications Officer and Executive Vice President of Field Development for the Americas. He served in
that role until November 2016 when he was appointed Chief Communications Officer. Prior to joining USANA, Mr.&nbsp;Macuga was employed at the Chrysler Corporation, where he spent 15&nbsp;years
working closely with independent dealership entrepreneurs to help them build their businesses, increase awareness for their products, and keep them focused on effective customer relationship
management. Mr.&nbsp;Macuga received a B.A. in communications from the University of California, San Diego. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Robert A. Sinnott, M.N.S., Ph.D.</B></FONT><FONT SIZE=2>, 52, joined USANA as our Chief Scientific Officer in August 2016. From 2005 to 2016, he was Chief Science
officer of Mannatech,&nbsp;Inc. From 2009 to 2012 he also served as Co-CEO and from 2012 to 2016 as CEO of Mannatech. During his tenure at Mannatech, Dr.&nbsp;Sinnott has served to further the
company's proprietary science, research and development, and initiated independent clinical trials, was responsible for oversight of quality assurance/quality control, global regulatory affairs, legal
department, human resources, and global supply chain. Dr.&nbsp;Sinnott has held scientific and business positions in both industry and government over the past 25&nbsp;years with experience
in life sciences, chemistry, biotechnology and nutrition. For the past 18&nbsp;years, he has worked directly in the dietary supplement industry both in the United States and internationally. From
2006 to 2011, Dr.&nbsp;Sinnott held a seat on the Board of Directors of the Council of Responsible Nutrition's (the "CRN"), the leading trade association representing ingredient suppliers and
manufacturers of dietary supplements. From 2009 to 2011, Dr.&nbsp;Sinnott also served as chair of the Senior Scientific Advisory Committee (SSAC) for the CRN. The SSAC is comprised of the
highest-ranking scientific officers of member companies. Its role is to assist the CRN with development and implementation of scientific strategy relating to scientific publications, scientific
policies and programs by government agencies. Dr.&nbsp;Sinnott holds a B.S. degree in Biological Sciences, a Masters in Natural Science, and a Ph.D. in Plant Sciences from Arizona State University,
in Tempe, Arizona. His focus was on applied biological sciences, including biotechnology and plant medicinal chemistry. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Walter Noot,</B></FONT><FONT SIZE=2> 51, joined USANA as Chief Information Officer in December 2016. Mr.&nbsp;Noot has more than two decades of executive
leadership experience and has worked with a wide range of businesses in many industries, from start-ups to multibillion-dollar companies. From 2014 until 2016, he was an executive officer of Young
Living Essential Oils, LC, where he served as Chief Information Officer and Senior Vice President of Operations before joining USANA. While at Young Living he oversaw improvements to the supply chain,
implementation of a new ERP, and a software systems rebuild. Prior to joining Young Living, Mr.&nbsp;Noot was COO of MonaVie, another direct sales company from 2012 to 2014 and has held leadership
positions with Computer Associates, Canon (Oce), and Onyx Graphics. He holds a B.S. degree in mechanical engineering from Brigham Young University. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>David Mulham,</B></FONT><FONT SIZE=2> 57, Chief Field Development Officer. Mr.&nbsp;Mulham joined USANA in 2009 as Field Development, Marketing and Customer
Service Manager for Australia and New Zealand. In February 2011, he was appointed General Manager, for Australia and New Zealand and served in that role until June 2011, when he was appointed Vice
President, Pacific Region (Australia, New Zealand and Philippines). In February 2014 he was appointed Executive Vice President of Field Development, Pacific Region and then in May 2015 he was
appointed Executive Vice President, Pacific Region. He </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=19,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=897107,FOLIO='14',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_de14905_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>served
in that role until January 2016 when he was appointed Executive Vice President, Pacific and Europe and then in September 2016, he was appointed Executive Vice President, the Americas, Pacific
and Europe. He served in that role until February 2017, when he was appointed Chief Field Development Officer. Prior to joining USANA, Mr.&nbsp;Mulham had extensive experience in the Direct Selling
Industry having worked for Amway, Mary Kay, Nutri Metics and Dorling Kindersley Family Learning. He subsequently worked in property development as Director of both Hunter Valley Gardens and Tempus Two
Winery. Mr.&nbsp;Mulham has a post graduate diploma from Macquarie Graduate School of Management, Sydney, and received the Silver Stevie Award in 2015, for Executive of the Year&#151;Health
Products&nbsp;&amp; Services and Pharmaceuticals. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="de1"></A>PROPOSAL #1&#151;ELECTION OF DIRECTORS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Bylaws provide that the shareholders or the Board of Directors shall determine the number of directors from time to time, but that there
shall be no less than three directors. The Board of Directors, by resolution, has set the number of directors at seven. The Governance, Risk and Nominating Committee of the Board of Directors has
nominated seven persons for election to the Board of Directors. Six incumbent directors will stand for re-election: Myron W. Wentz, Ph.D., Gilbert&nbsp;A. Fuller, Robert Anciaux, D. Richard
Williams, Frederic Winssinger and Feng Peng. In addition, the Governance, Risk and Nominating Committee has nominated our Chief Executive Officer, Kevin Guest, to stand for election to the Board. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance, Risk and Nominating Committee believes that all directors must, at a minimum, meet the criteria set forth in the USANA Corporate Governance Guidelines and in the Charter
of the Governance, Risk and Nominating Committee, which specify, among other things, that the committee will consider criteria such as the director's independence, expertise and experience applicable
to our business, substantive knowledge of our industry, high personal and professional ethics and the ability and willingness to devote the required time to the business of the Company. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
director who is elected at the Annual Meeting will hold office until our annual meeting in 2018, until a successor is elected and qualified, or until the director resigns, is
removed, or becomes disqualified. The Board of Directors has no reason to believe that any of the nominees for director will be unwilling or unable to serve, if elected. If due to unforeseen
circumstances a nominee should become unavailable for election, the Board may either reduce the number of directors or may substitute another person for that nominee, in which event your shares will
be voted for that other person. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Governance, Risk and Nominating Committee has determined that each nominee meets the criteria and qualifications set forth in the Company's Code of Ethics for Directors and
Employees, Corporate Governance Guidelines and the Governance, Risk and Nominating Committee Charter. In addition, each nominee possesses the personal qualities and attributes we believe are essential
to allow the Board of Directors to fulfill its duties to the shareholders, including personal accountability, integrity, ethical leadership, risk management, business acumen, and the ability to
exercise sound and independent business judgment. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="de14905_director_nominees"> </A>
<A NAME="toc_de14905_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Director Nominees    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You will be asked to elect seven directors at the Annual Meeting. The nominees to the Board of Directors in 2017 are Robert Anciaux, Gilbert A.
Fuller, Kevin Guest, Feng Peng, Myron W. Wentz, Ph.D., D. Richard Williams, and Frederic Winssinger. Messrs.&nbsp;Fuller, Peng, Williams and Winssinger are independent directors under NYSE
Standards. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=20,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=6992,FOLIO='15',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_de14905_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following information was furnished to us by the nominees: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Robert Anciaux</B></FONT><FONT SIZE=2><B><I>,</I></B></FONT><FONT SIZE=2> 71, has served as a director of USANA since July 1996. Since 1990, he has been the Managing
Director of S.E.I. s.a., a consulting and investment management firm in Brussels, Belgium. Additionally, since 1982, Mr.&nbsp;Anciaux has been self-employed as a venture capitalist in Europe,
investing in various commercial, industrial, and real estate venture companies. In some of these privately held companies, Mr.&nbsp;Anciaux also serves as a director. Mr.&nbsp;Anciaux received an
Ingenieur Commercial degree from Ecole de Commerce Solvay Universite Libre de Bruxelles. We believe that Mr.&nbsp;Anciaux's financial expertise and experience in providing consulting and strategic
advisory services to complex organizations, and his extensive experience and familiarity with the business of the Company qualify him to serve on our Board. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Gilbert A. Fuller,</B></FONT><FONT SIZE=2> 76, has served as a director of USANA since September 2008. Prior to that, he served as our Executive Vice President,
Chief Financial Officer, and Secretary since January 2006. Mr.&nbsp;Fuller joined USANA in May 1996 as the Vice President of Finance and served in this role until June 1999, when he was appointed as
the Company's Senior Vice President. Before joining USANA, Mr.&nbsp;Fuller served in various executive positions for several companies. Mr.&nbsp;Fuller served as Chief Administrative Officer and
Treasurer of Melaleuca,&nbsp;Inc., a manufacturer and direct seller of personal care products. He was also the Vice President and Treasurer of Norton Company, a multinational manufacturer of
ceramics and abrasives. He obtained his certified public accountant license in 1970 and kept it current until his career path developed into corporate finance. Mr.&nbsp;Fuller received a B.S. in
Accounting and an M.B.A. from the University of Utah. In December 2012, Mr.&nbsp;Fuller was appointed as a director of Security National Financial Corporation, a NASDAQ-listed company. We believe
that Mr.&nbsp;Fuller's more than 12&nbsp;years of experience as an executive officer of USANA, his deep understanding of our business, people and products, his 15&nbsp;years of experience as a
financial officer in the direct selling industry, as well as his accounting, finance and corporate strategy expertise qualify Mr.&nbsp;Fuller to serve on our Board of Directors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Kevin Guest.</B></FONT><FONT SIZE=2> Mr.&nbsp;Guest is our Chief Executive Officer. Biographical information for Mr.&nbsp;Guest is set out above on
page&nbsp;11 under "Executive Officers". Mr.&nbsp;Guest's important role as the leading force of our management and sales efforts and his talent as a motivating leader qualify him to serve as a
member of the Board. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Feng Peng,</B></FONT><FONT SIZE=2> 43, was elected to the Board in May 2016. From March 2013 to December 2016, Mr.&nbsp;Peng served as Chief Financial Officer
of Ossen Innovation&nbsp;Co.,&nbsp;Ltd., a China-based manufacturing company listed on the NASDAQ exchange. Prior to that, Mr.&nbsp;Peng served as Senior Vice President at MZ Group from August
2007 until September 2012 where he was responsible for providing strategic consulting services related to U.S. capital markets to Chinese clients. At MZ Group, Mr.&nbsp;Peng conducted extensive
financial and industry due diligence, performed analysis on companies' financials, and provided management teams of client companies with extensive coaching, including detailed intelligence on
investor expectations, perceptions and concerns, industry analysis, compliance, and reporting and disclosure requirements. Prior to working at MZ Group, he served in various capacities at Thomson
Financial and Citigroup. Mr.&nbsp;Peng has been trained in both finance and accounting. He received a Master of Science in Computer Science from the New Jersey Institute of Technology. He also
received a bachelor's degree in Automation Control from Shanghai Jiao Tong University in Shanghai, China in 1995. Mr.&nbsp;Peng is a certified Senior International Finance Manager (SIFM) in China.
Mr.&nbsp;Peng's qualifications to sit on our Board include his extensive business experience in China, as well as his financial and corporate strategy experience. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Myron W. Wentz, Ph.D.,</B></FONT><FONT SIZE=2> 76, founded USANA in 1992 and served as the Chief Executive Officer and Chairman of the Board from 1992 to July
2008, when he retired as Chief Executive Officer. Dr.&nbsp;Wentz continues to serve as Chairman of the Board. In 1974, Dr.&nbsp;Wentz founded Gull Laboratories,&nbsp;Inc., which was a developer
and manufacturer of medical diagnostic test kits and was the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=21,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=562541,FOLIO='16',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_de14905_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>former
parent corporation of USANA. Dr.&nbsp;Wentz was Chairman of Gull from 1974 until 1998. In 1998, Dr.&nbsp;Wentz founded Sanoviv,&nbsp;S.A. de C.V. ("Sanoviv"), a holistic integrative
medical center and hospital located near Rosarito, Mexico. Joining a pathology group in Peoria, Illinois, from 1969 to 1973, Dr.&nbsp;Wentz served as infectious disease specialist and directed the
microbiology and immunology laboratories for three hospitals in the Peoria area. He received a B.S. in Biology from North Central College, Naperville, Illinois, an M.S. in Microbiology from the
University of North Dakota, and a Ph.D. in Microbiology and Immunology from the University of Utah. Dr.&nbsp;Wentz is our largest shareholder and as our founder and the visionary force behind the
science and mission of USANA, his vast education and professional experience as a microbiologist, immunologist, and pioneer in the development of human cell culture technology, as well as his service
as our Chairman and former Chief Executive Officer, uniquely qualify him to serve as a member of our Board and as our Chairman. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>D. Richard Williams,</B></FONT><FONT SIZE=2> 60, was appointed a director in March 2016. Mr.&nbsp;Williams has served as non-executive Chairman of
Primerica,&nbsp;Inc. since April 2015 and as Chairman from October 2009 through March 2015. Prior to that, he served as Co-Chief Executive Officer from 1999 through March 2015. Mr.&nbsp;Williams
worked for Primerica beginning in 1989 and served in various capacities, including as the Chief Financial Officer and Chief Operating Officer of the Primerica operating unit of Citigroup.
Mr.&nbsp;Williams serves on the Board of Directors of Crawford&nbsp;&amp; Company. Additionally, he serves on the Board of Trustees of the Woodruff Arts Center, the Anti-Defamation League Southeast
Region, the Atlanta Area Council of the Boy Scouts of America, and the Carter Center Board of Councilors. Mr.&nbsp;Williams received his B.S. degree and M.B.A. from the Wharton School of the
University of Pennsylvania. Mr.&nbsp;William's qualifications to sit on our Board include his extensive expertise in senior management, finance, M&amp;A, strategic planning, and risk and asset
management. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>Frederic J. Winssinger,</B></FONT><FONT SIZE=2> 48, became a director in May 2016. Mr.&nbsp;Winssinger has been a Managing Partner of RW Partners&nbsp;LLC
(RWP) since 2006. RWP is a commercial real estate private equity investment company based in Phoenix, Arizona. Mr.&nbsp;Winssinger also oversees his family's general investment operations and in
2014, he co-founded PlanninCore Wealth Advisors to provide investment advice to individuals and families. Prior to 2006, Mr.&nbsp;Winssinger worked in strategy consulting for the Boston Consulting
Group and as a Portfolio Manager/Financial Analyst for JP Morgan Asset Management and other privately held asset management companies. Mr.&nbsp;Winssinger received a B.A. in Mathematics and
Economics from Claremont McKenna College and an M.B.A from The Wharton School of the University of Pennsylvania. Mr.&nbsp;Winssinger's qualifications to sit on our Board include his 20&nbsp;years
of experience in financial analysis, and his training in evaluating corporate strategy towards the creation of shareholder value under sound corporate governance. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="de14905_recommendation"> </A>
<A NAME="toc_de14905_3"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RECOMMENDATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE "FOR" EACH DIRECTOR NOMINEE.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=22,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=385944,FOLIO='17',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_de14905_1_18"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de14905_compensation_of_directors"> </A>
<A NAME="toc_de14905_4"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION OF DIRECTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The table below summarizes the compensation paid by us to our directors for the fiscal year ended December&nbsp;31, 2016. Note that shares and
per-share amounts reflect a 2-for-1 split of the Company's common shares, which became effective November&nbsp;22, 2016. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fees Earned<BR>
or Paid<BR>
in Cash<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Myron W. Wentz, Ph.D.(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Robert Anciaux</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>100,950</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>249,740</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>350,690</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jerry G. McClain(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,650</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>238,033</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>264,683</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Ronald S. Poelman(5)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>28,250</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>238,033</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>266,283</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gilbert A. Fuller(6)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>111,150</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>249,740</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>360,890</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>D. Richard Williams(7)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>99,150</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,180</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>204,330</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Feng Peng(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68,550</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,180</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>173,730</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Frederic Winssinger(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>68,550</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,180</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>173,730</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David A. Wentz(9)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>During
fiscal year 2016, each non-insider (non-management) director was paid a cash retainer of $22,200 for the first quarter of 2016 and then $22,850 per quarter
thereafter, with the Chair of the Audit Committee paid an additional $4,550 per quarter, the Chair of the Compensation Committee paid an additional $2,800 per quarter, and the Chair of the Governance,
Risk and Nominating Committee paid an additional $1,700 per quarter. In addition, in February 2016, the Board created the position of Senior Director, designating Mr.&nbsp;Anciaux as such, and the
Compensation Committee authorized payment of an additional $3,400 per quarter cash compensation for this position. No director compensation is paid to Company executives for their service on the
Board. The Company reimburses all directors for the out-of-pocket expenses that they incur in connection with their services as directors, which include travel, lodging, and related expenses from
attending conferences to continue their education and expertise as directors, as well as participating in meetings of the shareholders, Board of Directors, and committees of the Board.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>In
February 2016, the Compensation Committee of the Board of Directors (Messrs.&nbsp;Poelman, Anciaux and McClain) approved the grant of DSUs to Robert Anciaux,
Gil Fuller, Jerry McClain, and Ronald Poelman on the following terms in accordance with the form of deferred stock units ("DSUs") grant agreement generally used by the Company: (i)&nbsp;4,000 DSUs
to each such director; (ii)&nbsp;date of grant of February&nbsp;8, 2016; (iii)&nbsp;vesting in eight equal quarterly installments of 500&nbsp;DSUs each, commencing on the last day of the
Company's first fiscal quarter of 2016; and (iv)&nbsp;all vested DSUs to be exchanged for shares of the Company's stock upon the termination of service of the directors. In May 2016, the
Compensation Committee (Messrs.&nbsp;Williams, Peng and Winssinger) approved the grant of </FONT><FONT SIZE=2><I>DSUs</I></FONT><FONT SIZE=2> to each of directors Williams, Peng and Winssinger, on
the following terms: (i)&nbsp;1,780 DSUs to each such director; (ii)&nbsp;date of grant of May&nbsp;2, 2016; (iii)&nbsp;vesting in four equal quarterly installments, commencing on the last day
of the Company's second fiscal quarter of 2016; and (iv)&nbsp;all vested DSUs to be exchanged for shares of the Company's stock upon the termination of service of the director, or, at the election
of the director, upon vesting. In addition, in May 2016, the Compensation Committee approved the acceleration of the vesting of the DSUs granted in February 2016 to Messrs.&nbsp;Poelman and McClain
to vest in full as of May&nbsp;2, 2016 upon their separation from the Board of Directors.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dr.&nbsp;Wentz
is our founder. He was not paid any fee for service as a member of our Board of Directors in 2016. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=23,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=98279,FOLIO='18',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<A NAME="page_de14905_1_19"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;McClain
served until May 2016. During his service on the Board, Mr.&nbsp;McClain was Chair of the Audit Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Poelman
served until May 2016. During his service on the Board, Mr.&nbsp;Poelman was designated as the Lead Director.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Fuller
currently serves as Chair of the Audit Committee and as Chair of the Governance, Risk and Nominating Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Williams
was appointed to the Board March&nbsp;1, 2016. Mr.&nbsp;Williams currently serves as the Chair of the Compensation Committee.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Messrs.&nbsp;Peng
and Winssinger were elected to the Board in May 2016.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Wentz
resigned from the Board and as Co-Chief Executive Officer of the Company in November 2016. As an employee and executive officer of the Company, he
was not paid any additional compensation for service as a member of the Board of Directors.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
determining director compensation in 2016, the Compensation Committee considered recommendations of the Company's CFO and a number of other factors, including director compensation
data available regarding members of the Company's industry peer group, as well as the 2015-2016 Director Compensation Report published by the National Association of Corporate Directors and other
resources. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="PRO2"></A>PROPOSAL #2&#151;RATIFICATION OF SELECTION OF INDEPENDENT<BR>
REGISTERED PUBLIC ACCOUNTING FIRM  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee of the Board of Directors has selected KPMG&nbsp;LLP ("KPMG") as the independent registered public accounting firm to
audit the financial statements of the Company and its subsidiaries for the fiscal year ending December&nbsp;30, 2017 and internal control over financial reporting at December&nbsp;30, 2017. KPMG
has served as our independent registered public accounting firm since September&nbsp;16, 2013 and audited our financial statements for the fiscal year ended December&nbsp;31, 2016 and internal
control over financial reporting at December&nbsp;31, 2016. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder
ratification of the appointment of the independent registered public accounting firm is not required. We are asking shareholders to ratify the appointment because we believe
it is a sound corporate governance practice. If our shareholders do not ratify the selection, the Audit Committee will consider whether or not to retain KPMG but may still retain them. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
ratification of the appointment of the independent registered public accounting firm requires the affirmative vote of a majority of the votes cast at the Annual Meeting.
Representatives of KPMG will be present at the annual meeting, will have an opportunity to make a statement if they desire to do so and will be available to respond to appropriate questions from
shareholders. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="de14905_recommendation_1"> </A>
<A NAME="toc_de14905_5"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RECOMMENDATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE "FOR" RATIFICATION OF THE APPOINTMENT OF KPMG&nbsp;LLP, AS THE
COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2017.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=24,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=594227,FOLIO='19',FILE='DISK135:[17ZAA5.17ZAA14905]DE14905A.;11',USER='CHE108066',CD='20-MAR-2017;22:50' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg14905_1_20"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dg14905_report_of_the_audit_committee"> </A>
<A NAME="toc_dg14905_1"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE AUDIT COMMITTEE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee oversees and monitors the Company's financial reporting process on behalf of the Board of Directors. Management has the
primary responsibility for the financial statements and the reporting process, including the Company's system of internal control over financial reporting. In fulfilling its oversight
responsibilities, the Committee reviewed and discussed with management the audited financial statements to be included in the Company's Annual Report on Form&nbsp;10-K for the year ended
December&nbsp;31, 2016, including a discussion of the quality and the acceptability of the Company's financial reporting practices and the internal control over financial reporting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee reviewed with KPMG&nbsp;LLP, the independent registered public accounting firm which is responsible for expressing opinions on the conformity of those audited financial
statements with accounting principles generally accepted in the United States of America and on the Company's internal control over financial reporting, its judgments as to the quality and the
acceptability of the
Company's financial reporting and such other matters as are required to be discussed with the Committee under the standards of the Public Company Accounting Oversight Board (United States). In
addition, the Committee discussed with KPMG&nbsp;LLP its independence from management and the Company, including the impact of any non-audit-related services provided to the Company, the matters in
that firm's written disclosures and the letter from KPMG&nbsp;LLP to the Committee pursuant to the applicable requirements of the Public Company Accounting Oversight Board (PCAOB) regarding the
independent registered public accounting firm's communications with the Audit Committee concerning independence. The Committee also discussed with the independent registered public accounting firm the
matters required to be discussed by the statement on Auditing Standards No.&nbsp;1301, as adopted by the PCAOB (which replaced PCAOB Auditing Standard No.&nbsp;61). </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Further,
the Committee discussed with the Company's internal audit executive and KPMG&nbsp;LLP the overall scope and plans for their respective audits. The Committee meets periodically
with the internal audit executive and representatives of the independent registered public accounting firm, with and without management present, to discuss the results of the examinations, their
evaluations of the Company's internal controls (including internal control over financial reporting), and the overall quality of the Company's financial reporting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
reliance on the reviews and discussions referred to above, the Committee recommended to the Board of Directors that the audited financial statements be included in the Company's
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2016 filed with the Securities and Exchange Commission. The Committee also evaluated and reappointed KPMG&nbsp;LLP as
the Company's independent registered public accounting firm for fiscal 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Respectfully
submitted by the members of the Audit Committee: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Gilbert A. Fuller (Chair)<BR>
D. Richard Williams<BR>
Feng Peng<BR>
Frederic Winssinger<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_policy_on_pre-approval_of_audi__pol02605"> </A>
<A NAME="toc_dg14905_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policy on Pre-Approval of Audit and Permissible Non-Audit Services    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee pre-approves any engagement of KPMG and has the ultimate authority and responsibility to select, evaluate and where
appropriate, replace the independent registered public accounting firm and nominate an independent registered public accounting firm for shareholder approval. While ratification of the selection of
accountants by the shareholders is not required and is not binding upon the Audit Committee or the Company, in the event of a negative vote on such ratification, the Audit Committee might choose to
reconsider its selection. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=25,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=200350,FOLIO='20',FILE='DISK135:[17ZAA5.17ZAA14905]DG14905A.;8',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dg14905_1_21"> </A>


<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the performance of any services, the Audit Committee approves all audit and non-audit services to be provided by the Company's independent registered public accounting firm and
the fees to be paid therefor. Although the Sarbanes-Oxley Act permits the Audit Committee to pre-approve some types or categories of services to be provided by the independent registered public
accounting firm, it is the current practice of the Audit Committee to specifically approve all services provided by the independent registered public accounting firm in advance, rather than to
pre-approve any type of service. In connection with this practice, the Audit Committee has considered whether the provision of non-audit services is compatible with maintaining KPMG's independence. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_independence"> </A>
<A NAME="toc_dg14905_3"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Independence    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KPMG has advised us that it has no direct or indirect financial interest in the Company or in any of its subsidiaries and that during 2016 it
had no connection with the Company or any of its subsidiaries, other than as its independent registered public accounting firm or in connection with certain other services, as described below. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_services"> </A>
<A NAME="toc_dg14905_4"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Services    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During fiscal year 2016, KPMG performed services consisting of the audit of the annual consolidated financial statements of the Company, and the
effectiveness of our internal control over financial reporting, review of the quarterly financial statements for the quarters ended April&nbsp;2, 2016, July&nbsp;2, 2016 and October&nbsp;1,
2016, stand-alone audits of subsidiaries, and accounting consultations, consents, other services related to SEC filings by the Company and its subsidiaries, tax compliance services and transfer
pricing services. KPMG did not perform any financial information systems design and implementation services for the Company for fiscal year 2016. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
fiscal year 2015, KPMG performed services consisting of the audit of the annual consolidated financial statements of the Company, and the effectiveness of our internal control
over financial reporting, review of the quarterly financial statements for the quarters ended April&nbsp;4, 2015, July&nbsp;4, 2015 and October&nbsp;3, 2015, stand-alone audits of subsidiaries,
and accounting consultations, consents, other services related to SEC filings by the Company and its subsidiaries, tax compliance services and transfer pricing services. KPMG did not perform any
financial information systems design and implementation services for the Company for fiscal year 2015. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table summarizes the fees paid by us to KPMG during fiscal years 2015 and 2016. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="77pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Type of Service and Fee

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fiscal Year 2015 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fiscal Year 2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,634,529</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,958,641</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Related Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>57,050</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>64,650</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All Other Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,691,579</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,023,291</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dg14905_executive_compensation"> </A>
<A NAME="toc_dg14905_5"> </A>
<BR></FONT><FONT SIZE=2><B>  EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_compensation_discussion_and_analysis"> </A>
<A NAME="toc_dg14905_6"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Discussion and Analysis    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_introduction"> </A>
<A NAME="toc_dg14905_7"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Introduction    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following Compensation Discussion and Analysis describes the material elements of the compensation and benefit programs for our Chief
Executive Officer, Chief Financial Officer, and the three other most highly-compensated executive officers as of the end of fiscal year 2016. In this Proxy Statement, we refer to these officers as our
"Named Executive Officers." Our Named Executive </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=26,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=197663,FOLIO='21',FILE='DISK135:[17ZAA5.17ZAA14905]DG14905A.;8',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dg14905_1_22"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Officers
are also included in the group referred to by the terms "Executive" and "Executives" in the Compensation Discussion and Analysis. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_executive_summary_and_overview"> </A>
<A NAME="toc_dg14905_8"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Summary and Overview    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Summary of 2016 Accomplishments.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In fiscal year 2016, we surpassed the $1&nbsp;billion mark in net sales for the first time in our
history,
generating our 14th&nbsp;consecutive year of record sales. We also reported the highest earnings per share in the history of the Company and finished the year with a record number of active
Associates and Preferred Customers. Customer growth remains our highest priority as we strive to improve the health and nutrition of individuals and families around the world. In November 2016, we
effected a two-for-one forward split of our common stock. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
results for the year were driven by execution of our 2016 strategies, which included (i)&nbsp;advancing our personalization strategy through new product launches and offerings;
(ii)&nbsp;continuing to invest in China, largely by completing and shifting production to our new manufacturing facility; and (iii)&nbsp;investing in information technology systems and
infrastructure to support our growing customer base that further enhances the experience of doing business with USANA around the world. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
introduction and launch of InCelligence&#153; was perhaps our most significant accomplishment in 2016. InCelligence&#153; is our proprietary, patent-pending, technology
that is designed to support the body's natural ability to nourish, protect and renew its cells. The science behind InCelligence&#153; reflects a significant shift in nutritional supplementation
and Dr.&nbsp;Wentz, with our team of exceptional scientists, has positioned USANA as a leader in this technology. We also introduced our new core product, CellSentials&#153; (which fully
incorporates the InCelligence&#153; technology), at our 2016 international convention in August. This product, and others, were received by our customers with tremendous excitement. The
InCelligence&#153; platform represents the future of our various product lines and is intended to keep USANA at the forefront of nutritional supplementation. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During
the year we also continued to make investments to improve our infrastructure in China. Our most significant accomplishment was the successful completion of, and transition to, our
new China production facility in the fourth quarter. This accomplishment was the result of a significant undertaking by our U.S. and China operations/regulatory teams, and extensive cooperation with
the Chinese government. Adding 350,000 square feet of production capacity to our manufacturing operations, this facility is now fully operational and will provide the production capacity we need in
China for the foreseeable future. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Overview of Compensation Program.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We believe that our Executives and employees, as well as the compensation programs that incent them,
are key
factors in driving our strong financial and operational performance. Our executive compensation program is designed to provide a competitive and internally equitable compensation and benefits package.
We also strive to ensure that our executive compensation program reflects a pay-for-performance philosophy and promotes Executive motivation and retention. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
executive compensation program includes base salary, short-term incentive compensation (in the form of a cash bonus), and long-term incentive compensation (in the form of equity
awards). Short-term incentive compensation is performance-based and designed to motivate our Executives to achieve annual financial and non-financial performance objectives. To minimize potential
risk, the potential for short-term incentive compensation has historically been capped at 100% of an Executive's base salary. Long-term incentive compensation utilizes equity awards, which vest over
several years. These awards reward the Executive for sustainable Company performance and align the financial interests of our Executives with those of our shareholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other
than as described above, we typically do not provide benefits to our Executives that are different from, or in addition to, those that are provided to our general employees.
Additionally, we typically do not enter into pre-arranged severance agreements or contracts with our Executives that </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=27,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=704406,FOLIO='22',FILE='DISK135:[17ZAA5.17ZAA14905]DG14905A.;8',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dg14905_1_23"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>contain
post-termination or change-in-control payment provisions, or provide significant perquisites or personal benefits to our Executives. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_compensation_philosophy_and_objectives"> </A>
<A NAME="toc_dg14905_9"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Philosophy and Objectives    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our compensation philosophy, as approved by the Compensation Committee, is to establish and maintain executive compensation programs that are
designed to accomplish the following objectives:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To attract and retain, through a fair and competitive compensation plan, Executives who have the intelligence, education, and experience that
is required to effectively administer the affairs of the Company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To motivate our Executives to achieve certain financial and non-financial performance objectives for the benefit of our shareholders by tying
components of their total compensation to individual and Company performance; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To ensure that compensation practices do not impair our financial strength or future success. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee acts to meet these objectives by utilizing and maintaining a balance among three major components of compensation: base salary, short-term incentive
compensation (cash bonus), and long-term incentive compensation (in the form of equity awards). The Committee believes that these three components provide an appropriate framework to attract, retain
and motivate our Executives, and align a significant portion of executive compensation with short-and long-term performance objectives that drive shareholder value. As shown in the compensation tables
following
this Proxy Statement, our Executives do not currently receive retirement benefits, pre-determined severance arrangements, deferred compensation opportunities, or other perquisites that are commonly
provided to executives of similarly sized companies. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_role_of_compensation_committee"> </A>
<A NAME="toc_dg14905_10"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of Compensation Committee    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our executive compensation philosophy and practice has been developed through a collaborative effort of the Compensation Committee, the CEO, and
the CFO. During most of fiscal year 2016, we were led by Co-CEO's. Since November 2016, we have a single CEO. The Committee seeks input in meetings of the Compensation Committee from the CEO (or,
historically, the Co-CEO's), including their ideas, opinions, and proposals regarding executive compensation; however, the Compensation Committee functions and votes independently and is responsible
for all changes to the executive compensation philosophy and program. The Compensation Committee consists of three members of our Board of Directors, all of whom are "independent" under the rules of
the NYSE. These members are appointed to the Compensation Committee by the Board of Directors. The Compensation Committee acts under a written charter, which outlines the committee's authority and
responsibilities. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_role_of_corporate_leadership_i__rol02643"> </A>
<A NAME="toc_dg14905_11"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Role of Corporate Leadership in Assisting Compensation Committee    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has the primary authority to determine the Company's compensation philosophy and to establish compensation for our
Named Executive Officers. It is responsible for ensuring that executive compensation decisions are thoroughly researched and implemented. All of our Executives and employees participate in an annual
performance review with their immediate supervisor, during which the Executive or employee receives input about his or her performance and contributions to the Company's results for the period being
assessed. The Compensation Committee seeks input from the CEO and CFO to identify key factors and to obtain information that is related to executive compensation. These key factors and information
generally involve the individual Executive's level of responsibility, his or her years of experience, his or her current overall compensation level in relation to external market studies and internal
equity analysis </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=28,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=182357,FOLIO='23',FILE='DISK135:[17ZAA5.17ZAA14905]DG14905A.;8',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dg14905_1_24"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>between
executives, the impact of current compensation practices on our financial statements and condition, and the relationship between executive compensation and performance of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
CFO takes direction from and makes suggestions to the Chairman of the Compensation Committee in establishing the quarterly committee meeting agenda and preparing the materials to be
presented to the Compensation Committee. These materials contain minutes from prior meetings, key items to be addressed, and background information to help the Compensation Committee in its
decision-making process. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_compensation_consultant"> </A>
<A NAME="toc_dg14905_12"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Consultant    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In late 2014, the Compensation Committee retained Frederic W. Cook&nbsp;&amp;&nbsp;Co. (the "Compensation Consultant"), who the Compensation
Committee determined to be independent, to assess the competitiveness of compensation levels for certain of our officers, including our Named Executive Officers, relative to survey market data. The
Compensation Consultant provided services to the Compensation Committee only in late 2014 and early 2015 and did not perform any work for the Company outside of the services it performed for the
Compensation Committee. In 2015, the Compensation Committee made certain decisions regarding Named Executive Officer (i)&nbsp;salaries, (ii)&nbsp;the mix between base salary, short-term incentive
compensation, and long-term incentive compensation, and (iii)&nbsp;the amount of target long-term equity incentive awards for the Named Executive Officers after considering the input of the
Compensation Consultant, survey market data, Company performance, and other relevant factors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a basis for the market data provided to the Compensation Committee, the Compensation Consultant utilized compensation data from a group of 22 peer companies set out below. These
companies were all within a reasonable range of the Company's revenue, operating income, and market capitalization. As of January&nbsp;1, 2015, we were at or near the median of the peer group with
respect to revenue, operating income and market capitalization. This information was gathered and analyzed for the 25th, 50th&nbsp;and 75th&nbsp;percentiles for annual salary, short-term incentive
pay elements and long-term incentive pay elements. Where possible, our Executives were matched to appropriate proxy and survey positions based on job duties and level of responsibility. The following
companies were included in the 2015 peer group. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Blyth,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Nature's Sunshine Products, Incorporated</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Coty,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Nu Skin Enterprises,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Elizabeth Arden,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Nutraceutical International Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>GNC Holdings,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>NutriSystem&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>The Hain Celestial Group,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Perrigo Company&nbsp;plc</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Herbalife,&nbsp;Ltd.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Prestige Brands Holdings,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>International Flavors and Fragrances&nbsp;Inc.</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>Primerica,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Inter Parfums,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Revlon,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>LifeVantage Corporation</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Tupperware Brands Corporation</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Mannatech, Incorporated</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Vitamin Shoppe,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Natural Health Trends Corp.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Weight Watchers International, Inc</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
late 2016 and early 2017, the Compensation Committee again engaged the Compensation Consultant to advise the Compensation Committee on Executive compensation, including total
compensation benchmarking and aggregate equity compensation and incentive practices. Representatives of the Compensation Consultant delivered a report to the Compensation Committee at its February
2017 meeting and discussed the same with the committee. Going forward, the Compensation Committee has requested that our CFO work with the Compensation Consultant to prepare a plan to implement an
updated long-term incentive program for Executives. While the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=29,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=859141,FOLIO='24',FILE='DISK135:[17ZAA5.17ZAA14905]DG14905A.;8',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dg14905_1_25"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Compensation
Committee has been undertaking this study during 2016, no additional equity grants were made to Executives other than to new hires. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_2016_compensation_determinations"> </A>
<A NAME="toc_dg14905_13"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2016 Compensation Determinations    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In 2016, the Compensation Committee referenced updated data from the above sources in considering the appropriate levels of base salary, bonus
and long-term incentive compensation for our Executives, as discussed below. In addition to the Compensation Consultant's market data, the Compensation Committee utilized the following materials,
along with other resources and tools, to render compensation decisions for 2016: (i)&nbsp;surveys and reports of executive compensation paid by public companies, with characteristics similar to
USANA, on a national basis; and (ii)&nbsp;surveys from Mercer, ERI, and the U.S. Direct Selling Association of executive compensation paid by certain of the Company's direct competitors, consisting
of both public and private companies, on a local and national basis. These materials and resources help provide solid benchmarks for each component of our executive compensation as well as a general
understanding of the total compensation offered by companies in our industry who are competing for top talent. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dg14905_components_of_compensation"> </A>
<A NAME="toc_dg14905_14"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Components of Compensation    <BR>    </I></B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Base Salary  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base salary represents the fixed component of executive compensation. It is designed to compensate our Executives fairly and competitively at
levels necessary to attract, retain and motivate qualified executives in our industry. Consistent with this philosophy, the Compensation Committee, on an annual basis, evaluates our Executives' base
salaries. The Committee asks for input and recommendations from the CEO and CFO and then considers (i)&nbsp;the Executive's scope of responsibilities, maturity in role, demonstrated level of
performance, accomplishments and contributions to the Company; (ii)&nbsp;the performance of USANA, both financially and operationally; (iii)&nbsp;current market data and salary levels for each
Executive's particular position; and (iv)&nbsp;the total compensation paid to each Executive. The Committee then renders a decision for each Executive's base salary based on the total mix of the
foregoing information. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
part of its 2016 Executive compensation evaluation, the Compensation Committee, after reviewing the information outlined above, approved the Named Executive Officers' base salaries
from July 2016 through June 2017 as set out in the table below. At the time of these base salary determinations, Mr.&nbsp;Guest was serving as Co-CEO, Mr.&nbsp;Brown was serving as Chief Operating
Officer and Mr.&nbsp;Macuga was serving as Chief Communications Officer and Executive Vice President of Field Development for the Americas. In November 2016, Mr.&nbsp;Wentz resigned as Co-CEO and
Mr.&nbsp;Guest was promoted to CEO. In December 2016, Mr.&nbsp;Brown was promoted to President and Chief Operating Officer and Mr.&nbsp;Macuga was appointed Chief Communications Officer. While
these Executives were promoted in late 2016, the Compensation Committee decided to make compensation determinations relative to the promotions at its February 2017 meeting. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="34%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="34%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Executive

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Appointed Office </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2015&nbsp;-&nbsp;2016<BR>
Base Salary($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2016&nbsp;-&nbsp;2017<BR>
Base Salary($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Kevin Guest</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>618,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>636,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>President and Chief Operating Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>411,600</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>411,600</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Jones</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>CFO and Chief Leadership Development Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>357,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>357,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James H. Bramble</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Legal Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>394,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>405,820</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dan Macuga</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Chief Communications Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>376,980</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>376,980</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David A. Wentz</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Former Co-Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>618,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>636,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=30,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=137310,FOLIO='25',FILE='DISK135:[17ZAA5.17ZAA14905]DG14905A.;8',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di14905_1_26"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee, at its February 2017 meeting, approved the following base salary increases for the Executives below in connection with their 2016
promotions: (i)&nbsp;Mr.&nbsp;Guest's base salary was increased to $800,000; (ii)&nbsp;Mr.&nbsp;Brown's base salary was increased to $520,000; and (iii)&nbsp;Mr.&nbsp;Macuga's base salary
was increased to $415,000. The Compensation Committee utilized 2017 information and data provided by the Compensation Consultant in making the foregoing base salary determinations. In particular, the
Compensation Committee, acting on the recommendations of the Compensation Consultant and other market resources and information available to it, determined it would target the cash component (base
salary and short-term incentive) compensation of the Company's Named Executive Officers to a level that is approximately equal to the median of our peer group compensation for fiscal year 2017. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
actual cash compensation paid to our Named Executive Officers during the year ended December&nbsp;31, 2016 is reflected in column (c)&nbsp;of the Summary Compensation Table on
page&nbsp;25 of this Proxy Statement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2016 Non-Equity Incentive Plan Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We offer our Named Executive Officers non-equity incentive plan compensation in the form of a cash bonus that is based on USANA's achievement of
certain financial performance objectives during the applicable year. Cash bonuses are based on a percentage of the Executive's base salary. Each year, the Compensation Committee sets the range of the
cash bonus for which each Executive is eligible and sets the performance objectives on which cash bonuses for that year will be based. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
2016, the Compensation Committee approved the 2016 Executive Bonus Plan (the "2016 Bonus Plan"), which was based on growth in net sales and profitability. The Compensation Committee
approved this single financial performance objective to: (i)&nbsp;focus the Company's Executives on growing net sales in 2016 without sacrificing profitability; (ii)&nbsp;continue to align the
bonus opportunity under the 2016 Bonus Plan for all Executives to promote internal equity; (iii)&nbsp;foster teamwork among markets and Executives; and (iv)&nbsp;align the 2016 Bonus Plan offered
to Executives with the profit sharing plan offered to all other employees of the Company. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the 2016 Bonus Plan, 9% of the Company's adjusted operating profits in excess of 10% of net sales, were to be used to create a bonus pool for payment of cash bonuses to Executives.
For purposes of the 2016 Bonus Plan, the term "adjusted operating profit" is calculated as (i)&nbsp;the Company's earnings from operations, plus (ii)&nbsp;positive adjustments to earnings from
operations for Executive and employee bonus accruals and equity compensation expense. Payments under the 2016 Bonus Plan were distributed as an equal percent of the Executive's base salary. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the 2016 Bonus Plan, eligible Executives had the potential to receive a cash bonus of between zero and 100% of their base salary, depending on the performance of the Company under
the criteria of the plan. Each Executive's target bonus percentage under the 2016 Bonus Plan was 50% of the Executive's base salary. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2016 Executive Bonus Plan Payout  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shortly after the end of fiscal 2016, the Compensation Committee reviewed the foregoing performance objectives and evaluated the actual
performance delivered by the Company under the 2016 Bonus Plan. The Compensation Committee determined that the Company delivered strong financial and operating performance in 2016 and, in particular,
noted that the Company:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Achieved 2016 net sales of $1,006&nbsp;million, which is a 9.5% increase compared to fiscal 2015; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Achieved 2016 adjusted operating profit of $168.9&nbsp;million; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Achieved 2016 adjusted operating profit in excess of 10% of net sales of $68.3&nbsp;million. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=31,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=698928,FOLIO='26',FILE='DISK135:[17ZAA5.17ZAA14905]DI14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_di14905_1_27"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on the Company's performance, and the criteria of the 2016 Bonus Plan, the Compensation Committee determined that each Executive had earned a cash bonus equal to 49.0% of the
Executive's base salary under the 2016 Bonus Plan. Consequently, the Compensation Committee awarded this bonus amount to each Executive. The actual cash bonuses paid to our Named Executive Officers
under the 2016 Bonus Plan are reflected in column (g)&nbsp;of the Summary Compensation Table of this Proxy Statement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Executive Bonus Plan  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For fiscal year 2017, the Compensation Committee approved the 2017 Executive Bonus Plan (the "2017 Bonus Plan"), which is based on the same
performance objectives as the 2016 Bonus Plan: growth in net sales and profitability. As part of its determination to again utilize this bonus criteria and structure, the committee noted:
(i)&nbsp;the strong operating results delivered by the Executives and the Company in 2016; (ii)&nbsp;the successful alignment of the Company's Executives under the 2016 Bonus Plan, and
(iii)&nbsp;the internal equity among Executives that was created by the 2016 Bonus Plan. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the 2017 Bonus Plan, 9% of the Company's adjusted operating profits, which exceed 10% of net sales, will again be paid to Executives in the form of a cash bonus. Payments under the
2017 Bonus Plan will be distributed as an equal percent of the Executive's base salary. Under the 2017 Bonus Plan, Executives will have the potential to receive a cash bonus of between zero and 100%
of their base salary, depending on the performance of the Company under the criteria of the plan. Each Executive's target bonus percentage under the 2017 Bonus Plan is 50% of the Executive's base
salary, with the exception that the target bonus percentages for Mr.&nbsp;Guest, our CEO, and Mr.&nbsp;Brown, our President and COO, are now 75% of each respective Executive's base salary. The
Compensation Committee set the target bonus under the 2017 Bonus Plan for these Executives pursuant to recommendations of the Compensation Consultant and other market resources. Future estimated
payouts under the 2017 Bonus Plan are reflected in the Grants of Plan-Based Awards table of this Proxy Statement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity compensation is an integral part of USANA's compensation philosophy. We believe that equity grants that vest over a period of years tie a
portion of our Executives' compensation to the Company's long-term performance and, thereby, align the interests of our Executives with the interests of our shareholders. Our equity compensation
program delivers additional compensation to Executives when the Company performs and the value of the Company's stock increases. Historically, we have provided equity-based compensation primarily
through the issuance of stock-settled stock appreciation rights ("SSARs"). In recent years, the Compensation Committee has also granted deferred stock units ("DSUs") to outside directors. The
Compensation Committee awards equity compensation to supplement our Executives' compensation to ensure that total compensation is competitive in the marketplace and to align compensation with our long
term goals and objectives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Grants
of equity awards are made for both Executives and other eligible employees at regular Compensation Committee meetings and at special meetings, as needed. To further align the
interests of our Executives and shareholders, we have implemented stock ownership guidelines for our Executives. Pursuant to these guidelines, our Executives voluntarily agree to hold ten percent
(10%) of the shares of USANA common stock issued to them as a result of a SSAR exercise for a period of five years or until they are no longer employed by the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee's philosophy has been to issue intermittent SSAR awards to Executives to drive long-term Company performance as well as individual Executive performance. In
general, SSAR awards are granted to Executives as they enter into a qualifying position and vest annually in equal installments over a five-year period. Additional grants have been awarded to </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=32,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=305773,FOLIO='27',FILE='DISK135:[17ZAA5.17ZAA14905]DI14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_di14905_1_28"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Executives
as seen necessary by the Compensation Committee to maintain sufficient long term incentive to accomplish the objectives outlined above. These additional grants typically do not vest in the
first two years, but only at the end of years three, four and five, and such vesting for a particular Executive commences when the vesting schedule of that Executive's particular SSAR award ends. The
grant price for equity awards is the fair market value of the award as of the date of grant as determined by the closing price of the Company's common stock on the date of grant. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2016, the Compensation Committee made no equity award grants to the Named Executive Officers as it continues to review potential changes to the long-term incentive component of
Executive compensation. As indicated above, in December 2016, the Compensation Committee engaged the Compensation Consultant to provide the Committee with updated data and recommendations related to
benchmarking, aggregate equity usage and incentive practices for the Company. The Compensation Committee will consider further recommendations of the Compensation Consultant and the CFO at a future
meeting regarding a plan for new equity grants for executives. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


<A NAME="OTHER"></A>Other Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other than as described above, USANA does not at this time provide benefits to its Named Executive Officers that are different from or in
addition to those that are provided to its general employees. Those benefits are described below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retirement:</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Executives may participate in Company sponsored 401(k) retirement plans on the same terms and conditions, including Company
matching
provisions, as other employees. For the year ended December&nbsp;31, 2016, we contributed matching funds totaling $1,593,674 to our 401(k) plan in which all eligible employee participants shared.
During 2016, each of our eligible Executives participated in our 401(k) plan and shared matching funds totaling $58,996. Except as disclosed in this paragraph, we provide no other retirement benefits
to our Executives. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Severance:</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;USANA has no pre-arranged severance agreements or contracts with any of our Executives that contain post-termination or
change-in-control
payment provisions. We have, however, provided severance benefits to Executives on a case-by-case basis. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Perquisites:</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;It is our general practice not to provide significant perquisites or personal benefits to our Executives. The Compensation
Committee,
however, retains the discretion to consider and award reasonable perquisites or personal benefits to Executives as necessary to accomplish the objectives under our compensation philosophy. In this
regard, it should be noted that we do not currently provide pension arrangements, post-retirement health coverage, or similar benefits for our Executives or employees. In 2016, we paid health, life,
and disability insurance premiums on behalf of our Executives, all on the same terms as those that we provide to all of the Company's employees. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insurance Plans and Other Benefits:</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;We provide insurance plans and other benefits to our Executives that are similar to those plans and
benefits that
are customarily provided to general employees of the Company. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Indemnification:</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Article&nbsp;VI of our Amended and Restated Articles of Incorporation and Article&nbsp;5 of our Bylaws provide for
indemnification of our directors, officers, employees, and other agents to the extent and under the circumstances permitted by the Utah Revised Business Corporation Act. We have entered into
agreements with our directors and officers that will require us, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or
officers to the fullest extent allowed. Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the "Securities Act"), may be permitted to directors, officers,
or persons controlling us under the foregoing provisions, the SEC has stated that such indemnification is against public policy, as expressed in the Securities Act, and, therefore, such
indemnification provisions may be unenforceable. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=33,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=837083,FOLIO='28',FILE='DISK135:[17ZAA5.17ZAA14905]DI14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_di14905_1_29"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="di14905_section_162(m)_treatment_regar__sec02348"> </A>
<A NAME="toc_di14905_1"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Section&nbsp;162(m) Treatment Regarding Performance-Based Equity Awards    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended ("Section&nbsp;162(m)"), a public company is generally denied
deductions for compensation paid to the chief executive officer and the next four most highly compensated executive officers to the extent the
compensation for any such individual exceeds $1.0&nbsp;million for the taxable year. There is an exception to the limit on deductibility for performance-based compensation that meets certain
requirements. We intend that compensation paid under our incentive plans be generally fully deductible for federal income tax purposes. However, deductibility is just one among a number of factors
considered in determining appropriate levels or types of compensation and the Compensation Committee may approve compensation that exceeds the limitation in order to ensure competitive levels of total
compensation for our executive officers. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di14905_report_of_the_compensation_committee"> </A>
<A NAME="toc_di14905_2"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE COMPENSATION COMMITTEE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of Directors has reviewed and discussed the Compensation Discussion and Analysis required by
Item&nbsp;402(b) of Regulation&nbsp;S-K with management. Based on this review and discussion, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be
included in this Proxy Statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Respectfully
submitted by the members of the Compensation Committee: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="41%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="41%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>D. Richard Williams (Chair)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Feng Peng</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Frederic Winssinger</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=34,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=180316,FOLIO='29',FILE='DISK135:[17ZAA5.17ZAA14905]DI14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_di14905_1_30"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="di14905_summary_compensation_table"> </A>
<A NAME="toc_di14905_3"> </A>
<BR></FONT><FONT SIZE=2><B>  SUMMARY COMPENSATION TABLE    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth all compensation paid to each of the Named Executive Officers for the fiscal years 2016, 2015 and 2014, who were
serving as executive officers at December&nbsp;31, 2016. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="69pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and principal position

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option awards<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-equity<BR>
incentive<BR>
plan<BR>
compensation<BR>
($)(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All other<BR>
compensation<BR>
($)(3) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(f)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(g)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(i)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(j)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>626,628</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>306,923</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,275</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>942,826</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CEO(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>608,516</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>75,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,035,676</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>350,383</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>4,078,675</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>589,843</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,036,679</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>274,156</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,934,778</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
401,122</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
83,333</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
196,469</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9,275</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
690,199</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Operating Officer(5)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Paul A. Jones,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
357,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
174,859</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9,275</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
541,134</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CFO and Chief Leadership</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>348,042</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,517,838</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>188,403</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,063,383</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Development Officer(6)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>329,534</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>148,666</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>487,300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James H. Bramble,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
399,501</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
195,676</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9,275</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
604,452</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Legal Officer and</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>388,032</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,517,838</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>223,429</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,138,398</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>General Counsel</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>376,843</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>655,677</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>175,155</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,216,775</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Dan Macuga,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
371,110</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
181,770</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9,275</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
562,155</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Communications</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David A. Wentz,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
2016</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
624,180</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
68,186</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
692,366</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Former Co-CEO(7)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2015</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>428,423</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,035,676</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>246,686</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>3,719,885</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2014</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>469,231</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,018,958</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>218,096</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>9,100</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,715,385</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
in this column reflect the grant date fair value of stock-settled stock appreciation rights ("SSARs") computed in accordance with Financial Accounting
Standards Board Accounting Standards Codification Topic 718. These amounts do not represent the actual amounts paid to or realized by the Executive for these awards during the applicable fiscal year.
Assumptions used in the calculation of these amounts are included in the Equity Based Compensation footnote to the Company's consolidated financial statements that are included in the Company's Annual
Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
paid as cash bonus in subsequent fiscal year for performance realized in prior fiscal year (e.g.,&nbsp;results of 2016 bonus pool paid out in first quarter
of 2017), under the Company's short-term incentive plan discussed in the Compensation Discussion and Analysis section of this Proxy Statement.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Amounts
in this column reflect employer's matching contributions to the Executive's 401(k) plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Guest
was President&#151;Americas, Europe and South Pacific until August 2014, President of USANA from August 2014 to August 2015, and Co-CEO from
August 2015 to November 2016 when he was named Chief Executive Officer of the Company.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Jim
Brown was Chief Operating Officer from November 2013 until November 2016, when he was appointed as President and Chief Operating Officer. The cash bonus
reflected in Column D was </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=35,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=705344,FOLIO='30',FILE='DISK135:[17ZAA5.17ZAA14905]DI14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_di14905_1_31"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>paid
as a quarterly bonus to Mr.&nbsp;Brown during a period when he assumed responsibility for the Information Technology department while the Company searched for a Chief Information Officer. </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Jones
was appointed Chief Leadership Development Officer in August 2015, in addition to his position as Chief Financial Officer.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dave
Wentz was Chief Executive Officer of USANA from July 2008 until August 2015 when he was appointed Co-Chief Executive Officer. He resigned from all positions
with the Company in November 2016. Column (i)&nbsp;reflects the following compensation paid to Mr.&nbsp;Wentz: (1)&nbsp;$9,275 in employer's matching contribution to his 401(k) plan; and
(2)&nbsp;$58,911 in accrued vacation payout.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=36,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=570329,FOLIO='31',FILE='DISK135:[17ZAA5.17ZAA14905]DI14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk14905_1_32"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk14905_grants_of_plan-based_awards"> </A>
<A NAME="toc_dk14905_1"> </A>
<BR></FONT><FONT SIZE=2><B>  GRANTS OF PLAN-BASED AWARDS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No grants of equity awards were made to our Named Executive Officers during the fiscal year ended December&nbsp;31, 2016. The table below
summarizes estimated or targeted payouts to the Named Executive Officers under the 2017 Bonus Plan described in the Compensation Discussion and Analysis section of this Proxy Statement. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=8 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated future payouts under<BR>
non-equity incentive plan awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Threshold<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
($)(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>600,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>800,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CEO</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
390,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
520,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief Operating Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Paul A. Jones,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
178,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
357,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CFO and Chief Leadership Development Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James H. Bramble,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
202,910</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
405,820</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Legal Officer and General Counsel</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Dan Macuga,</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
207,500</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
415,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Communications Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>There
is no guaranteed payment to our Named Executive Officers under the 2017 Executive Bonus Plan. If the minimum performance objectives are not achieved, they will
receive no payout under the 2017 Executive Bonus Plan. The amounts shown in column (d)&nbsp;reflect the target payout, which is 75% of base salary for Mr.&nbsp;Guest and Mr.&nbsp;Brown and 50%
of base salary for each of the other Executives. The amounts shown in column (e)&nbsp;reflect 100% of the Executive's base salary, which is the maximum payout that can be obtained under the 2017
Executive Bonus Plan.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=37,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=5460,FOLIO='32',FILE='DISK135:[17ZAA5.17ZAA14905]DK14905A.;14',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dk14905_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="OUTEND"></A>OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table includes certain information with respect to the value of all equity awards previously granted to the Named Executive
Officers outstanding as of December&nbsp;31, 2016. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk14905_outstanding_equity_awards_at_fiscal_year-end"> </A>
<A NAME="toc_dk14905_2"> </A>
<BR></FONT><FONT SIZE=2><B>  Outstanding Equity Awards at Fiscal Year-End    <BR>    </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=14 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option awards(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
securities<BR>
underlying<BR>
unexercised<BR>
options<BR>
(#) exercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
securities<BR>
underlying<BR>
unexercised<BR>
options<BR>
(#)<BR>
unexercisable </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
incentive plan<BR>
awards:<BR>
number of<BR>
securities<BR>
underlying<BR>
unexercised<BR>
unearned<BR>
options (#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option exercise price ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
expiration date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(f)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>58,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>28.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>15&nbsp;March 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CEO(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>120,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>70.75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1&nbsp;March 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
32,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
28.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
15&nbsp;March 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>President and Chief Operating</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>

<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>70.75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1&nbsp;March 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Officer(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Paul A. Jones,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
14,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
14,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
19.12</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
17&nbsp;June 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 CFO and Chief Leadership</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>70.75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1&nbsp;March 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Development Officer(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James H. Bramble,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
37,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
28.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
15&nbsp;March 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Legal Officer and General</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>70.75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1&nbsp;March 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Counsel(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Dan Macuga,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
34,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
28.81</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
15&nbsp;March 2018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Communications Officer(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>70.75</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1&nbsp;March 2020</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David W. Wentz,</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>former Co-CEO(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>All
amounts adjusted to reflect our two-for-one forward stock split effective November&nbsp;22, 2016.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
SSAR grants to Mr.&nbsp;Guest, Mr.&nbsp;Brown, Mr.&nbsp;Bramble, and Mr.&nbsp;Macuga which expire on March&nbsp;15, 2018, vest 50% in August 2016 and
50% in August 2017. The SSAR grants to Mr.&nbsp;Guest, Mr.&nbsp;Brown, Mr.&nbsp;Bramble and Mr.&nbsp;Macuga which expire on March&nbsp;1, 2020, vest 50% in September 2018 and 50% in
September 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
SSAR grant to Mr.&nbsp;Jones, which expires on June&nbsp;17, 2018, vests 20% annually, beginning on the first anniversary of the date of grant. The SSAR
grant to Mr.&nbsp;Jones, which expires on March&nbsp;1, 2020, vests 50% in September 2018 and 50% in September 2019.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Wentz
resigned as a member of the Board of Directors and Co-CEO in November 2016 and all of his outstanding equity awards were cancelled at that time. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=38,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=71371,FOLIO='33',FILE='DISK135:[17ZAA5.17ZAA14905]DK14905A.;14',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dk14905_1_34"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk14905_option_exercises_and_stock_vested"> </A>
<A NAME="toc_dk14905_3"> </A>
<BR></FONT><FONT SIZE=2><B>  OPTION EXERCISES AND STOCK VESTED    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes information regarding the exercise of SSARs and each vesting of SSARs, for each of the Named Executive Officers
on an aggregated basis during the fiscal year ended December&nbsp;31, 2016. All amounts adjusted to reflect our two-for-one forward stock split effective November&nbsp;22, 2016. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="56pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="53pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>(a)<BR>
Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(b)<BR>
Number of<BR>
shares<BR>
acquired on<BR>
exercise<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(c)<BR>
Value<BR>
realized on<BR>
exercise ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(d)<BR>
Number of<BR>
shares<BR>
acquired<BR>
on vesting<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>(e)<BR>
Value<BR>
realized on<BR>
vesting ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Kevin G. Guest</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32,570</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,117,115</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jim Brown</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>18,208</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,193,326</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Jones</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10,134</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>701,890</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James H. Bramble</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>20,754</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,361,935</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Dan Macuga</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>19,238</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,253,053</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David A. Wentz</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32,208</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>2,109,675</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk14905_equity_compensation_plan_information"> </A>
<A NAME="toc_dk14905_4"> </A>
<BR></FONT><FONT SIZE=2><B>  EQUITY COMPENSATION PLAN INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information regarding outstanding awards and shares reserved for future issuance under our equity compensation
plans as of December&nbsp;31, 2016. All amounts adjusted to reflect our two-for-one forward stock split effective November&nbsp;22, 2016. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:67%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"120%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="120%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="116pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="91pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="136pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Plan Category


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities to<BR>
be issued upon exercise<BR>
of outstanding awards(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted-average<BR>
exercise price of<BR>
outstanding awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities<BR>
remaining available for<BR>
future issuance under equity<BR>
compensation plans<BR>
(excluding securities reflected<BR>
in column (a)) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans approved by security holders</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,404,485</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>54.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,839,260</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans not approved by security holders</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>None</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>None </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,404,485</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>54.69</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>7,839,260</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Consists
of shares of common stock issuable under the USANA 2006 Equity Incentive Award Plan and the USANA 2015 Equity Incentive Award Plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
(i)&nbsp;13,813 DSUs that will entitle each holder to the issuance of one share of common stock for each unit, and (ii)&nbsp;3,390,672 SSARs. A SSAR is
the right to receive the appreciation in fair market value of common stock between the exercise date and the date of grant in shares of common stock. Based on the closing stock price of $61.20 on the
last trading day of fiscal 2016 and the exercise price of SSARs that were in-the-money, 590,999 shares of common stock would be issued upon the exercise of these SSAR awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Calculated
without taking into account 13,813 shares of common stock subject to outstanding DSUs, which are issuable without any cash consideration or other payment
required for such shares.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk14905_employment_contracts_and_other_arrangements"> </A>
<A NAME="toc_dk14905_5"> </A>
<BR></FONT><FONT SIZE=2><B>  EMPLOYMENT CONTRACTS AND OTHER ARRANGEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has no employment agreements with any of its executive officers. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=39,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=895570,FOLIO='34',FILE='DISK135:[17ZAA5.17ZAA14905]DK14905A.;14',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm14905_1_35"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A> </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="PRO3"></A>PROPOSAL #3&#151;ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR<BR>  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> NAMED EXECUTIVE OFFICERS (THE SAY-ON-PAY PROPOSAL)  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;14A of the Exchange Act, enacted pursuant to The Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank
Act"), we are required to conduct a non-binding shareholder advisory vote at least every three years to approve our executive officer compensation (commonly referred to as a "say-on-pay proposal").
Our shareholders supported a three-year frequency for this shareholder advisory vote at our 2011 annual meeting (65% of the votes cast at the meeting). Consequently, the Compensation Committee of the
Board previously recommended and the Board determined that we would provide shareholders with the opportunity to cast an advisory vote on executive compensation every three years. Going forward, as
noted in Proposal #4, we will provide shareholders with the opportunity to cast an advisory vote on executive compensation every year. This vote is on whether to approve the compensation of the Named
Executive Officers as disclosed in the "Executive Compensation" section of this Proxy Statement,
including the Compensation Discussion and Analysis, the compensation tables and the related narrative. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
our 2014 Annual Meeting of Shareholders, approximately 91% of the votes cast on the "say on pay" proposal voted in favor of our executive compensation. The Compensation Committee
believes the results of the 2014 "say on pay" vote in 2014 demonstrated that shareholders generally agreed with our compensation program and policies and the compensation of our named executive
officers. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;While
this advisory vote to approve executive compensation is non-binding, the Board and the Compensation Committee will review the voting results and seek to determine the cause or
causes of any significant negative voting result. Voting results provide little detail by themselves, and we may consult directly with shareholders to better understand issues and concerns not
previously presented. The Board and management understand that it is useful and appropriate to seek the views of shareholders when considering the design and implementation of executive compensation
programs. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors asks you to consider the following statement: Do you approve our executive compensation as described in the "Executive Compensation" section of this Proxy
Statement, including the Compensation Discussion and Analysis, the compensation tables and other narrative executive compensation disclosures? The approval of our executive compensation as described
in the "Executive Compensation" section of this Proxy Statement, including the Compensation Discussion and Analysis, the compensation tables and other narrative executive compensation disclosures,
requires the affirmative vote of a majority of the votes cast at the Annual Meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dm14905_recommendation"> </A>
<A NAME="toc_dm14905_1"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RECOMMENDATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE "FOR" THE APPROVAL OF OUR EXECUTIVE
COMPENSATION.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=40,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=1031929,FOLIO='35',FILE='DISK135:[17ZAA5.17ZAA14905]DM14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dm14905_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> <A NAME="PRO4"></A>PROPOSAL #4&#151;NON-BINDING ADVISORY VOTE TO APPROVE<BR>
THE FREQUENCY OF NON-BINDING VOTE<BR>
TO APPROVE EXECUTIVE COMPENSATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;14A of the Exchange Act, enacted pursuant to the Dodd-Frank Act, and as implemented by SEC Rule&nbsp;14a-21(b), we must
conduct a separate non-binding shareholder advisory vote at least every six years to determine whether the non-binding shareholder advisory vote to approve our company's named executive officer
compensation will occur every one, two or three years, in any proxy or consent or authorization for an annual or other meeting of our shareholders. Our shareholders previously supported a three-year
frequency for this shareholder advisory vote at our&nbsp;2011 Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Board of Directors is providing our shareholders with the opportunity to cast a non-binding advisory vote on the frequency of the non-binding shareholder advisory vote to approve
executive compensation at our 2017 Annual Meeting. This vote will not be binding on or overrule any decisions made by our Board of Directors and will not create or imply any additional fiduciary duty
on the part of the Board. This vote is not to approve or disapprove the Board's recommendation. However, our Board will take into account the outcome of the vote when considering the frequency of the
non-binding shareholder advisory vote to approve our Company's Named Executive Officers' compensation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
consideration of this proposal, the Compensation Committee and the Board of Directors have determined that a vote on the compensation of our Named Executive Officers every year is
the best alternative for the Company. The Board of Directors historically has emphasized long-term strategic planning for the Company and the Compensation Committee has fashioned executive
compensation programs that place a greater emphasis on the attainment of long-term growth objectives than on short-term success. An advisory vote every year is consistent with this long-term growth
strategy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
selection of "one year", "two years" or "three years" that receives the greatest number of votes cast on this proposal at the Annual Meeting, in person or by properly executed proxy,
subject to quorum requirements, will indicate the shareholders' preference for the frequency of future votes on the compensation of our Named Executive Officers and the Board of Directors encourages
this input from the shareholders. However, since this vote is not binding on the Board of Directors, the Compensation Committee or the Company, the Board of Directors may decide that it is in the best
interest of the Company and the shareholders to hold future advisory votes on the compensation of our Named Executive Officers less frequently than as indicated by the shareholder vote on this
Proposal&nbsp;#4. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dm14905_recommendation_1"> </A>
<A NAME="toc_dm14905_2"> </A></FONT> <FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RECOMMENDATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR "ONE YEAR" AS THE FREQUENCY FOR FUTURE NON-BINDING ADVISORY
VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=41,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=968358,FOLIO='36',FILE='DISK135:[17ZAA5.17ZAA14905]DM14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dm14905_1_37"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm14905_security_ownership_of_certain___sec02525"> </A>
<A NAME="toc_dm14905_3"> </A>
<BR></FONT><FONT SIZE=2><B>  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding the beneficial ownership of our common stock, as of March&nbsp;1, 2017, by
(1)&nbsp;each person known by us to be the beneficial owner of more than 5% of the issued and outstanding common stock based upon their most recent filings or correspondence with the SEC,
(2)&nbsp;our Named Executive Officers and the directors individually, and (3)&nbsp;the Named Executive Officers and directors as a group. Except as indicated in the footnotes below, each of the
persons listed below is believed to exercise sole voting and investment power over the shares of common stock that are listed for such individual or entity in this table. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Address

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Shares(1) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent of<BR>
Class(2) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><B>Beneficial Owners of More Than 5%</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gull Global,&nbsp;Ltd.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
12,558,220</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
51.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>PO Box&nbsp;N-4899, 2/F Bahamas Financial Ctr.</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Shirley&nbsp;&amp; Charlotte Streets</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Nassau, C5 BH1-1000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Renaissance Technologies&nbsp;LLC(3)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1,632,900</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
6.7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 800 Third Avenue</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 New York, New York 10022</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FMR&nbsp;LLC(4)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1,436,122</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
5.9</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>245 Summer Street</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Boston, MA 02210</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:9pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=2><B>Directors and Executive Officers</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Myron W. Wentz, Ph.D.(5)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>12,558,220</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>51.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chairman of the Board</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Kevin G. Guest(6)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
673</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Executive Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Jones(7)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
9,522</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>CFO&nbsp;&amp; Chief Leadership Development Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Jim Brown(8)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1,090</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:28pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 President&nbsp;&amp; COO</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James H. Bramble(9)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
2,722</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Chief Legal Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Dan Macuga(10)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
697</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:37pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Chief Communications Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>David A. Wentz(11)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
432,936</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1.8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Robert Anciaux, Director(12)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
13,487</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Gilbert A. Fuller, Director(13)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
7,161</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 D. Richard Williams(14)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1,780</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Feng Peng(15)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1,780</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Frederic Winssinger(16)</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
1,780</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:18pt;text-indent:-9pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Directors and Officers as a group (12 persons)</B></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
13,031,848</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
53.2</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Less
than one percent.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>All
entries exclude beneficial ownership of shares that are issuable pursuant to SSARs that have not vested or that are not otherwise exercisable as of the date
hereof and which will not become vested or exercisable within 60&nbsp;days of March&nbsp;1, 2017. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=42,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=980024,FOLIO='37',FILE='DISK135:[17ZAA5.17ZAA14905]DM14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dm14905_1_38"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Percentages
are rounded to nearest one&#151;tenth of one percent. Percentages are based on 24,504,413 shares outstanding on March&nbsp;1, 2017. Shares of
common stock subjected to SSARs that are presently exercisable or exercisable within 60&nbsp;days of March&nbsp;1, 2017 are deemed to be beneficially owned by the person holding the SSARs for the
purpose of computing the percentage ownership of that person, but are not treated as outstanding for the purpose of computing the percentage of any other person.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(3)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the number of shares held at year-end, as reported on Form&nbsp;SC 13G/A filed on February&nbsp;14, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(4)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the number of shares held at year-end, as reported on Form&nbsp;SC 13G/A filed on February&nbsp;13, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(5)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
12,558,220 shares held of record by Gull Global,&nbsp;Ltd., a Bahamas company, which is 100% owned by Dr.&nbsp;Wentz. Because of his control of Gull
Global,&nbsp;Ltd, Dr.&nbsp;Wentz is deemed to be the beneficial owner of the shares that are owned of record by Gull Global,&nbsp;Ltd.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(6)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
673 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(7)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
9,522 shares that are issuable pursuant to SSARs, which are presently exercisable or which become exercisable within 60&nbsp;days of March&nbsp;1, 2017.
This share count assumes settlement of this individual's SSARs at the closing market price on March&nbsp;1, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(8)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,090 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(9)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
2,076 shares held of record and 646 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(10)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
697 shares that are held in the executive's 401(k) account.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(11)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
432,936 shares that are held of record.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(12)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
5,179 shares that are issuable pursuant to SSARs, which are presently exercisable or which become exercisable within 60&nbsp;days of March&nbsp;1,
2017. This share count assumes settlement of this individual's SSARs at the closing market price on March&nbsp;1, 2017. Also includes 8,308 shares that are issuable pursuant to DSUs, which are
presently vested or which become vested within 60&nbsp;days of March&nbsp;1, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(13)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
4,661 shares that are issuable pursuant to SSARs, which are presently exercisable or which become exercisable within 60&nbsp;days of March&nbsp;1,
2017. This share count assumes settlement of this individual's SSARs at the closing market price on March&nbsp;1, 2017. Also includes 2,500 shares that are issuable pursuant to DSUs, which are
presently vested or which become vested within 60&nbsp;days of March&nbsp;1, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(14)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,780 shares that are issuable pursuant to DSUs, which are presently vested or which become vested within 60&nbsp;days of March&nbsp;1, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(15)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,780 shares that are issuable pursuant to DSUs, which are presently vested or which become vested within 60&nbsp;days of March&nbsp;1, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(16)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,780 shares that are issuable pursuant to DSUs, which are presently vested or which become vested within 60&nbsp;days of March&nbsp;1, 2017. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=43,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=154022,FOLIO='38',FILE='DISK135:[17ZAA5.17ZAA14905]DM14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dm14905_1_39"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm14905_certain_relationships_and_related_transactions"> </A>
<A NAME="toc_dm14905_4"> </A>
<BR></FONT><FONT SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dm14905_policies_and_procedure__dm102509"> </A>
<A NAME="toc_dm14905_5"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Policies and Procedures Regarding Related Party Transactions    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the ordinary course of business, we may engage in transactions which have the potential to create actual or perceived conflicts of interest
between USANA and our directors and officers or their immediate family members. The Audit Committee charter requires that the Audit Committee review and approve any related party transaction or, in
the alternative, that it notify and request action on the related party transaction by the full Board of Directors. While we have not adopted formal written procedures for reviewing such transactions,
in deciding whether to approve a related party transaction, the Audit Committee may consider, among other things, the following factors:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> information regarding the goods or services that are proposed to be provided, or that are being provided, by or to the related party; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> the nature of the transaction and the costs to be incurred by the Company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an analysis of the costs and benefits that are associated with the transaction and a comparison of alternative goods or services that are
available to the Company from unrelated parties; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an analysis of the significance of the transaction to the Company; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether the transaction would be in the ordinary course of our business; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether the transaction is on terms that are comparable to those that could be obtained in an arm's-length dealing with an unrelated third
party; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> whether the transaction could result in an independent director no longer being considered to be independent under the NYSE rules. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;After
considering these and other relevant factors, the Audit Committee either (1)&nbsp;approves or disapproves the related party transaction, or (2)&nbsp;requests that the full
Board of Directors consider the matter. The Audit Committee will not approve any related party transaction which is not on terms that it believes are both fair and reasonable to USANA. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><A
NAME="dm14905_related_party_transaction"> </A>
<A NAME="toc_dm14905_6"> </A></FONT> <FONT SIZE=2><B><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Related Party Transaction    <BR>    </I></B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company's Founder and Chairman of the Board, Myron W. Wentz, PhD, is the sole beneficial owner of Gull Global,&nbsp;Ltd., which is the
largest shareholder of the Company. Gull Global,&nbsp;Ltd. owned 51.45% of our issued and outstanding shares as of December&nbsp;31, 2016. Dr.&nbsp;Wentz devotes much of his personal time,
expertise, and resources to a number of business and professional activities outside of USANA. The most significant of these is the Sanoviv Medical Institute, which is a holistic integrative medical
center and hospital located near Rosarito, Mexico that Dr.&nbsp;Wentz founded in 1998. Dr.&nbsp;Wentz's private entity, Sanoviv&nbsp;S.A. DE C.V. ("Sanoviv"), contracts with Medicis, S.C.
("Medicis"), an entity that is owned and operated independently of Dr.&nbsp;Wentz, to conduct the operations of the Sanoviv Medical Institute. Sanoviv leases the medical building to Medicis and
Medicis carries out all of the operations of the medical institute, which include employing all of the medical and healthcare professionals who provide services at the medical institute. The Medicis
medical and
healthcare professionals possess expertise in the fields of human health, digestive health, nutritional medicine, lifestyle medicine and other medical fields that are important to USANA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2016, Medicis performed a variety of contract research services on behalf of USANA, which included: (i)&nbsp;research and development of novel product formulations for future
development and production by USANA; and (ii)&nbsp;research and development of improvements in existing USANA product formulations. Also, in 2016, Medicis performed health assessments and physical
examinations for certain of our executives. In exchange for these services, USANA paid Medicis approximately $322,000 during 2016. The Company's agreements with Medicis were approved by the Audit
Committee </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=44,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=889235,FOLIO='39',FILE='DISK135:[17ZAA5.17ZAA14905]DM14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<A NAME="page_dm14905_1_40"> </A>

<P style="font-family:times;"><FONT SIZE=2><A HREF="#bg14905a_main_toc">Table of Contents</A></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>in
advance of the Company's entry into the agreements. Our collaboration with Medicis is terminable at will by us at anytime, without any continuing commitment by USANA. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has had a long-standing relationship with Drive Marketing, a promotional product distributor located in Sandy, Utah. Drive Marketing provides the Company with customized
products for Associate recognition. The Company paid Drive Marketing $523,000 in 2016. During 2016, Drive Marketing hired Nathan Guest as a sales representative for its various network marketing
accounts, including the Company's account. Nathan Guest is the son of Kevin Guest, the Company's CEO. Drive Marketing is one of many promotional product distributors utilized by the Company. The
Company's relationship with Drive Marketing is terminable at will by the Company at any time without any continuing commitment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm14905_other_matters"> </A>
<A NAME="toc_dm14905_7"> </A>
<BR></FONT><FONT SIZE=2><B>  OTHER MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholder Proposals.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;As of the date of this Proxy Statement, the Board of Directors does not intend to present, and has not been
informed that any
other person intends to present, any matter for action at the Annual Meeting, other than as set forth herein and in the Notice of Annual Meeting. If any other matter properly comes before the meeting,
it is intended that the holders of proxies will act in accordance with their best judgment on these matters. Shareholders who intend to present proposals at the 2018 Annual Meeting under SEC
Rule&nbsp;14a-8 must ensure that such proposals are received by the
Secretary of the Company not later than November&nbsp;24, 2017. Such proposals must meet the requirements of the SEC to be eligible for inclusion in our 2018 proxy materials. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm14905_annual_report"> </A>
<A NAME="toc_dm14905_8"> </A>
<BR></FONT><FONT SIZE=2><B>  ANNUAL REPORT    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of the our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2016, as filed with the SEC, will be made
available on our website and, to each shareholder of record at March&nbsp;1, 2017 who requests such materials, mailed concurrently with, this Proxy Statement. The Annual Report on Form&nbsp;10-K
is not deemed a part of the proxy soliciting material for the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
any general language that may be to the contrary in any document filed with the SEC, the information in this Proxy Statement under the captions "Audit Committee Report"
and "Compensation Committee Report" shall not be incorporated by reference into any document filed with the SEC. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm14905_further_information"> </A>
<A NAME="toc_dm14905_9"> </A>
<BR></FONT><FONT SIZE=2><B>  FURTHER INFORMATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional copies of the Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016 (including financial statements and
financial statement schedules) that has been filed with the SEC may be obtained without charge by writing to USANA Health Sciences,&nbsp;Inc., Attention: Investor Relations, 3838 West Parkway Blvd.,
Salt Lake City, Utah 84120-6336. Our reports and other public filings, including this Proxy Statement, also may be obtained from the SEC's on-line database, located at </FONT> <FONT SIZE=2><I>www.sec.gov</I></FONT><FONT SIZE=2>. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g1016655.jpg" ALT="GRAPHIC" WIDTH="199" HEIGHT="70">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>James H. Bramble, </FONT><FONT SIZE=2><I>Corporate Secretary</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Date:
March&nbsp;24, 2017 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=45,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=658899,FOLIO='40',FILE='DISK135:[17ZAA5.17ZAA14905]DM14905A.;9',USER='CHE108066',CD='20-MAR-2017;22:51' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<div>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">VOTE BY   INTERNET - www.proxyvote.com Use the Internet to transmit your voting   instructions and for electronic delivery of information up until 11:59 P.M.   Eastern Time the day before the cut-off date or meeting date. Have your proxy   card in hand when you access the web site and follow the instructions to   obtain your records and to create an electronic voting instruction form.   USANA HEALTH SCIENCES, INC. ATTN: Joshua Foukas 3838 W. PARKWAY BLVD. Salt   Lake City, UT 84120 Electronic Delivery of Future PROXY MATERIALS If you   would like to reduce the costs incurred by our company in mailing proxy   materials, you can consent to receiving all future proxy statements, proxy   cards and annual reports electronically via e-mail or the Internet. To sign   up for electronic delivery, please follow the instructions above to vote   using the Internet and, when prompted, indicate that you agree to receive or   access proxy materials electronically in future years. VOTE BY PHONE -   1-800-690-6903 Use any touch-tone telephone to transmit your voting   instructions up until 11:59 P.M. Eastern Time the day before the cut-off date   or meeting date. Have your proxy card in hand when you call and then follow   the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return   it in the postage-paid envelope we have provided or return it to Vote   Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE,   MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR   RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY   WHEN SIGNED AND DATED. For Withhold For All Except To withhold authority to   vote for any individual nominee(s), mark &#147;For All Except&#148; and write the   number(s) of the AllAll The Board of Directors recommends you vote FOR the following:   nominee(s) on the line below. 0 0 0 1. Election of Directors Nominees 01   Myron W. Wentz, Ph.D. 06 D. Richard Williams 02 Robert Anciaux 07 Frederic   Winssinger 03 Gilbert A. Fuller 04 Kevin G. Guest 05 Feng Peng The Board of   Directors recommends you vote FOR proposals 2 and 3. 2Ratify the selection of   KPMG LLP as the Company's independent registered public accounting firm for   the fiscal year 2017. 3Approve on an advisory basis the Company's executive   compensation, commonly referred to as a &quot;Say on Pay&quot; proposal. For   0 0 1 year 2 years Against 0 0 3 years 0 Abstain 0 0 Abstain 0 The Board of   Directors recommends you vote 1 YEAR on the following proposal: 4Non-binding   advisory vote to approve the frequency of non-binding vote to approve executive   compensation. 0 0 NOTE: To consider and act upon such other business as may   properly come before the meeting or at any postponement or adjournment   thereof. Please sign exactly as your name(s) appear(s) hereon. When signing   as attorney, executor, administrator, or other fiduciary, please give full   title as such. Joint owners should each sign personally. All holders must   sign. If a corporation or partnership, please sign in full corporate or   partnership name, by authorized officer. Signature [PLEASE SIGN WITHIN BOX]   Date Signature (Joint Owners) Date 0000321363_1 R1.0.1.15 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1007" height="1301" src="g10496bei001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=46,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=74055,FOLIO='',FILE="DISK112:[17ZAA6.17ZAA14906]1049-6-BE_ZAA14906.CHC",USER="SCAVALI",CD='Mar 21 14:06 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Important   Notice Regarding the Availability of Proxy Materials for the Annual Meeting:   The Annual Report, Notice &amp; Proxy Statement is/ are available at   www.proxyvote.com USANA HEALTH SCIENCES, INC. Annual Meeting of Shareholders   May 3, 2017 11:00 AM This proxy is solicited by the Board of Directors The   shareholder executing and delivering this Proxy hereby appoints Kevin G.   Guest and Paul A. Jones and each of them as Proxies, with full power of   substitution, and hereby authorizes them to represent and vote, as designated   below, all shares of common stock of the Company held of record by the   undersigned as of March 1, 2017, at the Annual Meeting of Shareholders of   USANA Health Sciences, Inc., to be held at the Corporate headquarters, 3838   West Parkway Blvd., Salt Lake City, Utah 84120, on Wednesday, May 3, 2017, at   11:00 a.m., Mountain Daylight Time, or at any adjournment thereof. This Proxy   is given in accordance with the instructions indicated and carries   discretionary authority related to any and all other matters that may come   before the meeting and any adjournments thereof. This proxy, when properly   executed, will be voted in the manner directed herein. If no such direction   is made, this proxy will be voted in accordance with the Board of Directors'   recommendations. PLEASE SIGN EXACTLY AS THE SHARES ARE ISSUED. WHEN   CO-TENANTS HOLD SHARES, BOTH SHOULD SIGN. WHEN SIGNING AS ATTORNEY, AS   EXECUTOR, ADMINISTRATOR, TRUSTEE OR GUARDIAN, PLEASE GIVE FULL TITLE AS SUCH.   IF A CORPORATION, PLEASE SIGN IN FULL CORPORATE NAME BY PRESIDENT OR OTHER   AUTHORIZED OFFICER. IF A PARTNERSHIP, PLEASE SIGN IN PARTNERSHIP NAME BY   AUTHORIZED PERSON. PLEASE DATE, SIGN AND RETURN THIS PROXY CARD PROMPTLY   USING THE ENCLOSED ENVELOPE. Continued and to be signed on reverse side   0000321363_2 R1.0.1.15 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1007" height="1301" src="g10496bei002.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=47,EFW="2231431",CP="USANA HEALTH SCIENCES, INC.",DN="1",CHK=533139,FOLIO='',FILE="DISK112:[17ZAA6.17ZAA14906]1049-6-BE_ZAA14906.CHC",USER="SCAVALI",CD='Mar 21 14:06 2017' -->

<BR>
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g429027.jpg
<DESCRIPTION>G429027.JPG
<TEXT>
begin 644 g429027.jpg
M_]C_X  02D9)1@ ! 0$ V0#9  #__@!%35),3%]'4D%02$E#4SI;55-!3D%?
M2$5!3%1(7U-#245.0T53755304Y!7TA%04Q42%].15=?1U)!65],3T=/+D50
M4__; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_   L( (@ 9@$!$0#_Q  >   "
M P$!  ,!           ("0 '"@8% P0+ ?_$ #80  $$ P ! P,# P$'!0$
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M#JU(,V)#A3/0NP*]H<"2.C)O9]J@-:Q52^Y0;(Q1<\:Q%Q,*D%QIU<:ZC#B
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M0EP1U[M/2VMZ;+S4RJ]R!M3K<,,ITK%=F!@[)&'X6XIE@**"CI5I1$N80+'
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MZC$L)=FYNV.D)AQX( 9YP="Y B196,VT\ZPG#J<X=6WC"LXM:&M/2O'NRKI
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M*_!UJLK)?!&MNQ;/@22?A8N0+%.8@8B*C).>GW8X]Q#,7%#/3"$D:L_5([F
MN<,O?W*M$?UK+_&ZLC5-@N$+=18EPKXG9R!8OKDC7+JT(UGVX";,K8YQ#:FD
M38CKB6D:[M&[LUQT;J2A;OU'86+3KK9%?%L=8FF$+86\(^IQ@D,X-[&"(V9B
M)!@N'G8@I*#(B9!.C3$((%<3]8WOU+SK0_?7(1#[B&6&=,UAYYYU6&VFF1^@
M)9Y]UQQ6<(0VRTE3CJU*PEMM.5KSA./7ZVXY<;PSE[+C>&<>KV7<K3AK#6%?
M+EW+F<^S#>&_Y^_U]OM_EZ^GU@&\*^C_ /U2;7\G.CH^:Q#8W+R!MJCQ%GQ]
MTN.C)&W;A&17),MP+^Z]&_>8&+)'95EP^+:,::0ZA2\?7D\V;'\Q_B7=VEI#
M7G)=C?;M=R'LMA)E>=;_ +B@3YJ'B6*]^6I&P]:'!Q,Y6I".8"4QA4G)CLK;
M^5@:&D29D1T_N7OU$O3M5Z#JNGO('I&M4NKVR?@X&5L4/0K]J.^:RQ:B!HZ#
MLTY2+Q+RZ;%3D'/M/RSS+<-)BQ3ALK%O3"H[,60(NUAZ)O']2!9XCH)F"EM7
M070*@[0%<BQ$T]JF:4Y^S98EJS+E?CBT5($RJ#3$^')>D,Z%^1:D\N1Y!GR.
MK\R>Y_'CT3X\=V04%OKEG86R]>5$2Z:.CZEM;64Y=HBX0DK"X'#H<="3SDJM
M4U"Y.@I&%B6'AY&$*(;?!>:&:4PC#6FS+9%_IP.BZR/)/9BB^XX'6[:$NJ0L
M:HV63U-?)R)0K'O^4*2GLFO$C?VFW4R9>%J4E64J?=^G!U!KRK^/6#VG$5F,
M9V!MO8NTW[U;%B#.3DP)4+M*4VM0JY)3/WB(&&B85M84/A[(34B=+27Q9+DB
M75I7Z^UW4^<?U%&B!=+PX&OXRT[OY1O1<+6Q6XV($FMIR[=;V%@"/']HP@=L
M9S+&2H(K; 2RYZ64T,VDE2<_#OJKT7<GZDV7J>^,Q<[JZ-W'5R+*%;B06:JS
M3=6<R1^Q 8VPJD/9%MTR-/@$GSPTAE,:_%_DT2:\B%&96X_S);H\>/17CQW7
M!P.^^6=A[+U[41+IHV/J6UM93MUB;A"2L+]N)0XZ%GG)5>9N$R=!2,-$L/#R
M,(60A\%YH9I3'U?TR$Y*2/C^OL6:<\5'UCJ'9$7 ,.JRM$;'25.UK93!!O7.
M<('?G)J4DLMIQA."3B7,8]759SW/G<\7]Z[NUA0MHZ&"!EM]:-:L0(M--/'B
M<[-UW:%@F358C)60?'BPK7"R\6).5A,F3'1TD@B=AR9$0D^/?:0AGMOSWOZ9
M5QRO2^_'"7816L5W5SES8?\ K@NO*C\Q"H-S9;@6*S]XJ%]8]5Y7&8LF0L_D
MLVS\KG\[].#\8G"6V_%)P]U/U!?:/FS=7W/5<E8J[IV!"-NY59C-?P<[(ZWU
MH0Q45/FV&RVFW2S<C=0:P6<V,VF+@H@\HN**D20D3YP/-<E.$J\?T/[\8QA>
M4<G]8X1ESTQ[\IQ_5F?XY5ZY3ZYSGT]/7.<_O]#')\_>3KS7]>:KO71G/TQI
M#7U1 K]4LEU-U7;]0TBGZNBK8]/V@: ;V*83;KY>9LHF38BHT(R22*<6,\ZF
M!@Q3"W;F&YFVS;_U#E\G+1I/;B]+77?&W869OSFLKHS0R:A;^9K13BS6KH17
MG*ID,G$HN.$D5GO N22VA\9>?S]NHA>S?TZ/+>@N2]V[7T?8>J=A[8UUKDJ;
MU]3'Y2GVY%BL #T<.+'/UJI:F$LD[A\9PA2@88H4YQQ.'6W<);6VL&:7SQO\
M?P(;RUT]HG=+.P#_ ""4FQ1]$>U/L!JZG5T>!UBT]/AU-=<38"H1EP0IMZ7'
MC7(YIP8A#A*5,.X1I!\"5)NFO?&GJ*K; I]KHEG"NN[7S*W=:W-5.P",'[9M
M)@+Q4)8 8Z4'9-#>9+$=>$0@H9ULAA3C+B%J35Y$]([ILOGZYOV+6]/;6L.O
M8R[<4/R=]@=;W69I,:Q W5Q^<?D+=&P95="9A6,X>EW2I)IN,9_NG*';_E]>
M+:.;]IW']1M9K%/:7VN5I2W;+L,%-W_&N+GC7Y%9LW'!U*E7TWA4"NJI&<?D
M"(ALQ4DL9$ME ><K*Q]OFU.S?TZ/+>@N2]V[7T?8>J-A[8UUKDJ:U]3'Y2GV
MY%BGX]Z.&$CGZU4M3"66<P\,X1E0,,4*<XM.'6W<);6VOK?"SN+87"W$LW7=
ME\=]I7&<V!T[MB8#B-;Z"G)"3@(J"UWHX)F0M %L,IYL<'8B9 IFLE,#&C2S
ME?L:$/-.13K:G3]0]B;1T=>]]U6GZF,V)':TXL+Z(AI*&'KJDP-R8F]O1B<[
M 59-DTEXRBJ8HD01]A30).T*PU858<PIV+9^JVD.R=XF=?4W1T4]0X6AFT;F
M*U3;RM>PMCE9,W=!-WS9@<6&S=1ZEE*T&RS5! JVY5M2[C/'(/=(D8TTA <0
M;U6J._9+8G;EXT 52"HG1QCUPUYI#;9%/V%& 7_=6E$#%[DK@MZDXEG6-GCS
M!RK4%18ZF39\^(3HO:AMF::%/K[3'!SG;^U[7PS3NCM3;#YW#V[&5"HVO:^O
MI2M2^P@FU6RV1%)Q%B0T!N*IV.AJC)24=,67/.611:P%PN1!2'G#Q+(V[U7O
MK1=QL&NSZ/&[NFJIQI?-[2UFUO4XJFA-WRIVV3@Q3Y.MW[=[;L7K\L$8=;]?
MA+)<+7]VR:IB24RH=OZ)LK<L^!R*5T&Z+5/ZH"YS<W X'+21]>HOY]K6&+JH
M:4EE)DSX&I?D_P"T=*+:D"HF%^4QQ!+HZLK7;1?(5NEWGK?%NNK6J_\ 5;6=
MEYLAD$DU*2J&N-=072,A48,38^QI:I[FW72[;K.D9F9Z]NV77NXTDR]'AF$V
MF.UR^6F6<O,+K+:$%3=CH/O7.^Z++KWI[E_3+EXU%&7.*JQ=<WQL;4E8L,=9
M*D=:;<%6-CU2%ODJ\*- ;8O$:ZARKSDY'P3Y9=87X6ONN=VW7MO9.CBC*/$:
MQH6YI36X8K.NZZ7-2\5&Z=I]]0\;?93JV#MX4\7-VAX=M$-S)9H; 08HB9%S
M[B3F87@.:O(AN'9FQN=-3[3H5+K%LW?=-XSL.=6A+$[7K[S_ $>L;5.J]DI)
MDE-.LPVQ*?=J1"T;<=4F"93 69B M,*AJO7V%?B>WYB[+VOMZPZ8EK5?>7Y&
M'WO3ML6?&CJ6/?8[=VC2Z$VR8-"VR3)L5LC+L;7UJ73=L8GJ9I5NJWE\0*O.
MV%3K4653FA?(%T+>^6=R= V\C3>;#5N=(C:M-K$M5JWJFCBW"=#*?"'GKY&]
M9[LGWJ2*=D  ^4NE"TJZ*P\U(2AD-AV2&@#>XEZ$NN]ZMM%C9A<$_>=8[,13
M)<6%HA6OW8P61HM.N<6%-Q0>U-ZTD^5^WLJR6IK7NX;I79&%(B'B<0,YF5A1
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g263414.jpg
<DESCRIPTION>G263414.JPG
<TEXT>
begin 644 g263414.jpg
M_]C_X  02D9)1@ ! 0$!L &P  #__@ \35),3%]'4D%02$E#4SI;55-!3D%?
M2$5!3%1(7U-#245.0T5374M%5DE.7T=515-47TM?4TE'+D504__; $,  0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_   L( #H H@$!$0#_Q  ?  $  @(" P$!
M        " D'"@$% @,&! O_Q  S$  ! P0" 0(% P,#!0     % P0& 0('
M"  )$1,A"A(4%3%!46$6%Y$8(X$:(C)QH?_:  @! 0  /P#?XXY31WL;Z9%T
M(T/D<JP O<IM;G"=0G7;5D2R&CY >>Y>R24HW0)1^+E <C%R0O&8XS-FA88R
M(<A2IM(.)(6K4()-'5H^$D<G-<-8H;9L(ABV8VV-H,AE@K'AJ08 2R2E&!=D
MY?!1*+EVB,%.9/0HJQ8HN5D6K>ZQ)*^J=ME*5U[Z=V?79URG!L*V'S;:MD\F
MG1Y_:7& %_DS(PD-2UQ6X]*04>NJVAXNM[>J36LJ*!WY.Z^J@D>0;-GR[2P_
M!N:L;;&X?QMG;#\E93#&66(<"G4*D3&^VJ1$"?9)O&M5D:77*,B#6Z]1@6&.
M?D>"BK1Z,>I).VBZ=F5>....>I9=%O;2]=5-&RM]ME+E;[4[:WWU^6RRE;JT
MI6^^ZM+;;:5^:ZZM+;:5K6E.1UVVVLPOI-KWDW9G/LH2BN,\71UR<+.*425*
MFG]U:-@<3C ]59"I>6RPNJT!1L18JG<])O$J*JMVB;ETA^W5'8J*[<:UX-V;
M@X231N)9VQA$<H1\!,6*(^3!QDN$H%&XTRW:KNF-SUI16J-[H:[>"W]EJ;\6
M\=CG35RKB?<?L;THZ_D( XW!S_%,(VY1<2%M 43XV6FGDDOBB0I:1*LV$/CL
MD?(LQ%IP18\?OF[5C8X),FMKB]RO8E6#W_4>]*'CS_KWQQ3^*P?-=MWY\?\
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M=D9?KI)<EPX1*'Q$#K+-L0RF&M V4HF%=QHU-Y)'LMMAS:*9)6F65OL,#.-
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:-$$EW[M17O\ CCCCCCCCCCCCCCCCCCCG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g725724.jpg
<DESCRIPTION>G725724.JPG
<TEXT>
begin 644 g725724.jpg
M_]C_X  02D9)1@ ! 0$!1 %$  #__@! 35),3%]'4D%02$E#4SI;55-!3D%?
M2$5!3%1(7U-#245.0T5374I!34537TA?0E)!34),15]+7U-)1RY%4%/_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1"  U )8# 2(  A$! Q$!_\0 '0 !  (" P$!              @)!@<!
M @,*!?_$ #,0  $$ P " 0($! 0'      4#! 8' 0((  D1$Q02%2$Q%D%1
M@2)A<9$7(R4R,V*A_\0 %0$! 0                    '_Q  7$0$! 0$
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MTG*$RJJSM4L^D+%JV9H,FC,.W4R\7</ YZ:X\Y]Z\!1<1>$'4-E*_.[RNK[
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A/'E#QX\> \>/'@/'CQX#QX\> \>/'@/'CQX#QX\>!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g1016655.jpg
<DESCRIPTION>G1016655.JPG
<TEXT>
begin 644 g1016655.jpg
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M&'WA=BJ(F,(G$1$>6S80\5%D*G&QK"/3* @5-BR:LR% WR8"E;(I%* C\CX
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?!QQQP'''' <<<<!QQQP'''' <<<<!QQQP'''' __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g10496bei001.gif
<DESCRIPTION>G10496BEI001.GIF
<TEXT>
begin 644 g10496bei001.gif
M1TE&.#=A[P,5!7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M ( @0'*12&! V0; RB+ K@E%@($EAL!!$Z1!"!78PZ,,< 3 $<0 (A"#_0#
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M!  #9AFR@1$T/0\_GT@$ N#K" PX(7G8^48B\ <K>+WI(#' $R)PB9LY! -
M>'=!MK[RA9QB[3%P:4A2Q4Y'RB .=6=((YB,$ =(0.X)J8.4%8*!1*AT>4#
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M-J3CB0RG!4(  QS@!HCP#UO@ J%P"B+ ?Z_B V+P?F; =H62!RU @[\T@W\
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M$ )@D ,48#ARQ3HP$ &-,$!9, 0*T )8\WSTL )W)A!K.4,R\ 00, 4]8 .
M8 4;9P"1, 3UI AO< @S8 -BZ7Q<X%%FP -24 \6( ?+9)N960#^*$\:1 ,
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MIQB4"1# ?0F9[>L'FO\@![EZ.M09*A9@!C$ K"A*G5RJ!X;,FB"L98*0"I9
M9GFP!AD@K>AD Q- DJ:"!(!<M!I%7TQ0"4YC!!8  Z'W J?@F-5['1$P6R?
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M$$:0S*I=N4R>'A9>$.PL!Z!.$0YP")@%W"CQD*12;HU*JAQP22'' 8!@Y7G
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M@@0%3> L*;/#0:02 !RT4((0@ TV#!0V&J+3R(0N03$D^A+BX\=D@A( 0-#
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M,OY9HA 0? !$3P<X<$70&0BPX0563L@,6CWI4>2IT22-((](3(%@"3F,9-"
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M)"CQ  2)VR/H2-FG!,7#3/9L[\**CUQ&H$<$8M_#_0JB/YO00A0Z:4IWHO:
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M#5!FLHP)$($@'P !26Z0 UB\QS$W( "L.L6+4P8!$AR 51]9"94=$(!U>AD
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MA>TAK:3RLX5H",:S@! 8)*6PFQFP&SCXNRW)&V4S@"P(F@B  ![@A! 8A5D
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MJP,D4 $\D() Z(&-PH$-;0)$P ,0($AU<ABK<I<> )M12!@MD8$U\")CP2
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M*CB!_X!:F ,X 9+8 !7\"!J @R0(G<B45P<P!%&@ PUXBIA1)UDM#X$<!!Q
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M$YLTD$@T:E. 3#L)+M@SA/ #G3B% X#H,;NF+LF24O-H+72 /#B -Q3?LW.
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MGW  &Q $!K !2\0 3=B!AS &#,C''CD#_/*#%A@!#%@"&. !(!"3$? #ABT
M$964#L[(/8@.$BADOI3@)^"!%@H#SMB 2CB%+^""A,?)()BH;X5[&?"8AUB#
MP J!,8:!2WB!5  #<:(!U>.!"=@!4F $.BB"/<@ T?\(+$D6*#@ %_@!W,B!
MQ!=*18@(5\CH_V 4!*=N 23 #;3\R@)0@1[(C530)"K(T8_V]Z\P!6V$^T2
M3U38@5/ *@58QU0X!!2 (Z]0@X?5$L%U@$/HCQAX787H_;6?@<(OOEGR ZPQ
M@@IX A@=@CR(%F6Q@CP(D(0@GE3@ 8982Q@ " PK:@ H2(I-#1X6:M1!D<<"
MESRHE#Q8I*2>BS5A"#E0X^1)/8@26BC!P&F&GRDE@E12$ F%GT!["CJ(5 +
M!BD*UV#0$B*(H 3)!+T)D^/)!D4%M* \L@I!P:A2IU*M:O4JUJQ:MW+MZO4K
MV+!BQY(M:_8LVK1JU[)MZ_8MW+A6227Q8\$,@"HL=H290<H)CS() /\\^++F
M"PQ4*6:,<D6@H!$H#.B585"S!P<-6[HL8J2@()U*9[[( 4 C20864IY C:3$
M@!8N (P$!: B#AU$# I&:!$"-I<6-VL2"G/SP8HG+83LH2"5WHE4*I04!"/J
M,7$ #3:@B.'801@N&W(4/'4@R(H031BQ5.!@8E1[97#\Y<%F=^$#I %T8'/*
MIU3C$?  )U)L$4@1_RP10D%5I,!@1S. 00@!E U6AQ,9+ $$:U(Y ($?D0BB
MP!0S !#$"_;A   =M>451@@/R+"BC"O.)D-I (!'73)\ "'&%&,@$$$!&%B2
M@XQZ;*#!CU^L\EE!!A3 PTFCS$) 1U%@IP;_(INMH$0=(]"PPH]!\L#'8#I&
M,T--40! UV?)5&)/;6#D$%H&*^0HU6D*J%!"':Y -1X]B"1 6RI] 6 /%#X@
M\AD-4D E%Z656GHIIIEJNBFGG7KZ*:B8TF7$! 09\ 5?,]#A!(H1$#90)(6$
MXD,%,$:5#!0)=*!) A&X%HD4) B;RF,L5G+*%P2=A@ &7:10!A4QQ'&*)@P.
M!=4AKN0&I0$N_*9)<"8Z8*>B#\B"PRDB_"$#%\7:QX!P.DZ('2UN M 0!VX:
MT-<&JP!@ QM[^)#>>CP(@H #PA6[;P]_!L'&9^9:L1\I2BWA150.".@!(&L(
M2X(?"Q:4AQ9X$6<=_P%T*/*9E0Y(T(4+4-@X+@H@_%'&&U,P2,<+WIPPF)Q0
M5@%-")$-EH<,! & @2QZ-(B*B:.,L88W)#SQ@!9(^+"(*![,"(83POZS6T$\
MI/!#%^F-X@26+9BHHQHH_",L!6'2  4(PCYA@SYI.E!O1R40( (*4 U%0FT;
ML%<)!H X/941B8 P@3&-+*/C*(RP<K ]YQ3%H!%?=,'(8Y$V$"KJJ:N^.NNM
MN_XZ[+&[11<%+O0PVQ)4]/67$6S@E8PB"8S"1 YY6+))FK/E:L/*X)4PBJ$N
MVVBL'Q0G48 $"),40RC_R49/4*<JP4/2$02P%!? -81 %>&5*\,3$D#Z O^4
M1IR P_H&E!A5YNY-![8"2 :#4>3 >;-A@GH6-Q@7**%8 $@&'(H @P=88 </
M+$/U& 2V4^@L0#D@0!6.0)U38.(_#<S# 50P!,(L@@N&N,Y#8% 3)YB'?6JP
M%VT2X  .(")G,R" #5[@AQ3(9A0N<H#.JO %!C$O30^80 A<Y@?CW @& ,@#
M%>#T@",A2P^Y69$$GA"51HQ@-FJ[4H2*!084*,!\"@B3#61@!@+D 0=&T-/2
M"J &-D5"2_18"$YRP(-<F28'-!#-%TP4QHS%X 2%>UBO#C$$^1R**(J*C#>@
M8 P 1.(%DY(=*$,IRE&2LI2F/&6HZ(( 'F@A!4+_Z %X0K J!5S" A80@@6-
MP(G?&,6!IQI!$!1!@9J4P  J.$$**F"%J(0&60117!Y<D((42($!I"C##RQ0
MF@>TH P5^%($8L &"TB!"G4H PP6E(= L"$%W7,; #P@BVBE@ U"6&9!L!:*
M>K S#:& $@ ,$ @+I  ).&@$(NK9 P+P8 )[N,02A! (.,R@8 <# "I*\,D'
M9,$S +C$-'$Y+GMJP0D%N%C&!'0B@J9 "0X(@A;8<((08" -MT3"N"CD !%8
M(!%'F(4?5-!.(9#- )$H0QI<H %CZ R(8[A"$*:YA(OJ: /H#((MF9,Q4A#T
M!!H1ESCMN0>2L<&GLSA%_R16\81(L"$-:;#"Z0#  TVPH0)D*$$3V)8P>UW1
M!>T$ OY0X( NL)1--!BG$&! "D2LX89YZ4(KA5 #(_0- !Q  4L0$ 1DEL&"
M40D"$TI3"G%:(!0)T*?!/C>;+^"  _9<1.%0*=O9TK:VMKTM;D$5@0B<CDC.
M 4 $AN0<!Q#IDPIXS"D 6IXV\A8 %' 5 "!0@$\"USD4>,QN@5N  D#I%!&@
MP*2(I #PEF>Z.IIN!+!3@%-@-[PZ.L5TXUJ>X4K7 5/Y4"I<%0$%P+=8$!CF
M?W>[6_=\AKC0I4D?BP5?@$KWNP1(KU3VRQLB%:!81(*N;\N3/ CPM\#;I:X#
MN/_;1@"P5T<0CL ;]NO XCK7O%.Y,'"E E_H&H##W]7N8Z1+71(7( +)E3")
M'0C<4^07N-"5+D 7?-[=?K( SS4Q;X9T7!XKM[KA/85WEYM<YQ8+P-+EWHYS
M*^8QD[G,9CXSFLLBW["L64>W'2W$NB+D3-F7+7-.,UCJ')6' *$+4K BG@,M
MZ$$3NM"&/C0H(W  LB&ZT6&!P"70\%M'4[K2EKXTIC.MZ4USNM.>_C2H0RWJ
M49.ZU*8^-:I3K6I/B6 /88YP'ABM%44C( ^)2)Y6Z#$!*51YU;[^-;"#+>QA
M$]H +& 05XPP'[!$HHS$?C:THRWM:5,[+CX8:R)B, C_) R)!B>0+"G<@ @\
M "$0+_!!' APBB[4( (*$<):W?""5/PS B+8=0(,@ H\D)/10> $$TIP"A7(
MX <*T'<%% &"+:B@#'NX-Q+N7.V)4[SB%K]XIF. @@QP@@NG8,'SZ!>$[L4F
M#RN8 076,Z0E=&*S-0B"% XPGSP (@&-X'40RG" (XS 5VRD29A*H058<H 1
MIS@"(0I  SZ8P0:<H,@1WH;QJ5.]ZE:_NFPCX0I&6<8UZ G%$P@ FTX800:#
M43EL0@ &TD%F/K0Y ""1^(/]!!-*-8F#?0;C@27HIS0J"^!\(H3UP1.^\(8_
M/*6\0P_)-, U#<B#"%R B*6$_\ #^E@1#1B!  -4JQ$?;+L=H2!SI\E]/\P#
M:)B248:(R>(PI=$B&W3H6,33OO:VOSWN&[%U370]#A @P8!0Y1.C : )+>'!
M"G9 @^!!  1^<+L^WB <!QAA"3"P'@).5Q-74! O/*M>:8*@B0"R 0<.()K$
M<:_^];.__<(&P]8EP\F2!.($@Q#L!@:!!33-1@LGJ  ?=,(I--(@=,\AO  )
M:$ "U)0,O%)AE,;I1468?)3_W=.IA%\2!% 26,8->4 HR)K[A: (CB )8AH!
M8%=!Q%5V1054G&!!#,F#145PI:!^T02$Q9AVM)D,WB!T-4!<M=F!E: 0#B$1
M%J$1'O\A$B:A$BXA$S:A$SXA%$:A%$XA%5:A%5XA%F8A[$! *I!8V$4 !!Q
MAWBAJQA ATC =0'7 4S95)@APLA/&!Z &!Y9A[@A;TB ',HA!?C!;D! V%5%
M&#Y!@5& ''Y&'/YA',XA&GHAE@3BD.3A&@)7/AR BV%%!.#A 3@'K878=2E:
M)J:?%H:B*(XB*76$9VQ $># F*P 1064)9B '-1$:''4#T4 !]S 3=P7*DX&
M$W"!&MP '*S "ZR( ;RB%>TB9"P!*/0#'!1<%@R!_K -5?# $K!B**S2(JP
M$_0<&+C!#01/1P"C,'J#).1 !(!!)5S!*L)!#VR .'96!#3_ BLB J!AA1%D
M03\4 1<@P"BX 9L8133! 2<XP?20HD$>)$*R3A5D 2$ @!J,05&@0 %T 1(\
MD!N8P YT1#^4P .$UFR003\,P9W10DO001'L7 Y0@$H^A@U<9$:J04M$Q2F0
M A_L@ +HT@P8 -+=&1@@PA.,W'^\0 %<0F@5(R/LA@$X0TI2@ (D@QML@@*T
M0 [<D1(4 !@4@24( @,X&0'<40]DP!]X%E8XP-+!P.F P0!P7Q;, $(]09[$
MP:LEI%S.)5W"A2Y%D3,H0018 AP8'&$<P0N<7!X< 1PP0A,$A:\,PA(XAI -
MYACX@"4P#B>L @BLP74-9F#FY$YF_PP8Z -4T,$-H T?R,9]@8$)( $5/! ?
M/,YC$(C@S 8GU(QE<@ 3F, :1!T8C %V'-T8@  (K(@N#8*K;45->"9P30$3
M"((W\,$:I >4U25T1J=THD4R:  .=*3@&,$?2 (BT <<P, 1# $]K( 8P($E
MS ("W-$,J(%'284'L.()]$,.> (3:, )H%/Q:<!MEL =Y6(*JH$I8,DM3@ 9
MF(#23,4I<  9%,$.-,$8R)H1(!!HW, @3  ;4($:O(!3K( 7M  *%(L1D($&
M5&@(/ 8/N  3_%Q6(%& $L87 ,$*I(%R.LYTUJB-WBAQ;L#!T $?U$ ]F!\/
M  (79($)I/^!)! "#0A"/3B#&RQ#%?RB$)"!*509CQH#/>Q2'02% YP@1Q7I
M-@9!CTJ%3C;DDWK&0U:9 ^3!$S@ 1RD! $6 #]2  XQ"$>S&N"#F@.#F#2 "
M%5B"8^0!%O@ 'VR2JS@ ";315>*:53Q >!:$/:P ##@#*)B"2>K0)> 3CF:J
MID[G5:[!%!@=8,) 9@0"$[@5*,Q"(S@!B?2#%] #$PB!7>G&5*!B H I4YWD
M'#;!J[H &<S"!MBF'L+F3>1!%D2! UB"BF9,)!3!'GA#>BS='M!F#^2!&NB#
M%;7/&,CA$T2H'#CE&"C (0S"&K0 '+B ":!!(>K2"!Q "WB&R_S_(55$P-(A
MP6<L%@Z 04A>Z0]< B<(B@$<ZJ8&K, :I!$<P0TLFPVL@!L4 1[<%98\I"6,
MP+B8 (9J'@#0:4%VA!,@0&?Z@3/<@ F @B+\PPH(3D>,@27L Q.L;(GRJ-.X
M:@@L9 -1A1$LPLHJ 0(\ '+"@< QZ0V,0*TY@\HRP;GUS0-(@DCR@,$BP@ZH
MP="FHF6! M%:43&*)%4X0!-(0C^8P&  $(_^1@PP 1S$5A#,R,">+=JF;:%%
M0!T\CMJ^+=S&K::=@AC)K=W>K4%RV'EM%]_V[7.E(03$I55LF594V%A0V(?-
M6J_A+>,V[HW2@22(PDNMP#+" 1RD !RX_X$;P$$9M  L+N1K;L5"IEM6V ,?
M[,E7=,3F6JY86D5')*OCQJ[LTN6Q#D E/)@?-((^/ $$G,(4O0 5Z.Q&>H!'
M[A2WV2,3L(D/G$#YD5@,[%IJ\F@%G$"[T$ #T4,U/8 *[%I!-L@1Y$ J_)?8
M:=L_V9KYV40($<(#I, >$  &M,"V?<:)RL!"S:[]WB\4.@ IP,$45,)@M(\T
M$L;3T1%AHL!A#H8#7$+K5D651H(&B,$BO  #9"@)D,3?,*L:!,41. 8/O4$C
MH,# K-!47*G<'&I%E$$7D,$0T( "Y@$9% TG(,$*]$#.9@T',)T-\(' -"_^
M=LH&#  0#\ -J/^*"4C=57R(X%J% 61!3%;%*81!$(]!1E*%JQ)",O2#$:>%
MNY'!$)<'-03Q &3Q?(G%7@8Q1@* (8"Q$^Q&NI#! )B P76$"9B!+<)Q%JRQ
M&3708]#!&UL0/;A!/R ;Y'Y>$$@"&(\!#[@!&!.""YNQ2S7!'!<$/4A"3.X0
MU/(&!AS! /0#$BAJ#XM:,>9 $]0I83C#=4"&A!H!'/R!!O3OXEJ%(2BI<Y)"
M*JH!'Z1!#QS<1FA,)3"JB7B$ F! Y 4<5=!!?4Y 9]&!==:$*7# MQK!Z;;D
M/GPH</$ 81DH/9#!( !!/7ZRIFP $P#!%HB!&#! ,MP :5Y%5R9"-Q/_9Z2E
M7P2H 1R(\Q%HP(%&A:LJP2E@0?>F!1CP 1*0314X0Y>0<S]7 2K0<%AT1!'\
MR!$400)P@ F(<R!P@DAN "BP@1B@Z EE@2!Y-#_R010A5/)<\49JS-8B6R0P
M ?)<41=L9Q'\P1Y@@"2\P!;<= UPU#;_P2*8  X,3VGL$!QH %X4WR7GQ10T
M="#< %QZ\ZA%0#\*P2(4P<MZ9$%@K&D(P@&0@21H25:<0CWH<@X$@75:UJ/X
MP< D[QU%D1KD0 :L9@B5Q 0 P1\P76D&116D%P_EFU%$0@%M )IP !Q8@)"8
M1L&U0'>>PHER@FXZ]3>;@!6HY&?0@0F$0(*N_P ] A<-< *#WM$ ,&L6" $4
M#2 9"$)&EJT8',$84 %XC !_-0(3*$(][LN5S,8$E( #\,""?@\31 $]:$ (
M<,"3Q*,YZK8^-L"CLL$*6, +],K:04D$8(#-HD "0.X #&.#9 $*J.1UH2/[
M:$$H1,( N $AZ*CVH, IA'9ZG,(A,$$U90R 8@F=*@E$ZT@8,,(9>#1V7"7F
MN0$3U#>VH@>R%40R,,$*Y, 3#T)-_F4/1%VQ+.3GZ9(2\-=E9H$H%(0-P($7
M0/(V+4(/M( (H^+TY($S" (,G$(^)+%C8UH>+($&I, 2P.*;\,',D&37TE +
M!')Y %]5Z!(2T  "V?\#$_1 /8@0#[ SJ91 D.;T6D*0\B6OCE(!!QQUE*C!
ME10+G:*!#TS #B"K=(]!^XA"B,:L49R!)=!/#/2 +;K(BEO*!B@R$/NT#:"S
M,2MW=];Y$9A </0#8$B""226:?+#"2 0*4@"'/"#),S" X1!2X !$R@W*;](
M8Q?C+(SG"5@ $^R D$?!.<] ,@""&1!K"8QG&2S"Z1K!P@J!H.[  YARL3P
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M%Z;HQY60$(DP0,@8.8,,)0B@L(@_*MC#+[U,:1(E0\; H2>DWBRC @N8*(&
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M V3@AUC_A%($8]" #W]P RC6!H @:  &(+ ')[S@.$M40@&**<(BX-*<U8S
M&Q90 B/QHA0.=*012K(!'*C20#+.DI:U7%6Q;)E+7>Z2EV1T@ C(L#8#1((F
MU4.)?IP0ET4,XE3[*Q\0R( $6/XQ&B;H$!S,  9!>,-WX8/#!'[ @7ZX(4.T
M@T,7SBF(5%@B!QRH# !L((F=.2<9H(##7'; )M#]I0C_ .)?])$ KBB!BKTT
MZ$$1FE"%+I2A#54/VB)@ ]^1(FX2<E.(&&F,%CC0$"UC#I!X X<Q>+$Y;M%
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M!?5-AB(0 (81*  #2_C>>='"'F2 *L @!^B!#>C($F;!" (* .J L%8@!*I
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M$8; !G[F$$))(A7%'J"@'G!R^:KN>U!B'Z&BNE!B%!3R@ZI "_1 +4M@ Z3
M,, L'4G@<OR0^6(O!(( $=X VLSQ!10Q*9)A")5"#>R$!D(! 9(!$4BB'KSA
M"/3A%+[ "SCQM<K 9NB@$H* )0XQ"=K+^53& )8 "Z! H"SR*QB3%$A#%\L
M!L:O'G]Q(Q !"Q8A*$[!&]#@ $@" ]3 HR B"9^#D>3& ?( !*Y1)5S! 4@
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M&:'"HO0B9NJ:4Y1.#>" 1*'C"UD",*3.*DZVCP# $"K!&PS'#616ABL4XRA
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MFH0&)(%@__YY8<J@&ZSF #(R-:M.!A#A +K@!-;MOC=@$*1QD:4"ZK'MY&5
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M!RS,/)B0IDR-9%!H6F"XFQ9470*#!&C_2/0%%Y'D@( 12]3@@"4YV)#4 WM
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M-((6RB &%_!R!D8(1?Y4.0-2N0"[4BAL#3"P"#;\@1&G0$6<*FL!&2"!F1M
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M?NUS"M0P'0MG.P: +7F 3KB8!YL1 <?&@.$HCN.X@ Z0!P&@ B8P'H'R +*
M!_VA3:NC/Q!0#U.P"8.T%3UQ &F"1@3!$*/@!+LA 3QP!-CT!:SU+ !  TS
M!A:P EV4&)TA D2F34X &7UC/CPH S]0 .@!!B;0D +3' MY BGPD$' !]KF
M<&H0,TV0&USD#?#H3C[" X"PBP   0<0 UZ(%^=$!:%A#Q: .4\1 <3C(Y,R
MD/:8B5F@ 6RP!*CH%Z0P*A.A_Q3]$@$2X .<H 20EP&A!0#Z)T(E\#E.DW$P
M0"8(4!R$P $@Z9"K8#OV( -ZD RUDY8TX 0\6 0GX) CL"8(P%-]80]0X ,,
M&6D#\3T;<I0 ((JB 1NBH!@:\ .!$27>L$S:E AO((P$8)=^(H9*T3YGT#:0
MD4<HA4)V5P;_T#;DJ)JKR9HN5P=L@ ;>  @U$ G*-1%X$#_:H@B/Q8-2 # I
MB2<$M8^)DP0GR$ ;, O]A01KP &54  P"#,AX141< J#EQ@.L3ZZ<4.L (FW
M8S3J%EQ4$1&X40!8@0 +1PI><0JGH #*]%WF<P4P(S,)ITP\D!AUD -B2 (K
ML(L3%O^;,G 7*-"5>D #2< ![L,[6" >8E@VH4 "'& ]$Q$"ZUD780!7'& H
MR*$4B&(!/\ #B]"( GH"KV, *!@1:D (AD&6_Y$,8X"6C9"B.5"=$+!1/5$#
MUU$<4; ^5X 36$&C??F73^0#B$ %% J6Y/9%$1$:GB,*+(25*V NE;!-?1,>
M=],705 [L$-^35 )9Y F')<_R+$#4FEW;W&0K8FF::JFLU8%C@$ ', 'ZX@@
MJ?*%=8 (>500L"%(A*2/LA G!4I&G:4&3A $@Z  /,4(7HJ0\DD/,I M*F&#
M<H!O2L P8-0<GJ04YJ, ET 2&Y $&$('9=!-// $2H@!;5/_#VN0!_P9 2#P
M! YW"#$3'D\0 4:2 ?K0-[@AAD] $9NT!B,4$M"Q<"AC#'EP!'" 8* $!Z%
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M8ON!>$(9 8$ 3DT ?B" 'W U4L^LM26! 9MW"!5P E)462>05QF0!3<0!TW
M!OAA2 J)!*0SQ4C@T3> !"H0 NPK7(+WB.N<%Z?0"%MRMI"5MRVV3W"0 JD'
M$7/KN2(@KCRX ];<8I&X ;V' UKG>IZV_TG,NEDE0-"%2P\NQ040T%N602R1
M8#F.]:$7I@ T<"0L 'PO,%)!$%LN()X\> -.0 -%\-,8QKX<;64EL1T)P'$F
M.001X QNP%[!9<YRQ 9'0 @M 'QE<+88P+1"4*K] !6R+-F3?;^1P*R[6T,,
M,RGE4C<)8 ]BH "6$ (/P DOS0$M$8Q>P 'Q0S!R@#1D5 *G@ 7GT3)A- 9G
M8 '$10HOH!#E.B%X=";?L1&1<01*8--.!#_BMS-*@ !X01#E6A:K80R7@%'T
M  AK4# &T 4@$S^@\;ST4";&(2TG  .?@QAO$!J5508QB0.D8 )<8 13E1X0
M,QC%LX5P.2G-8?^$95  1^ *F[4*NZO=## H,G.GES(I"T>ZG;6'@\(K,T '
M=_H2)4 '17!*-H&?", #R P[6'"H'T$/?. %$3!!/#!Q!H *0T '0N#9;Z$%
M/K3;&#)C<F  BT!"LK3?-/$%5B!1ZHT#C; ,+T,5C9H 51&D/E(/JE@%8^9.
M>2"R_!('NYL'EF H6LH R6 "IT1=-$ X-9YG5USA;C0!(<!Q"G#:8D.N'$ 7
M83L=+GB"Q'7$&$!^E$WG=:YESE $L!("-30SPD4&3J &YT.,<:$[_,*8RH*<
MNV(;YY(!LPDF\FB7K, )$T"U3;(0AG$*+. %^5H/9) PCV(,CB$M25'_X!G2
MC@SQB > @GBNYP#@!_]P"'RP!BV "#] $A])Z4SPDNQ"+9/QAU$ H\KT#]U9
M!9.A%6 @!+[@ Z%@.\4> B@S*8.RD(,@ P_Y6/RA -[[%*<PQ3W0J:M@:>?3
MCKNCA&FCU!\8"2604]X9!!KC *A0 D&P)0=0PK-7#P%S&*E#!P9J-!MA"AF@
M"36 %_;@Z96.D"[D(WV3\,04 D]1#]W9&"'0"-/A#$HR 3?0,\9K.5] !8<
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M9$0MF$$RM/209"!INDEHX /BBW:UX/^!X/1(SEXV4++Z+J'L=7 O?NAP1XF
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M.E!#^D"#[]*1.<Q*K=Q*V>&!16 <39"#.C + ] "/4"6,@B$_5@;K2G+R.$
M[3&"9'* 48@"R9$IC0F8';DS,AD$"Z@H K"'-6L:N9*"VZJ#,4F&9?B6%$@
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MI3UJ!./D".^T4S;_+51#/51$351%751&;51'?51(C51)G51)?9^,.$:-B !
ME CWC  *J CWK @'.(4"*%-*/5543555]1ZENPA#(]2**(XP\@K(T(]-W0I8
M;9H56(46,@*1655@#59A'5;2@<0)8C:4B  ; Z./2$*)L(Y9)59IG59JK=:/
MN NY.H'X?"(<JM"%$905T( ?: ))& ,0X(0)4(0#D*M!N*DF\,MU>C@%T)=U
MT:%;60%G<2Y2D (;[)U?*\L0V(!CVE4-,8(CN($<6+>9L( ]R (W& '7*C=C
M (.2FS5588.. I'?P2T/+8,&I0$+J)8>>)=!& 0L8*K$,E5K75F6;5E._Q.+
M3"FC6(R#(DM)&E"/+_7%$'@ 3@B!@5*N&0W82IB+"6 +1CB%+[!#$'B"2P H
M6UR=82L(!KBGR'D=J/U#(Y"%JFT.^" %9S, 3>""HT2 4I,>S&BTR&$P#2$%
M*YM(&/B",;$!L(D. ,A"/QC(WS %^;1*E^U;O_U;37, 9^@Y/@B!)ZJ#K5N5
M2!B2%NFWZ-&#60D60[ XJ3 /3F$$>Y"TAS@%$@ !>'N,&="/=RF!@F 1L U8
M;ZD"BGR((T& JT  @"4%-B!;<JL"69A8N:$'3H"#;5NY^JJG)E@EGM,V1# &
M"/ &SQV# E@=A5B",L "!L!4P)U>ZJW>#,K H?]YHOG2&LR8FRJ AIV5'@#8
M.YZBCGE\G*JXB@Q8@2@IRU#P Q\8A,<( ?UH .8*$5H- 1Z!W=7MBZ%56Z?P
MB1<H+*R+'CFP-00PO<^"B"9X 1:8 72D*19 @E1XLE.P *OS@T;P0>OM8 _^
MX/Q1QZ8(F"<R+G*A ?10,M D"J.0 7^Q(X;Y@CF("IX2DZLXA24@E!C  HJL
MC4U@@%I-)H,U@:T%V/EJ -7U@JQ#$K9-@"  A!"8G#=#@8-B@M.0&P-8@M_A
M@4Q\" _@!,AS$4)P@ S8@@R0'E\<@S/0A#$)@OAT"ND"83F>8SKVGJV8@'%Q
M@#I@#CPU)2OA 7V" 8O_*0,00(6#*!2HF2$ZX$D'4 $S" (ED,]64H)Y91 \
M$()4Z((=N(0?2!\P +_7^8,:((5.GH[8H0?EJH(86 $D2(3\.H102 45T  Q
M",TFF(&I:)FC^: )J96E6A4<P!D\KA<JZ(*N("I<L0(]CHPZ;F9G?F8^*JPH
MH!WI?1/<4EEHSF9MWN8H8@\IO).P0H)-Y69R+F=S/F=T3F=U7F=V;F=W?F=X
MCF=YGF=ZKF=[OF=\SF=]WF=^[F=__F> #FB!'FB"+FB#/FB$3FB%7FB&;FB'
M?FB(CFB)GFB*KFB+OFB,SFB-WFB.[FB/_FB0#FF1'FF2!AVHXQ8).(#>@0 0
M_T"#)Y@*"0 !F6[I5(".F5X#K3E>-&CI)XB 4ZB'ET:(>@BE/+AI^($ $HB/
M3PMJJ ,!$J" X^#<&G& OB. F+[I:!7J%OHTIU;JXWT"!$B?HN[IIX,.L'8
MECX %OGIRI,(". !G&Z '42#5(B0"/A2LN;JH"YIONYKB.BO(7 >X;HR2QB
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MAXAD_RA<GK)Q+ IP9Y>0#7"#DH/0Z;H-8I^%/)CUAZ#M.1!T.1@%#9B"(D@
ME&<CU#$ [!;3=[?M("AM%%"#H45V6BP^27R"/L]T&% #R,8#,AB"*E #CM,J
M(. $0FB"@\\")1B%:,^!;DP $V5%%2B#%KBPY,(9/D@ ":B1#1@UCO_[BX8+
M4-@IVAXR!Q!TG@0 9#_YE&==.(B<WYASG@*#3=B> /^LL]+<"#B$RXH$.*@!
M C  4'?BQZ]L-VCV#5[@5+^$+O@!9=KQIND",4 #RW9=$S #-;!%RH=XCN.
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M$32\+LM+!\" E5E;Y$=.3P!,@6?Z(IT/Y:GX,;8#H]!KMA%?.$: $4"XP!(
M&"3B0F?$@GM("8-IXE,R?%Z;O/++,W\7!RA4%D0H$*"21AI2,,!#(A6D8/%F
M:0"AA1"I6/)"(!8@08,B-(.1@VF1F+ '!A8DD@82"3RO:QD[Y.&"$"F$(@AP
M $)B'$.L(Q1A!WZQ7B@*$(87_.$$PKK_1 H"D8@?M"0(G'@!%4B1A@H(H0<1
M@-0#4@/ 5!RB"-Q#@@,B(8@_6.!//*!?"GX0@4,@XGQ\"D(%*I ([P' "&1
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M'( *G-N0C0!0.10-(&$7<,(,-$'P<2$47D(M+8'_'MP4I.5 OZ5;EJA!_
M';#!&ES"A9$"%#S@X9V;19R")6S"Q3R/_E4'!S00I13*Q30"(11*"S+!'.1:
M$NR:,?G:)0!!"\I;$_P:V=G#!.S!):P (4S-#\P05I5 Y)A!RZU!$%C C+6=
M$92!,:@ ?WT9R\U@$'"$#9A #WA#!4@+*<"=""2$K[E;"!A!J,6 *^B9P5A$
M.0W<O@% Y1A "^Q!?^W!*?A./?R!M)3?-6)C-AJ( 8A !82"F0C''\03C@P'
M$%CC30'!&N#! 02!89P"%@A&,A3!?#D #60?#W3:CUQ&&NP!%OP(!@0"$N!
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MK0[)(B'!DHBK94B K>H*"=PJ:#;"&#R!X?S#&HB& ^3!LBJ'O8+ G.2!3SC
MMZ@ &V%$D'C#G&# $8R -RS!_RH8D*K20"4H@+7N*UNN0'%$P%Q*R47<"QJD
M:CU$265(0+I2J:WNBP04;+/ZP;ZNC3/@A 1 SA.0K$68+":\#&C^*@^8V=),
M:4X\4 +LGLI612,8A&5$PC+8R[7RJS[F@>>D[)N62<L\@;VRJV@\[;:RS:I:
M:M9JK;700';J7E?U21*XP!4"08&!);[Q!@^DP18$@HS%0!K\ 1OL "F 0B@
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MKL& &BA$) R/16! %FD*N9U"2^'Q ZR 'MC#"5@!!&R =/Z>>FD2"N"L 1E
M;(T"N4F4+<U 'Y?!&EC 'D" #4 !%?39+1D"X3W !,S8\,A@JAQ7120#'^
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M7Y_]]MVGK1$GA%H"ADAR (".%T!\\I06A%@A! ^P0 B<-32.@.%T>2!!!$A
M )#E( ^<D$/_2N" #7Q(*V @A#WX<*46+(,A=&"5 5@0 @B00"*6F $=BH"#
M'LT@$D,@ !WX<!.)M& &1B##K;1@A3#(T$2I",/0;O2$10P!?XB8CQ%8Y8!%
MN"Y8&+" &53@"K')X$\&^"$ )/"$ C0P EI0@M56U:HN H >&C"B$@@P"D2<
M80E1X0 B_@2 & S!B4BD0R7@R"(;L($!1V!C$^2WD"JXR!YEB,D&4& $6>CA
M6/D[E J0T A75"$+3HA (+B@%=0X(!(HH!T4.!<L_R-8P#(&<,$,1N$GS87
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MAIM0)@U2.%=CGW("*Q2@$?5DU0.6P")[0"J#A #F_I;A%E(DX5!AX,(&%'&
M @@-F!]QP0\6$0+G(7<A3&3##AIQ@AP<\D7VT,0!BLN0*D2UH76DAPQ<( K-
M.<4 6N ";SWTIU=JA5 '2,4BE% '"+*JG2A(11#X\(0!)K42/!!$1>AQ(CO%
M( [_/7I1,@11#RPRQ %3X (!N-HL%XU"80 8* :,I820+:0.(\B#[68 !C9
M5RO2LFN1#O %%I5JE<]%P& Y(H%&(,+#MJP$B&2* 4#@H 6157$PE0H%$'G
M C#H+@!L\(**?&8%/T[MF,E<9C-7Z,@U" (;$F!7RL   BXHP2E#D$X$.$ -
M)H 21VA 1QXDP1N(8$ &CJ J&A$-!:< @PD^9HA^DBMK\S'1G8=8!Q3(:J'9
MG6L). !=GM;( 4= ! Z:P D"EO"*GT6! FP0B@+H3I]UK((SC$JT'%!@5CAH
M! H2  :/9= )":!!*#B0 P7P@!-C-'2D''"(>S6"#T=]_U&?^D>(4QQ"$( #
M0!U" 0'X5N(-+1C!L4-QBBTGX[):&:(1EK"#:P_! T9J!$/+ (,\K!+/)M #
M/9C 1H9P.P)TO:L>P."$Q/K+3EK8@Y C(-U+_" "](!"*GS<)Q 5G (\Q<$&
MZ!@$%/" CGU*A1J4H  :O. 46B5 E[VQA53DH=WE.O/,:5YSF]^F$8.P0"AR
MM*.%Y*S>!+A$#QK2!:?4K%4<"<(2A("#V9X "#Y PBFV *((^. $2 B%ETC!
M!2/$@0 $ ,$>F,*3"-2A!M'2%P>X@('9 : +5G  #;(.!&VK>&D8",5'T"Y+
M7RC  /SREP.,+C:P>P4,Z7: "/^6P'.)@$X,H:CCXNNF@"HT0@8_Z$(/>,"C
M+6C;""X04B"L4/BO'RH&91 #<1@R8R68?G8. )WDJ\:B#/S +<=Q"@1:4(81
M56$+"A"!%P 0O'HO) A:,D @DEZ[&1 % %5 14P8GP3>:$4$<A@( :J ]L!/
M8!4Y6C,(0K&44_ K\B *P@2D<# .A*(>8/_:!$I.>)=D  E7N,3.CEE^)=T<
M  -0  =P,&*@>?C"@G* M.+B__J"0&!#]O;,.AQ@-AZ0 "\0 S-0 WU#!,)F
M+R( #%;!0<)$B\9M T\0!5-0!5>0!5O0!5\0!F-0!F>0!FO0!F\0!W-0!W>0
M!WO0!W__$ B#4 B'D B+T B/$ F34 F7D F;T F?$ JC4 JGD JKT JO$ NS
M4 NWD N[T N_$ S#4 S'D S+T S/$ W34 W7D W;T W?$ [C4 [GD [KT [O
M$ _S4 _W$ TG@@&6P@$P8+0B( ^P  M(X,YT"@NZP!"?  ,,D1%/@B,*T1"Q
M8+0,P =<HB% P#PBX!%'*Q!%H$LFT2PH, )X8 TBP!NR@@];T15?L3V.8 0J
MHJ!R@,3(8  &P 1" <]RT1='(!)\41=M**G<P!=-@ N"9LD @!3@P RT0@T&
MH @.)AA;*/K"H!]*8#-"S0E.X0CN!Q;#41S'T2LVP$\<@!XD_\@(.&'53H$&
MF !Q(F 4;B $' !DH*=:5(P)ZC$/"HT DH$)2@#F]LP!:,$$X$ .C&"DQ@!$
MZ&$%4L ),,L99@$"+&$6R!$C,Y(/MX4+0":86$@3'< 2(A( /,$$7@1D3" -
M*J ">L!+ /(% B$-)@!9B*8(6H"F[(06BF "EB$99& *IM&"G(#%G,(!G*$;
MOU$CEY(IYS "U" '@B:M#,$:%T(-QD A2.$&Y,"!P&  W  L38%-D,\-]@$L
M;T"&Q&8%3(#X0$P-]*$%G( #7D %Q@ '-&<(O+%YCG(6^A$<FQ(P S,-Z8$/
M?(".\,<$Y$H-2'(43O* 4HI D@$A%_]BT4#D'NM(I::*#]H@!SB@A6Q $GRQ
MA8ZR&RU2,$\3-<7P ;* "5!@*>R!$VQ1)OIM(>:112XS+H* "6Z3 S (9#;A
M"KRB"F@APM:R!PR!(1M! W[ ![!@!2IH(B% *5.3.JLS"PWA)-VB"<@ +)G@
MG!:"#AP39/KA!L#2,27+#<HS/0/J@/:)-*[R%&C-##RS'E; @  @$I+2"<[
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M#BI4"_9.#1!A"_"@#'1MU=XB#Q(!" (A$:@@9![ !1)A"U8@%#* $Y#@#\H
M1NFA K8 9N2 A<0@$-B@!FJG=4V-(>@A!8#@#T A!&Q "+H@#=C@"=2 <G@@
M#9 @$"2/(VQ@U "@":2@ %0@#;9 "*R 'O0'G#:@"+:@DR9E"C2 >Y' #R9
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M;)&)G")5Q*(*IL +MDDKY(Q0+"^<&6(4/OH<3ZH.7N#EPB!).")&'@J&9,@
M6J '#F'5"L!13A>;'T!HZCF_9N"FG\ /U""<H)$0G,>VT","QN4 2$F_T$@#
M+*,*OJ '"H '9, ,D)G#&" 22@"]2.$%O,A6K(8'K(P95P$#3N 9]R@($($*
M"J#3_L2CO5%H8V"H1X ""BM^3UFQ<8,#9"P1:/]@"/R)!Y# !UI 'W  K0#
M'LA  U8!04CA!+8W%1 (H& L#C+@;T#) V6)$?^ #$H@NP! SIQ-(H:HIK3
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M?O!> -!H2S8:&V *$UAIC, #?5,JGS(2&T (=U=J=M0X=3 !(:"$%L(VFI
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MG-JIGOJIH!JJHCJJI%JJIGJJ3,$#6L /*<!8P5(>G205&/ #@M.B<N, ('
M(L %L]$C'8.KK4(F & #_ZW*!BG0 SY:&>9AK,8: G:*JM :K=(ZK>225P5P
MK6 F8S$6%4^D,@;@#$4P$*H6 C3 >B97 EEC /Z4GAP 9>51 *?P8TNDKG!
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M:O!:U6C"H 0P@.($)M@#B:"#!#RTH QZB""%'A"&57CC"#G(@T0^D@PK:B!
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M$MO5>3^81M0N9 ]'4 (%O'R8A!C@8VF,80).X>/"_Z' RA$8,!]J(.0(9 !
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M'IB /2A+.-@!CL2"B<0!IX1*18(!FH(!10H!&]  *RC+B</)0)BX9-" /3@
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MV !$. #7JXH'L-$'F(#<@BEABP?V ,#Q,:CE<+E4N NWFHP:M8(I4 *^C"4
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MEZV"&""#%]B#*^!+(<""0"@# OPVJ> +(.B")2@*C=V+,#B6CP6).I"B#3(
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M:D\#22@"IZ<!?1 >1#@$0< "%5 ;#" #)TB*+T!1*:X TZ^ 4'@Y.\F"$G
MZFW5/%B$UP=) L2D/#[_ O( @S*H)<<P%"R(HQ>HAP^5!  "?1H "#(FD#
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MSG<731'636]=4QY!5P2!X@#8+30 #>2QQN%<2^TS11B@<38%,=K$N AKJ.0
MT64+C<$:?VO^-.F#T^2 !"3 G(?3]:3NN-.DW\TS!1&,7;?3.,'.]!H1$'XY
M&I [ ($(6) MUN^X1P!!/;OWC #C("AHO$Y=HT'HT@4-CST)8Z?"_4VG5+_]
M2Z?(DS37U>\\/P-R;X@T 78';354I(R!0/Z^L =+H*!W6^- $2:BER*D80E%
M2,449D,1#+DB C_RT$N2P00A5( )2)B"LZ"P!"4$P3:PR8(2$*,&%!2&"P"P
M1TLB_Q"!L/RH0I5I$1TT8"1OK&!:ZS*&"M( B"B]!$.5\-$B^F* ZO!I-@V
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MB 14@1KBI <LTVF"/CJ@"?T8@E>,((EOUD1>-W ) #A@ BXX8YIHT>8IU#F
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M @Q0 .Z)-Y#^A L ,+"'!+"T'Y5(@(__8RH)43C@)4/UT-;59).*,<$-SP?
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M8^0IJTT8 #6LDQA(PC])JFXPZ.C)HD4I 00X0S\TISN=P \\43+T@RLH4#0
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M@8%= R+)08$'LM@D 0<B&8$&11*((  $'OA""<WR6&$&T(H_ONHCHC#ZLR!
M@8.)$*"DAXE0,*N"DQE(*0('=?/ (Q 3\-BC[:,K]\Q*KP%HH.<N%C_:A1Z:
M'.6%"*SDG1#X-=. )D6@'BUPQ=>P1 \H_ZRO:YH!(&;H 3PK@6$$  S@HMYW
MJCQL87P R(,F8/"U4U&+,T: POA.94'WQ2^ 1%N4$<I0 P*D$'.;R<,B]G"
M 6*0?214% "M)$ 6CI!U1;Q7 08SLXE%X GU( 'JC!A%*;[, 6! Q!K^T;8(
M,,EH7CM%#<&T 4$D@!Z2,($<#'"$&6R1 */0!PZ*5P+( < (65CC^@18@*7E
MP8Y'.T4>G!$]5FV #VL(@!:Y>#2?14!Z!E###<;0.=S-8!2(Z*"ZDH$(!%X"
M"%MPW&<,  (%7&(-!D #!@(!A!H H IU8 (B@-"Y)FC@#VG8@0-HX814,@P
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MZ0&<X$(C4* &0@1!$ IP8RHX4 08Y($,3L" ,T3A@2K[P1FN.,,*D."'1:#
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MD&X #LPH!":)#@0!]<(E"!0+3VA "E+A$H '-&R ";@ #$0/3U#AKW@'"0I
M 1Q ?PC@V!+ TT!- 3YH!S! "\3NU B U'(,#"K!YXC&OQ2  P2! 1R@!6:
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M,WA "\H@%& @ II !H# %Y:&%":@#+# N3/#&T@T:X*@[ P 93E2!O"'))_
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M& 0<BQS <6D$PB*"(  8<A U(--#WZ&Y@KD1H7ZL42.(&I,#80RRAC.-C10
M9:@3:&=,IL?U!1>G \"YZ@\-3]?OP_\>?.JJ.P"]\\=;ISQ$I(Z^?&#51P\
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MH_ IN5:1A5 X(P= M\0(+(&"+!"" V.@@K_+R @$C$(0_\C"CQHAB%-8P@1
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M*R!U<PB)D?@IZ*9NLY$/]4 "[396$@ ;N><9]-8G+F4$^O: 5+!6UN< L32
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M>$=P:R.@*A% "F30#W @2[8R 4R0?_*#54805"IA5RM0!#[ !U1P (OK<S%
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M4_.35/T\DC^,681B)1A> !^0!1GP@PU(>$ *Q$(4 'A $U6TP>D  (89$,
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M5*O1\FJSG,(9 W!%$Y0=!#+<X 4X&(4)CK."'$2@$4RX03N#P 1^@$(04.4
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M4S0=T&:[*@:8Q^NHS_L,A9N*-P= Q5-( 8]")@=P3P]]3FD3& HP(H8(&P?
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M50#_!S#)!W !3=#9B(B!.&@!@#LDKJVK!_@"/7" !M6>%=" Q]%57FU:AB
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MY&5K=88%5&R>M:$'1KB"#<@!0RV(JO6L(I;7'+"'54 =@#8(_R.0A54XA"+
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M$9# 4#U_$E1/7O4\ 1&G!*BI::&)1H !%C  0"E#1C0&@0]H(&  "#Y@(>E
M'?S@7$00=$I0/OG_] 8#0PX$<.,E6/A)D $D1%!G:7F L$:J/-2*K)HR17#
M4A" @, I("3K@#SU)-L;N).2H&L#U#[1+&"7#I1'NR0LE<&DY/;:&R80F?J$
MI@"8>L !E%( P*?.(IPC!B  -:VMILD*0GH2I&=PP>I) ,(3?YGZ(P 0"!N5
M"'M@VENE V&0*,!4."7OH][L48"CBLKSIP,'0,0G%KU*H'+"/_-9KJ(27$S:
MKXJ"H( #D:8[4"EK=!6!H:GB;'#)\8(@,4$8U'!MH3ZL,2.X]5P7*:KF/@S
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M]X<TW3@O%VJK4QZPA$%8 *X.H,5@"&"$&(LU!'0(A?^=H8 #&HP@*)K @4&
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M/)7>0/" +_R% ]  ?:C'%,@ $@@!%?R!,:#"/]R5 ;3 "JR"Q*5.!-# !*
M;D3")#*% 6S!#[D(* 7!$LC 'N3<)4Q (@R:,:Z (_8&*EA/AS6, <0 '"00
M4U3!JE6!"F@</:! 9/# B+F('O3;"R2* =2!!I1!X=3!;I2C8Z1B"\C ":"
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M V@!%Z3I]8C%&!@/ZY#""Y J/2R6&'2!%?# "DA!(#!!"( !'XC!$O3I>6)
M-#!#H<K$@@E8\MT' 3Q %KCJ0"C6#UB"WP'J: J%"4Q OCG+ Y"!"238L_A"
MF1EC#W"KLF2!"6C<!HR!0SE %S0:EBA1?;BHZL HE()!)<3$@@4"">4<!ZS
M_H3C%.0   P( F3 (C!!%JJ&QUZC-B+!(<!!#YQ"'<!!&J )4TS?"B "U$2
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M&>3!!,Q )$]R"&Q )22 /3!!O1*$/0 ")"\!0H !'(@! R= )(!"/_!M8+R
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M^ZI)0M@;_B88=34:; ]$$+A!Q\%!"0#LI-S3DVX'DUVU$IS"$L3W0&PN$]S
MD$4$'2 I4G!"QX&"4:MJJGP'4JO!*F1!*!S9"A3"$6@R"ABY&MP * B=%:@!
M0@^(0P_VI/;8$<AZ%!,$&#C!(2 TP"(.8!]U,&^YRW%[(QBK2>?$6@397DN&
M)'0<$Y@@=?ALSA& (2#"-_.Z&GOUW^7A@,O #ACSE= #H=OZ 61!8FR ('1#
MP*:Z ]#!"H""">R<&O"!!3 !?52!0,>$ S3""KB!L#)%!#2!^7J'SL*T*_#
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M( :,+3"94?5%%TDY$#31-Y['"B%+]M562F^%,EQ3(*(LE$B.O#!N8(*)D@#
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MLUL.: (CB'N6460K+<G(;UY.@8H/I\4 T<T+=Q(QU&$-URYTL!8A7[ K>TR
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M:< ,59@"&U8@:/*M@'!EL0%% -#K*H@@0%;@7 J$$(@73)L-$UC%_B  HS+
MP ")6-4R\Y"("@6AYAP@&41!UH)@!5*OE.X$%'",%"K \0[H%%I  U*@$A#@
M:%RE!JK !5)@ E#@9KZ/<*2&1P@G M:+#:# C()@"<K C.A "EQ@!7K@7M!#
M!F10_) @$&)0 3K/P2A@>UQ !BR@!X3H\X2%%+R, (* #&[@\6 K"$Z !0G
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M(14B0<L@PB0C(A)J0\<0H!'&T@@$C3PBX076X&8:#CMB( X>P@9F 36.#S7
MH 2: ,=63<F4PE0C0 OTQ ,TX0W"@%/J0 DBRP:P#0S.U-]*B08DP3T>8A1
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M@;K!/^@ #O;@RAS 9?D+  K@%"1 "Z3L:^_THXZ#7CNS!<: ?.DB''FH*#R
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M4O>I+N@A!=I?"(A"D>1A?R+G"3!@;$@@=P   E1 "!8E D0 (!@ &!A$SD
M#X3@.,APH(-+*90T(%4#H2\" (*D09*@H<,8;/9@?/ GD16, /*(''CJCY =
M&(T$"B40@ ,:*7X@&.BMHDV</0@X$"&01R>4#//\ ;+0)H@G'@?2VV%3Q Y[
M(9!>TH,0B] @*9#4;&C# IL4H2CX2'&V1P$\2#T:$&%A#98$$2 B41 50(0Z
M0O8X\%'4"H J/M@$C7HJAA"H #"XV/\+X-*3I]Z,@7F1IL?.4RJ _/MQZBX
M&UX&TD$1-ZD*(8:C.K#'!2.&/0 ,_.!+2@@:7P@<:-Q;91&0EPVJ"@E:Y2*
MG@A5A$(#U4@*I@",<*G:47B*'A$\/M!YL$J7%'N"^XE184F)@7G0[$SY&H9#
ML$AV&G&!O?G\@3QLU!U8/Z37D -'")$(59$%@@0(#%2!1Q<5^ 2 / <PA!5*
M/(35D4?6(4$"&@3D9<%V57TWD!%_2%$3/8'\@ 4#&*!QF"]\"9=&'!A%0!$
M#5Q2D1&"^=%%&I9$T1J0I#0%'PCS!6&&0SQ88=F,C&$Q7P1@&7C;D@QAD 9-
MIXB 0 0@+)3_APL5]F6 :0=YPY5-:^57U8E"93 9#RCZ<<M_?04JZ*"$%FKH
MH8@6:D 6.;3FP!1C )KHH*3P,65#1H"BY*2%.@#-+)("P$$1.("): $!I,KI
MJHDB($&J%+ JZZQ].9"'=*;2VE>NNO9**Z^' NOKL ,U,L2A#M23P@S$&FJ
M%B$TZY&P41G0Q1X86&"AM(56$49JW(;+:G(#&:#"&ABP8-"AY(KK[KOPQBOO
M00]0LTQK!JAA"@'4)CH1'S6TNR(G,_2;J %A5,)O0X9LXB2K^:0:P+R(-G
M"?440+&XJW5D\,8@ARQRLS24T*\#'" 1WL8._+'MR%'1XX(,7(1*_[$#D:P+
M,\@8:%&&9SL'+?30("_::$,10/HQHI6^G!T<FS;K;26ACOKPJJBJ2O1!#4AP
M0 "Q;BWK UU@YP &@0 -'PD8D5)!(A7L)O;<=-=M]]UXYZWWWGSW75X8B. 0
MP>"#\Y#%+  L;6@0G Q!..$<,*$SL3@78<;C$9SAC"E\S?JUUG-_KK'?M1X2
M2A?:&A"C"^1%T (*._& 11>+.-$YZ;CGKOONO/?N^^_ GR8)$TR 0KSQ13CM
MJP&'%'_\\2C<WFP>SMS !!S.@\*'R;1F/?'<$7P>-LAYL V !*G85 \6D)TB
M^QH825# )7M(OV(2?*D00A"A($"/% AX0/\@F-"_@^1!"\H+G@(7R, &.O"!
M$,R=4OAA%@ODQ'[-\@X;*,B&-*Q$7&2S #_.P@8DI$]7^:@'"3)$MR<$(&,B
MPP ;&&  5$2K Q:H@+8 0 ,A!((-.W! '620!@LHH341B)4#6A "4O0O(3@H
M!1HN4<"?L":"6,RB%K?(Q2YZ\8L@\Q[=P@<KD1G !7*@AQ 2\"R#C,(5#NA"
M#2(0 R4 8 ,O",[*/"*<)"2  \M(22*:0@I8S.>,T0*C(A?)R$8Z\I&0Y-L!
M/E>W?&!L=" ;2BA$\,0O"*$"+JB$ I22 AG$(0(T&,&@>+"$*9'"%00P@!#F
M1(-0=,X(@XRD+G?_R<M>^O*7P 2 &,$W2;"-S 8O<,%VC'""!V%A#4M$P@%4
M<,0-A$)0]#C10&I) ".X:"!.G(\3,1C,<IKSG.A,ISIW%C'0B4UT(S. )0)W
M&%3,X!0TB,,IO@ #""PA#@B@ 1("98!%#*$ %$  +FO@@U"@))P#$0$LN08"
M<J[SHAC-J$8WFLYABBT"3ZB',47F # <#0#T.,$$V("#DFK@+ Y-9:ULX 8X
MK  10:S#2F'P4%A@Q &-> ^]OC GCAKUJ$A-JE(A^#D6ANZ2\60B0R( @?F4
M* (.V$D$;#:0!A#N% ,I$: (<(6#1" N#4  5Y?*UK:Z]:UPW9A'MP;2_Z^-
M;V-Y>)U%5P4F@<7UKX -K& 'ZZL4KK!N7X.AR/PP%L(Z]K&0C:QDFS57HI%Q
MI)/-K&8WR]G.@JR8WYM;.S'IV=*:]K2H3:U'*CNTRT) M;"-K6QG"]AVAO:=
M 3@ :6G+V][Z]K>_9*W07%5&X!KWN,A-+A8_=UNB60RJRHVN=*=+W;P)-VA=
MLVMUM\O=[GH77H9U*FX#L-OOFO>\Z$UO5*Z[L\O>5;WPC:]\I0O:NKE0L?/-
MKW[W*UOVPLR]_ VP@ =,J\$5( (%4  $SOHN ROX% EM< 0@?. #*ZXOMJTD
M=/G*(IJL-5"HK%D6(T"4J#3 &SPE5@/BL]>HY/_E:L["0HL;HM _A.()'_85
M#PRTLVY^<'=H@HS=!H.6&2-*(W$PLJ$< ((4#XT ><#");+2 ![,)!4YIA5H
M4E !+NPQ4%7>@PB<S-F;6& ":)Z #%[RY68]0 4J1?,)!@&$QDJ+!RZ(\P3F
M7#]=^7=DX=,NJ_*P"#B08159%L\1!*%DWSV !3"N2@)G%01---HA=9AT0\KD
M$WLD@@+],H(%@! ((=A96@X8!2,2W2QK-18#/[@PS(2#HH&06--".QL'!,%J
M0AEA"<_TE0,.D4B&., (/ I9$$Z@!E$ P!Y+0$(@I'#I51GA"T#X@PP8)"@A
M2F$*Q=ZL S; ! UDNP+_6_C#"HK [>DM@@]L^ .Z Y$")KS@0QGL ">*4 %2
MDWH))EB,YU(EWJW!<] (# (?(CTH>O#C! 9!DS>>*91+D  +) B._$" I3+-
M* +U$ B:% !E$>P!U!ZI,A;0X   U.,?)D<YTGRP<@08@ 03AT&;!P(!$8CA
M";;!@@\T\002\ 4")(A 'D2 );_(;@?AB0#-<>R C<\( U !^:GIH0D0[$$@
M9\,"%J@P$ Q<BR]1AE,$GK[SO*Q "FA0@!%8('8<YX;C0/<(*58= 3DFZYF#
M(X'@FQP!#*S!!^EQ@-2Q /4(D #F>]"Z7RJJFEF@Q.Q]YJ,$1+ &!:") J<@
M_X'(W]<CV67\%/4X$PE SP%   $F#V%\B2H*Y0 $!P*(/[5-,&!R!2B>!S]O
M0.A!<( 9&0 ->,>( 3B.Y3P$P <_@ SF<X0!L3.@RI88 Y;27I/E=P'H(%]?
MW GE@)YC(:&V.KOC2;"&2UC! ?( P1IX +^U ][QXI^/$9S0D5*L(3Q8YQ&.
M5WT95WXQ=S8JH ]B8!A5)P+RX0!^\ 03QP!55P <-WH4!P"XAP8ND!4,@0!Y
M< B"( ;V 8%,1TX@=RVQLG@GP4?FIW-1T0&)< A1P$.L80!B0(%^( (_D J2
M-W('LG8_5R*/9W([=T )@#.$8"MU!W]@!P+AD3),)/]K;E4%1[!J#?$ SF!Y
MW&(#3%!K!Y$,3% PJ*8&@H!O#J$&8Z![B?)G(@-2(O5>B"(4%! !'( (:-@I
M-( "044 #_ %JR "@U0%6? "/B %-5!2<*!#)6  +2 $:2 %IR!5R8 _JI,&
M8;$P!^$ R5 &.A0MC3 (/Z %R395&^!#)U #1L 'H? '+"47H9$&BI  <P<$
M+E $!X! HL(C9C<!'MB).C0E', &.I2(8+ "0F !/2 "*) =F@!C"B<$D]%-
M<.,".9 2.>0"1X0!ZI9(09!#%M!NY1(#<! 8<L<)D/@"% @8%8 _!V(L774:
MX!@"?R@$)Y "^*,&B" &@;#_!PT@ BD0"&4  P:P!*O0!4O !9' +$:@")V3
M#(&4'=>AC5$A&6D0&)-8 D$P0QG!!ENP0Y?@B4"$2S1D0WG0"'P !-LQ%%/@
M!'ZHBQS (S64!ANAB0?1,Y@('G7P C^D!_1 1$0T D9 0&6SCCX4/1L@ _P(
M.X]FBT>45[88/4%P!"^0@]FA;8F$1S]4 Z=@"2_0!640&X(RB5(P)G(W:I.Q
M3_:8"&QP"@E"1%(Y:A9 CX"(D.N" 8J@'X-T1D?1$![P!65PD3A@+IBX%SS0
M BE)%:)FB\RR >6H!3J)C$;4D8&0"#50!9'@0W 0;NHS!46 !/:1!RP !$9D
M/]ZA_T-*,&X^I BG%@$JD 85\ *19@2^T 3,$@2*8!_)D0=<Y@(HX#H,Z9!(
M(P)E$ @O4 -_>)!+( >M09(   9#P)N@E .GL) H-8L 0 I<P &3HUD/D 43
M96Q38 J]EBA- R)C2(6"@C *XQ%60ROAA5@;MBJI=@-V@B@.8$.DD 0VMP31
M0@.NX"W1L@%QT  TD$>*9P, M$0A0 >,< 4;<"\=0&T)81_&9D/.F #&0@!T
M  2FV05XT0A18 10T%)3F(6[D0=A( <;0 C=5 8X4 =#P* _=0C,,FXYH  8
M<)DL4!'Y%% NJ7A&P%)T<%(,T8D,D ="H(J11P]0D #)H/\(-9 '>>< *SH0
M=9 6$J![$1 (#/)K@[D@0YJ$"QD7.%.#MJ8"[Y$,C' &FK &*; &+,  C4 (
M , #0' *($ %$1 )2O!H<C!N41 $+Z  8("F#<$#;/ $>4!F!]$$L/0_"9!2
M)Q M58 *5/%*5= "5+%C1F!I!K @"*$):$@/^_*<0T  4D4'4N"'FE!4!W&H
MW?0#9Y "%;$!0V /+^ -%G )C) !,K 0*C ##Y ".'"I7$ *>42BM(@(3Q"!
M/J8 ]O"*AA U-H$*VU$%/7I'^J1, ."GA&(#C*  .,@ M11 FI"+:U 7FD %
M8; ',K &0D %PPH '? "I\ "9C#_;G::'523&RD0 MX$8PC"+%O5 ?B3$%SA
M 7F)I4?TJ0E "@YY)@#0! B* %6@!6Z4 SPPKE7@GTO"IBC1!"-  !GK-/4
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M3QYHPN%@5"8" (PH2H 4#(JC20%4T5(#:808$V3$0>"VTE$#+5:P"0& %(K
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M(7B"XHME8^S;CCUF&3E22 -TX69)6[EEFV_FUH CVHLUOIK-L\]@=_?[F3P
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M! =(H L^  6_>80!+&"!;E7(@C W@_+V1,) /.#=@?P@NBX\ 0$/$,$/K.,
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M8 (VD(0Q4(!(* ,+@ .A20I2T  <<*DA,!<38 )$Z$=]0(!D, &P0PI2@(.
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M+5"L)+&/S,$ "T 2#J#+1H #&3@.&HA'N@@"(7 !@%H!KORV2'C&FE@H!7B
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M1?W<(GB#BM9BS.$\'I!A - [UTWG&8A3'YB"F?S1 ^!=[G,&DI7COQG RHF
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MX(-YQCP:LHMH!*!!:)<'P$9ZWCA2<'JS=( F( .,/(I(_[!%&#T$)C !>#&
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M\%I2$N,$V?E$#6-(0#)F8<"H*")3F@$>3SP A98X('XMB@ J I,3'@@13_9
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M110!"X<))Q92.9]+' $18FB)^NZIDU.(8 N5XR@(C DL$/#R60;X_U87UH"
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M"$GF) A+>$%$ 1#_YSFW)B<;$$(73A "#W B%%T  @5R@P01)$$!B"I#!82
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M"C8"(:A!#R2"%9#""]2B)E#!+@* !]S=_(V;%$1 "PQ! 4@ D8@  T1 +!*
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MTU-O(?9OX>A! 2,60?S'Q2U@0HD(P <N*_CK=R]X @+RQ#=C&0X.JT@  Y4
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MEX,"1&(&4P5 ($+P !?L  -BP%$$ZO X .04!T8H P/H4%.TGC44!?BH \+
MA?\\_$&@ 'A !9Z  ;WF87P8  +&'-"('(1A!(F  3VD<(H@"&*C(R! $YB6
MD%,LXG^<=< HBK &#'3" ^/S@Q;D4,P=&,"Y07R"#9*0@"ID801^ ,&?YD6T
M4VBA!GE(XD(B0*@"U%5U/<A#('I @Q=PP F-B$(5/.A000T4#C ( AL40(I5
M./97N$,L ;2'@E/48;'A'6]RBZJ"'D@P B"$08UR2@4>E!4#6H !#P*KD#+A
MX01XT 05P# $\,7! 2I@DPH*=0HU[!$ $0A"T !@!$#L0'@0%4(J.%"$6!6O
MMAR@)0\ ,8,,_--&8)@!^"+( T40CR$/X&\>+& &.@C_@@H:2X -5A'9%TAP
M7J9   U"<0H7&!C!#C"8'V)0R!08XY%29*^%V3!112A@SJU][;]N'&D7_, 9
M/X "I5?!@":(. LI13( G%H#EIWS+.ZY3E'(DC.,T*$(A^ #* AA"8)Y@ RF
M,H"9\JF&?9#3NA))!M,<FJB02541-3I%!'Y(@%(XE[&^11T=9GB *54A$G1S
M:*3HU<$=G((&C$" @Z.&$ @<P =?D$/(/(8##BB!  _@1V\CX(=ZJ( 1IV#!
M6X_D '>G.P^H<P!HZ?"K1Z<V:?^NE3U9T%M2K  ) :CE\'P8!>'Q2T=YT (#
M]#7AA)@YGR[HU, .TH!+$6!J_RJEP$Y;JP6A6DZD $@&(PK^I]5580IE6 ,#
M?D0 &KAB?[:J0L0;,00%V.!M$T?" 0Q;!QGTX( ,R8,$?  %*I,+#4!72/&4
ML&146+8 )&B"/A)@!$6,ZY8BK"H Z#""U69WV3%00@9X"@#.TD *%/"#2)76
M=H088F)UI:BQC@[P9*9 V2, -* Y$(73/0'-&*L8B,-@!D)1 )*)H@<WFQP(
MDZD] 0\_R-&Y4 "^.RDAPH-9K1J. QLPX@EY2(3(#]+6':1A#2PX+Q<HP/=3
MI"#UV,UG"TR&D,__R,U^NWT=?@  #YQ#J*J[Y:'2CMA\,N04^?"&%N* :D7,
M7-WU\/_&"4) !W-[ %%M-4,="O5U#BQC;6DX@ N4/4<PR. '-?B1!QCO(#P.
MW$J X7 +IXPNXD@A"9[@O':@JL)@#5!G\R")"FHNM>P)%3J%U=#)*9C#0C("
MO/Y!$OI!"70MRIB ;D)G"/(I#% @W1S"!@HJRBP 1Y8M(9*A$FJD1QH!:MC+
M"@ MRCX- &C@:NBF!:]/YN"JL[KG=4"E!UE%!60@<'!*%.I-"W! 8E"M;[XN
M"/PH#7 NA)JL:,)@KV8*"A# ^LJM:,:N"PX&MVJ #N0JWA8"55:HK1)E \Z$
M!?ZD1_Z% 2+@]KZ.L_(I$ 0%Y?+I4N N!Y0&#B9@EQ(  P#_IB%DYN8R '4
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MDF$62&8&(O_@ ;!  221_)HL#.AFZ'*N"ER 3+! D#2A[4B!Z !@-=\1"\&
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MBQ/8](J81GN$H O8X*T&40K^@/$>!0G2@,B", ]X*@C*0 Q:H 1^Q & 00Y
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M!"6NR&*++KY(68?8\878 1_"B&...N[(XU(G[H6 !(GU2&211AZ9(V@SZM7
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M%6'^_C.N-;[HJRSW^Y\!S[:_HT0@ FI98 0<D)K^'7""=4L=5S@@A IH4(-
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M$&.I !T!'A &4#!BY;3A0:%U$@$>_.#D8K$YSW.^<YZ,(@<;5V<DQM=I5.R
M!J%H.%,(0(]5T-PG$: !$HK^TPB@1B(1R ?/,4, >ULE"$*8>D1.40'X[<0(
MBDC #0O@])] @ )8?\LIADR0&2QEY' H 41&08BQ9@22/JF"%O:M*UKOX7G[
MGEZOC2<4>EA@.UK0>P14X'>M&("E8LE#!89,@%.,(B&],8"J>?( E<_%]&K/
M2>K-#@ 'C$(4827V!@@1$0.\C^EU1\HI./\/E#P,&2U!*&U$'$ /%/2^,@9
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M.1@$;& !9; #,B@$$\!K$2"%5W@*$:@(,- [6. ",E!51J!Z ! $$Z !#P4
M@[@3GH (%D"%!(!0>H@3/" &*@ ' S&)$W"$.QB+"F $J) &$V""/S%T:O$
M>T@*B"@#>H=/$_ "7]4$:7 ",'%RS*0%<%!H5= "9# +<9&";% &-;"&;1@[
M#Z!02A 1/" $F7B#DR@#%D!T.<%,+K "(0< &# %(0A[*2B-"D '9%"$/4
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M5I";(L<&Y>EVPY@*=9 # $ *+Y *3< (IR"A % 'XI@'7[ #H&, +H">E><
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M "X@!Z=Q"C& DS0@ WM0  WP )K 3@CAG8?P FM0 '%!#ZJ7#,I7!2X0 D'
M" 3@ ;R6JGKG 9JP3RW ! 8!5*>  5K0 YOK%@; .O_9][--"P";6P,;,#X;
MUW6GX .#P "6B[GS9ZXH,*5Z\  IX!:DD /VX 0;T:Z-$'AA%$83,0HH4+P,
M:P ,  $I2 5AL 8R8 Q"0 6T"0!YT'8 ( (M"@#-B@81,+X/<+\ZD;[K*P,X
M0 <SEWHP@( +H0A7<*T ,+LX  $%4 "4BP T8+[LAK]Q$!$1*@5/(&;%&\ Y
M00=$Y[N-X'=&( 0,8 3=B455H DX@1!^H G9&PH98 '[!#X_00^*P %\@ =7
M2@KFZP$,^\"^"P91X(DXV8'-*KHT00_="P V>I5:L -T8+YYP+"Q)P)((#T)
M\;I4\ ?D1PK7J!-^0 &,$0?_!!&Z<*<3EZ:[2V 0)?RSI-=\9E"\-:RM;J$0
M"US"J2?#"3'$IW!X0%'"P1H((4 03("M],MV8FL0VF%X[,0!V-9\SY<'N@D
M-D!T'(!TXTMUJ0 !/" #5% 202 %IY &:Q &(+#%!I &F=FN=7!^"U$)D&$
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MB?!_Z55F'$> H2,1,:#$LI<#"@ !($#<L</F$5 /&<T!.;"Y<(D!I3DZWI
MFQE^4\S$VPVA%A "0_R0L&L2D=!-1H &"O  +F ![V0 *6"<)6"\4\R/>TMX
M21@7R: !R;@3&(R+SEL/-6  CUYTU @'K72]O-,$0X !AVH [=H-RZD3:ZW%
M"3!T#[@$[2OB_T"4,? #NGOJ&VQN(,  !O"FDNI^6FK"2P"FXIR%%QF/+T 0
MW?0 :' %C9" ;*X -&!\$N$#+5H*:&#M5]1^.QT1[FQX.&"TO@0"7_C?!F !
MDD[-\<V;_[O;L$IWS3J1LT[ "FX@Y5[LV*0> 7EPZAS02J4[=1$  A3P (>
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M6.\'L.N@#UEB PO\ "\1$ 'I8N:-[!V10QN@CD+8LL%Q!5*0@R1D(0TIDP*
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MJY!/<DXDX\  ))#QGGT"_P'1ZG;*88V J(=,E!\'F:]TSK2,UQ 3.S]T+:'
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M1 7:@8KG4@D"((G3P)BK""(-2C(#0 6ZV !UP0X0K '-<!4;2 24&(V.6 8
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M;7+)7[O0&JT24X&ON_^/)YBD=6D[$BB [^H?"X"!DOL)>LF8+ZT*"*@:Y(J
M4\ +!W!]FO[?>GB"V^H.TVJE+'> '&6K+)=]D > TN>0+%<83(*Z^BT >G$
MG2R VU6(',U]WU'^,8I]T,^.'+V"J<A1#IF*V1=^H^+]Y8^ XXRU2$(MW_%^
MZ@\Z"A!DM,I]!PBR9#F%]N>0T^%]"#"J"%A]#KF"[( W@% 0 0#!"*<B*"!
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M0FH<>@0>/4Z,%T0.UT5P""CZX+?A<2'XQ@,0W\WF !APE$$@24TPP4<-5M'
M"2C) 1F:DP7PZ1LIC(Q'0QQ-;AA$$E@:=Q%!1D"!%:81J(!G;AL0@BD 0:P
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MN X_*$@,8J;@TL(AB7HE1>= W0A0(*(&1F"31AEE@UX"P :4*L6PB<E$#[P
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M6<NK-5$:F%6SH(TQI%L4T$ .^  2=(&F64!KJ>*OD10ABM0)[ P _XR' ;!
M<D3",C",664<T4U;&@* "\R!(!* [-6 BKG%MQ$$/2B74R!6!&0 &OC![:3;
M=4T$'@K$ZK4;3<C>O(U"JHQ; ^2!&"" OIW" X"  N0= RKD0C(DKE"@QB <
M!$3< 0C$1" 2Q>T&(X6"#P@! Y "&ZR!&GP<"X@8*20!"3Q! XP@_.4  H#!
M*I" "[S$I$C$*X6"-UC #D +=8D= "3#+# $'?!!#]A44?S!'G *&(P!'J1
M#RB$]ED%&$C!&H 5A>P!![B*7R&!#[ !#FBE#V@"_S4$%.(!!XQ,][T**;P
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M_SOS,T-S-$OS-%-S-5OS-6-S-FOS-G-S-WOS-U,S*, !.)-S-<N &S!Q!5?
M.)=S.[OS.\-S/,OS/'NS&]!S.9_SF4AP%QL(5*0"0V1O"C * 0SQ=8" &&QQ
MKU2 !'!)!>2#"2]T0O-*! P"ETS !2_PCAB #RQ!$BG=O5(Q_18'"6R!1.]*
M1&])!:0S!:NT2>L* 9P EVC !?-SA!A 'H3O>)0Q<!RT2^<*2FN)0T/T0_OT
MK41 3&_)15MPY_8(#[B [<(!$(3@12HS0A=UE[3TEB3"2D]P5E_UEAPUEZP
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M##B@0Q/_0?& ]?)XXL 005ACO5-.).&?)_S+X\94 ' @#Q3_22"C![Q!@P$
M3F%Q2"@S>K+&4\ZS[A\J0C02107\H*#$+T/D,48'8AQ2@O4TTO&? X0<\A00
M2%" 2!JC5""#%,\:LTR0/EP04.2JX."$$V0((2,'-@@%@9T>V(/.HO+8 H>-
M'D@$AH_H2:32CZH H5..#%!A@A-"07*K('KH,-"4'"!E!0TF^$'-C4+<H]5<
MB3M@K>S@(LJ#+V2P (X9\'.@!25818D'%);ER0 7RJ#5B".8@/^#B1<2,**,
M4!^P%A0X-(#!@2F*Z'2#%?A980P%D@'E6E"<0#4C>U889(DBR!6!C!N8F &
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MX0T5K'!(ED#$&NIPKCQP@ E P%%ZLO"V6?)C!J2XP0QH$(I&%.$'(D J&%Y
M@JR2[ B#$(,(:!4)%!P@$DY 6D*1AM:-&&+_%HW"P HL\((U^& %7 B",\:
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M*XS !L;@  2@5PD1_S "G-];Z8\8H(AD0 &J-I"#1FW@!8!&! <$#(  XJX
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M@<)@&33'#4R@8?* 'VJ@;V1H(^0L1HD& :;31U'@%/@3/PP&40@10']"A)B
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A7=[GG=[KW=[O'=_S7=_WG=_[W=__'> #7N ''@ " @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g10496bei002.gif
<DESCRIPTION>G10496BEI002.GIF
<TEXT>
begin 644 g10496bei002.gif
M1TE&.#=A[P,5!7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M=^_]]^"'+_[XY)=O_OGHIZ_^^NRW[_[[\,<O__STUV___?CGK__^_/?O__\
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M.,EN"Q%:V+H@!4+(P4#"$ (^V+4B%M#'(9J+D7OP8*W0K6X(1A #*=B@(DM
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M 7Y8#PSP:E;  P$@!V\P7/5W?PKI:P:Q!>P  E4@>'<U!T&8=GS0;3\0 #!
MC;[X5H<E7 !PAO6  P^ !]4X?[O6C@2! >>8#C1P7EN0!6V@ =?_((U/^()@
MU0%N%Y+\<(Y1U@(L( AGP # 9G;GB();90"DV 1,P 9\L K%Z >#\&%#P L"
M=FU6L&/LUY07 ("-P'P&,0<P( (\@&*0U0A/^0&<-@=Y0(TQ]U93M6>AYPI[
M-@2YF) @@ &[!7ZM1P/&!5M3U0.$]P+<^ :^9GVP@(,?X%@&X(90R&8X]P%U
MZ I^V(H#9@==, O8)A#T!@#3>()*]@-^V 1.$ BX!0"X^ ]R\ &^=H.)*(<N
M\ $=  %O$' T8)>@V04,, >-( FVR \%* 1,8%7 &5A=F -S0%M<%0^\:5A_
ML 'Z!60!P <]P ]5X(AK.'U/-@@4$)E._Q8'D#A]5G !\>@$'7!IPM=[4G!^
M5K /)?E^]]>  ("1 2"&.?8$<&8 :1>/*0@ %T!Z+39R#'"&_1 '01!_", $
MCJ!V#/"*?)"&6"5OL94"C2 &1O!9# !??*"@10 +?L"(6L ":"@&CI &HW8/
MM_"A\$ "\58&'1 ,<L !9*F">?8&4B $#D!S[49[&J "8O!<(R "LY" 3.
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M2Q#48%E]' *;M;AGP&E(-@+\, <\2GC 6<+NRU5X"0 '@ $%P \U0 -3$)2
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MKMVG=YKPC].GF0H7 &? ?!KK &[&>LZ> YDE!GZ [NQ :1V@J A@!O'&L,$
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MJX&>""".,DKT7+(RZ&FB!0($#V /$3"SH8"*H%N"EQ$&'<SU&0,HA*Q;;*%
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M"'$)HH*8"*6<"($#UD#:A+STN2P45Q!"&,\6"7L9(?0WMDVIP@)5Q)D\,*$
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M/=2-XUI!P+P0"?"+46P:P'3,QT04B) CR.S+&>$#.*+,J3G,S.3,SO1,P,2
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M_>@O@._?_,5G_MQG?M[__NJO?V6]_TJE?.,'" ( !@*0("'(P80(%R8L01"
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M0&1#D(?%QI8$=87M!R61 L$Z 0-W'8)I=9L%&UST 1TPPFGS((8LO60(N]T
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M%*>K:![CJ6(T @ &Q( >-,8#& ","<%=+AD?;">+:4*"&9H<,$ !@%LB9IA
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MG(\%F1MN:@NF)9=)64I@FI<Y5ZK)W4,$6?.M[$[0 3]HW!G@P$.HYLT)WDX
M*H?E(0C ZXW!%A,"VTI@FDWD@=[] $'.&M&Z(GB5WD[D'<.N9FQ%72\V1EX=
M6A/<G [B)$W8%=91*1_$' '>:&MJ(X[Z_P!!^"-P3EL5^('0ONNF(AO3^BRI
M'"<XOJKIFHH%.((@*&,<Q!ML54 "B-G&A4/FO5GSH:'D35D]6MJMT224,AOD
MN4$3A*G342MLR:<#3.O>SD0+#%?(.=?"?8'%K6T=.%\39 *=ZB>[@EWIFE@)
M&,&2"<$'9.^,C:^@\8$*[  _:"*;Y2Y/_-L#\ #A]J.@Q:2"*<$"!H!^\5>@
M&9E=N:D24&83Z%=C5&[SID0V7EG*<IBM"MT+D$"D+8 3]!6R[>GJDLK.LDK/
M;G"I?%+;>!H_N U<F"QDK@T E# !P%8)6](*8P!GJ,2V/A@_B(!M8< !M+#-
MKHT/J\U% ?%*=/]L =R#V_RP$&XKOHG ^YYP34Z;V\@;IKJ-<RFQB1G V_QP
M?1W _3Q QZI$)JV-;57G$9?Q0Y0P%JN$#!R"T!'% =Q5VJ2$#A, ^94P#LLQ
M#(,P!WLC<GZ5'C,+SDY*]/TH; 5RK1CR0R"RHQ1 NE4!#'#AIRCR'U=*!Z_*
M!T\R-]8 $;0Q)AL+ZEI?.'8R%@Z *"]+):O*)9>R*J]RJ[#JA*DN*\>R+)O*
M*:=**L\R+N>RIGRRT86R+O\R,$]*+:/*+0>S,1_S2[ARK+AJ<B(SI1B $B1
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MN=T#R'AP^;U+C"] 6$L1($">.@"&^&F2 P#"6P%6-<00 QX)5P1; +#PD"&
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M"3T*] P&'F!OSP>J".F@K_C)T">K4F2(OO_""@2[]TSZ\P0-)@.@ @$?F",
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MT,X,ZI$2)-0C:&"HWDK03WYT0 )+?( >)( Y%DA H "@J/]R)(%$ZJJB !@
M14?JD1I(0 +A\-SM%DHT+[( HU6S@ 0V,)H@=*TA*^UH3]$0_PX*V($/E@"I
M308P!(YJP8OW"*@_Q1*#A8HT.U9QZ!(-L-"J3+,$:%C$/FH0A"L0X!Y:51E&
M*^J5D[8T1V+UH@$H&HY]?.4&!O5B# )*  .(]"M#<"C1&C* &Q0A'.XL*TM=
MJD_%+E9V_")(/?_"6,E.EK*,K0(3BJ '/92@0MRK[&=!&UK*TK-U]A3M:5&;
M6GW9H9C*291J81M;V18LBI"UXFQQFUO=TF5G+N!#^4P@S=T.E[C%%0QI[>4Z
MXRZ7N<UU[G.A&]V&.#8 ^*)B9*6;7>UNE[O=]>[ID'LEY7Z7O.4U[WG1FUZV
MU+:TV%7O>^$;7_G.5[?AM=)XZ9O?R?_Z[:5?\=ND]O(  /0W+>H*RZ0(#!9&
MV41=Z7*P.Q<#89LD6"P"IK!)+QP6_H8%70,&RX/U&V+)4M>V 1/QB>-YCX=$
MRY]EPXA>,# + *K@J!7N@!3VDX4WO+0&^BF($R"<P!E)9$<04D,!)#Q-7QV9
M3W-@A_O(@@$\?$L(("B:1!Y!92:X:RP&>%#,$+@C3=0+(<4<Q)51G&8MVK=*
M^%7SFYNHFPC52W."TN-<KO6</*24+)]Y#IMPE,#GD.XKK%V(N&+4!#5<N%R
M!HO-F@"#"S_@!\G!B%=8NYQ*DJ4&WY)1#KQ8O%Q9*Y8HA/.IF<A>>UWWMJAV
M->I4'(!_Y,K_ !62T?0PP (MZ&$?+LFU%N8:6%VCN2%>;L((M/ "H)PIRIO+
M@Q-B<(&3'(2U+JP CCWK,>=H@D82B4 $1!"!S;EP,2_0$IN0+)$.G!O*Q8Y
ML"W0Q@]HH0KG2\_CBD/OG-2X(5O0@!"L$2TN8V!'&K"%N#3 /VF]FN'@)0CK
MDFO:AD]\8'9B"1:4B1,(F*W8%W#.29B@!7Y@Q;/K"4!'WA,#)20RWD$KBP$N
MP(XS42,G4-G<"+ISK3RDAP62T  .AQR6ZQTZ+$>\(:X6K4B%X##I#0GB31"U
MHEH?FAJ(JE.&Z)#DZJGA!7Z0PQ?>PX.0L"$+Z:D!&PKQK6MPF>)M_[\7B=O;
M:K?/G4H6V,T>7."T'\@!'@,QC>::$(<2(%$.F"G;SAM"!@[QVR./N.&YRO(
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M.L#,)^?E-L'01$ZS.V0%YX"S+9]1O**Q/\_R'H)!"/[#-PS4+7^C(VXL!?)
M#/ @#<I.*(AB)<NB DC@?*S@H.8@!3S+)JA!$/^$@ ]NZ'QX4B*\J1]@8!'"
MPEN$("<_A :$0)S.XG&JC#-3  L'@!:MR2,:- ]F(/G2I@T<= <2+(&$X$_
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M#T@@Y'KJ:C/ "=)E,"\  CYW"!(@ V:@ R"@#[;J=9F ;WO*")C 0PQ@%B!
M'V[WPK*J#1)@ :Z V#" -$G7G[R%#S # Y1@ :YUFF:A#;97*/ @ 2K(+[*
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M-QQ# 1Q T-;:T_"$3S:G"4Q;($#FD_Z- W; G6YXCONM/NGX_08J4)J J'>
M'PC/M//2);C($A1 "OB '4#  #+T_8[)+^]:.9,;<?8CE)XU4%H 1W[ ##X
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M&;##)<@@!?KA/PA>*%RXZ=&H(5A@U#^MT*8"%J8BP0J JND,7C)91@ "1 $
M! L"8#%+2H@  5H4^!'@# ."#P)I:%3&@" ^= !8<!,@1P$R?O\TK2B(@0
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MOO#%ARR\A2!*F,#'^& "[ED-BQ/HG$0>0)A6"<J$0LB#)(82*. \(HWLB-P
M@+,,SOSJ8_AJ0LXV=*S6K&8J/YM#&C[6A"Y(CB=LZ$?=^@$#I51A:7+ $ LD
MP3HA?$ I0RA)97C2!@I:,@=2I)\O?PE,]:A/ _-S7P#\%<QD*G.9W-E2$$9)
MD!<H07(/F$409D"0#BAA!D6I@1+$\,Q>6NT__"A!$(H HQLHH0CNPD 'P.D
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MPT<=,2 "/] "_. &AF,4CZ #X6 4=J "%0A]\S$:4X!U!K$$AV!_C] N,4
M..@N9- '_"![^,4#;W$/Q=<=R+>!V($!CK #'0 !24@0.LA>D[9HE28_)S &
M&$(-?Y  "/ !96 !1C !*L!S %  U  !8^@ /Y '"_ 'VA)_$W (3O (O(
M;Y 0>< $8-,(^H  /8 !+V -", $$? $J]!^"+  $[ "0P !KF %5T &'",=
MD&4&V6( ;3 #-2 %-E "4J"'6@!9KA Y<_ !//$'07#_"\0 "R/0 7G@A[ R
M!'X( 3I@5 ;@"(XS G40"''@"CK@!#5P 0@  7GP3R\0#Q" !3E0-@A@ DY@
M 7]0!]40#AE0!WFQ,A>0!R9P!1U C LP!HL  0O@"@?4C M@!ALP$)-1"$%
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MPA5@ HS@!HU#BFAP"!1P#V-P!5)P$O0;"%+S !)=$%-*#3H /?@:?%5  TP
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M2XZ$B^&B1R!, );H>#2BP ,C/@H N,=FQ8,+("Y$&@G  H05!GA\@7CB$ ,
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M@\@>>$*Z0 K1@P@"AN" .&KZ\/6@)S(* ^3ZRN#A#7GO(>$[$ HHH8@7WBC
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M\@'P(^MD)XNOP,[VE^_CA0:(3->C+O2[P%SJ!HV+U?F>OKW3.^*(GCBC#9"
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M8"\$.R-^U#1RFCGHL $J;!LH;$=8X(!G"H(%F $"4,,%R("3!$,1_PB"2#$
M- @9%[ "?J3#C2R)D_""GC !1]%"A:&!+.":#@#'&6 !1\PSMR$!H6$C,"0-
M69"$J@%''E! #+B#-_"",)R%*_"A%\ )>I$#&WB"#W"$0/2@F[(K.1*7?>S'
M8%2 ,X&30PQ!M R'"ZC!'SH)W D"4H@!(I!'XWL!$@ !N<O&/HC# G($0.1"
M+P!#S(NE!=#%1TB!-@2 +<@"%T(/(5 #?@A"EPP@1WB<$G#*-/F &-0T-70$
M%;@RR=") K" B1@+)6 " $ #);B) D(AIZL -'R#&)"$+*B,'Z*!#^@ !##"
M&> ':H))^VL#(3R(P 1#1GF#C1PB0&J;4_]40@.  ! IE$,A"1=(@35ZS!WP
MR*N\@A-P@T((!U+8AQ?81/T@S#<8E +"PU9R@7[XB7L;/#HKO$5C@078@/0(
M!^TP "F,@129@]<X/R=H$%\A ^OPG#IHD)G+B3P(!ST@ 1IJDCO(@X"$@1>(
M0"U(B1APA#>8#RUPB@IPR0[@@#IP QWD@1WH@-RQ(L"J #:XB$98!,\1 1KM
M !JH/!$! "50"1!@A&S9F@YP23+X -.[*C$00_%0@46XE,PRR3#H@CJX@!V(
M@(*8#T8(@U4(CX5Q@D<( =89@3J(OQK(@#KH %RRT 3E4*18A NH!^*0G1XX
MTR=EA!?X@ HX!&__\8$8N!D>Z(%^R81[>#"RN =9N((8D ),T X:B8B[J8(<
MZ  AL(%BN0(CV("PRH'N" =&J-,9\!L]2!$K&K]#S1SO4+G)T,$VB)<I8 0C
MR0(T%8(9> $=T ->V 'H 8$26( K<,H8B(ZT<8+YN- A6(!P"-08, $'P)U%
MJ)D&B8$U* (5" <28+XCJ8/ZT((GH)OB. 0MD <VC3]XV5 0 8EE,2BR45(0
M"),''4[MJ ';TH-$)0,QT()': 0]@!4E?8,G6(4"H#"86==YJ54]4(!P(!*D
MJ(.2"; CN8)9,$EY\14[,)Q#[0$%'1$=6 3&:1!&R,$*" $?*%$0T ,I_]@#
MB"B9HG#!B=DOXA 0$0B$1J@#[=#6< @NKBD)AY"7CD53%8@ 1P"!&!"$%ABT
M12B!-6"$8=$#%\B!%JV#.<@$HM&#"\B#@55:TUB">WJ!#+"9-^@ T)";+CI4
M$-A:A1*2!M$");""&(@'"92,+4B"5^HN20 3$- "+S !+<""*= ":T71 M6.
MEGB *] CS/-'?B")-@B'-< ),N@##(@!"Q@#7@H#Z8.([G("'>T! 2&.\E!4
M+5F8#7B!/M""2WF9)]4#^W@5I;6([C!:$6"#H9V"%M*"'V@$1J@O(3$",7 9
M!(V''C@7+? ;Q $;$MB #*F!:G" )XB#"G4>8_]BP:!M@S=@A.@@@R-(/7G;
M.'%3P4VS@ 1HTY\8CPXP P40 S=0 TE@#0$A %)BE6M0#--!'*[Q'/LU R(@
M@C,)!$JY!REPA$8H@!-P!28@ A+X "\8JZNK@D. !T?X@QTHLM48@C@P(PR(
M@!)@ TQ8C=8XA%G0BA9AOYSX *&0@%IL/@[0UJ)HA"!P!!HX)+4X@!BX (&U
MAG]MB:S<H#$H @1@,!* @2IHA"*(%-S  ];07]OHFL_YX&%R B]8(AI@ GB
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MX!6B&C!NUBCD VR-,;\#M+K1[P,9_GV &-""0/"('(,%K:#K7&(!+:C[KOF
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M^%E\!(, &14$<C*R9N/!G"D70  @TT7/GYU56A#XP:O%RP<T;5[+N3-"#39
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M0!DHCA9( F5,QB/T@0CTC=UL  :H2'GQ0(<LP03D66I8Y3]:40W\8SA4  W
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MAV3/%81!'YC/V6' #R! ."A!4$"KM4(A!LC#"-RJ 1C!#I0 SK@ Q^A .+A
M(=C)$O1!.(1!(S#" *V*'1"#_ZSD ;L&Q57X*1.M#Q06 &,MPP<4ZA0, 2^
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M'DPC#U@!FFRJ$*74(F'(&-0!'\=/%7B'%DW%"\2#"0SL9#6)G3$ &<0!QMC
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M23Y^ #-+@)W8@>2I#UO8:7:[B"PG^_J1!)TS8 OP0]-;PUDON 4&CIU2QQO
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M#A @J$,U-5YHI( [;$AKBZU*FHD!FWR D SYY@"A 'YL>Q*ADA[A:XPR>-@
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M S\0!$-0!$?P_^BO\J@/ DE0!5>0!5O0!5]0]C:P]3IP_&;C]&S0\TRO^1Y
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MI#(LH'(  N8#2 YF(B &7, *.@PGK?+<I,(FTP([G$ /.J -5L AT2PH#P
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M#UJU7)] "##!8/?5J,XT 5(JN+P@ :QA6.V@;Z=5!*;F3IWD24B@5*_@#"'
M#-Z@ F@  OI "O( 3#$A9=&TKQX!4EMWQ<YT 1 @!P)A%:A!6DU@!237!)P@
M$#K6"<XU72VU"\*!!!S 7-+T"IQW#? T[=9 >VW #KS7%7B%'Y2@?7C5&GQ5
M*=;B GC!"BX 8B56D% W:Q= #!H!%D(@#_+ +ZB!.KA""DP@1TAU 79@);Z
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M/$5P&*,:H.4#> 0]XH ":N *A@!63(:$ & D?O\ BI'K)/A!$L*A#8[Y \C
M2H9D US 6JW- !* 3S$&)Y'9KO_@"C+ !K2BMR2RE0"G@/;A$4##(\(A 1P@
M6^@@+6I+.,RD$<(C'BQ[30*!($R"H#0+>^P EH'#)G) .')@"0C"J]] I/%M
M2;#$A]B@=7J@30I V2"; "J@#N8@-88 FZ6T!QY!#6@9.1K:"AZA$1P@@AR
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M;,D"ZMPSB ,E<*0.</<R&$/G88$&IB"$1, %A*#3K?_E X!K#C!FQ6Y  H+
M%=0 LA6.#<+!+:B)U+(&8<A0 M@@#F+@",K@* %^"W)@#D*@T_]@!AX! ?H@
M]PJ%5P! Z35F"%KX#;0@$/;&5U+F!US?#/)@!V8[GXL T:E!DF" 'T36 6)
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M"%-@:>$P0YBD'%8+ 01@(9_D!!BP?8LZ!1C0.SSD  8 "Q+< M1P!*7U76&
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M\BJ_\G<H\?K'ZBP?\S*/B">/?"D_\SA_AO,Q11X/\H,N\@A8!1K !V$A!%;
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MC<<'._P0HI\F>B"H NH+*>$6DC69P0(I)-^+(.*G-L&5)J:(H7@^B/D;'T+
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MV)@Y"$,6=G"!/$CKO0"80Q<NC!;_PLZTQ!N!!-P 4QW?PP@;D.9L)4"".'2
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MH?80:\$3]O( -H" =4OE@!04\(&A4>-VN<L+[RK,B["!]P+_@)@<W R *L
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M8 39P( 8T%/6B0 ^K0F.;N9XUF<](&F7OO]I>Q"0>A:!C!Z F/9%>^8'@ :
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MO_6'M_.>XH-^$ (QJNI]>  ,:&J7B  ,0*/:)/_ZZ?.(GQ_Z' %Z#!!ZIP>
M!85L7%4+ ]@';<$ JX?LI3>(IAZ(VM3G \" J\^15ZN)L7>.?>"' Q 0##@
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M@C66988/+*(-[EV"E&@@V]S^# "WS:T81&  _YKL-I\1A!J>\@A7<-85'W"
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M75/7AT\%*,L!;BC+B_1"C:CIE@VC95R9@6&!CI13E0Z-#%37^!E,_D[%.P.
M(\QF5 #8T(2!!GP#&7@?!B D$ \.&_0#H+PP "A!'P)R:/&YLKNCUJFAF8B8
M&U(7>K% ?G^?OG  2?H;L [-@FU *T+%(T3D$C@'Y[4!J 5G8V>>"PQ?%8!
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M4B*!2R97LA;&X")B@ML AA#1Y[M(X"IJ*B[YR;,7")T5%%PM<*$'3PMC'#R
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M) 8,;H081' /-N#4FR,N2'/CX6#N8B \$'V#_Q8,P :*E%-+!9%3!VC ID?
MP"M+"(%&6_ "1?D8!)'R;(\<L=*=/$ C%+TQ $ILAC^(@2IAX 5/ 4H ;IHT
M#^YYP N2JX+EJA7,)G QD*OCJ=PB0 >PR.B%G_R?1QU&+#5@ Z<>X8>W/ 8+
M>[  ?0&\$ R$X:&N4,$5PO"!G+!FI0_@P5<G\.@AI$"C'V  ?%T15 -(X)[Y
MY$>05/S5/#!!!.'EZ00.D90\[%5.KW5H<'53@02X0@<[V(<!V@#<(\R ;A:0
M !O4RQH$A$"V'-"##L2RS1&8$Z>\7D%?(8I/%$J1EJIDIA$E&X<E4[8@2X"
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M24+.LVJ@XZYCY@QO!,#$!*S@5QZ/09B @$[@%LP+ **O(AX! G0 A7Z %S[
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M9.")"1F@6^J%##(29[2 'TK1'BWB$!@A+!@4 );A"%)Q.N@".^^O J,3.'1
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M")Z$41TU1Y,U Z[@U-20#6NV"!JL41^5/WQO YAO(60 #QN3PJYC$=: 5Q5
MRG:4+?_$$(&#!DR 3%QA#RI@ AJ58 G@!1KA>'LLCB8QF"+IB.(D"Q) $ J!
M 33Q>N8 $WX ?IF@!'Q -\N@+M=A$ @@""6A!7)L0YQ%"0+N 6Z5)Y[@ ^S)
MN'R0%QJ5%_3O#M.. @%@#HH2 H+ "(2 4$GE*0JB'$!8"D18<)_QXJH12ZF"
M!0[A[MSD*T1N5 Q@3LLM#@;/"I2 !A).)Q[38TH@"!# !Y;!_W<?(+7 U1(6
MP \LN V8( @$ 3D&0 EV .(\#JWF0 @6P!6RP &H08*I3Q*68R<" 83/EDS7
M4D,']T&$  ($.!BI1 >NP#])!4)X @V"@!?JH"2UR1'"00F:9"SYC@V@1";-
M$:WT@4T&(/)(A5TI% !\83GDCEM.M/+, P)2H 7"Q;#T<5EBH#5$H!JHJQ$Z
M( Y@$  BP !DX4<L("M+90UM0/9"U"($(0\@( 1RU2W9- )L]/[L '[C !Z4
M( 1Z $OT 1Z"0 (>[ ZN$P.D "_#F U& .3ZP02D0 @P@W2YZ@EZX <ZMR=Z
M *L\A0G^0"L9 HR/EBHT;'T2@/($@_\-UH,&#B1D\&L*UC!BEZ4"2, USJT^
MGD=,NV23WPX>\I?X?*\!=$X)WM(P,)!!@-/'(J'K=L8(3G@GM'!9]H$H2]H'
MJD %@L!&/.M-Q2 (PN%]\A<L]" >:EH06J!J!$H?0BW:Y@#KB'%41H0\7!@Q
M?H"-K2$+KH"U.H (7L '$MCHBEFDRXU&;G8G[L$(."!,<:-XQ< 1K+E=KR&7
M=R(&8"$.ZB!(.+@P9(\+U=HH=6\N%F(][Z\C,4/"CN"VQGD$GJP J"$#J#(N
M"K$B3B"M(0]^&5$L#T$,C" +-N"%?*C;^/>6BD@:K^!]@.Y(64 *-B NOGI+
M[: +GT(W<_3_ C3 @L=@ WCV,JV0)USV"Q?$ $@ !.3O#3#  +R #JDA3;@/
M*'[/#G*0'_! ONC42PWY8*5VR.K% BB3I06C#0IP+=GN*\9 K3-C3)]'3F)N
MYF0@K,S2>8WB5H?,/T2O<-'E!72 $8[. JSA(S50&AV@'RM@#<1*!)X@$WX0
M  )!"1]@RNZ ,<F/\E3J*\X- VS5!AYAWVR"!#; Y$B%&I3[LK"#%QF$[(#P
MX4;%):%$NG^D<+LJ79N30):AMR2L\3P7T/K 7^0/G\>B,T6 #!I!#U0@)\0N
M.K6K+M#J"3 !7!P1V%2+^NK "-C$\A2Z4R;6*[.:A7O;O8^D#39 _^%@H SF
M3\)6SRT7@@R"N :0./#N#@UY@"JZ[@W\T E$0 24 ,)'1"R ;08BI3#T4 MX
MH 3!51, NF9#=&D[I?VH!P:$A?K"00%^A#E%0'K5Y?\6@A[SZMI4'  ZP 0T
M<T$>(0WRX/Z8KP,.P6,"@0\<Y [?HP,6(-IX8 8XO:5'!2,9( 2WL,<Z@+1X
MKE,D@:T:Y%VV@*WR @28L"*HSP9D@ ,<  ,.[>3H@5.8DX"N@Y_]8!!L=04.
M@ 6,\S%%0!+6H Q\00V<G%2,L]RN82%J0 ?&T$=VPL)1KQ'*X 0^&@!<5+W'
M5@T)HQ!KX _46NX$K E.N'L;$:W4Y .,;O]!#JTT0@93A6[$U:!@SM(KXJ("
MDD!X4/ >JJ#=+)N'J"F(K(F(B#(P0LX7"H$('$$!'".:ZU/Z9& 0** 4(QA!
M?+K>,-,[' $PX-%+;Q%2CD ,D-@"+/(.8; #%, [B.!*E.QZ7  $8H";ITS!
MOA S*N (;,  /K[GKV0(C, [%.!*&"*("\(%5( (N'X&O)()N)X(]DK"B*#G
MB2"Z/ ,T7AI*IMKC%2!L/_[CW^#?X>0@9I,,_GHCN%X!\"3DO."Q?5 %[%<M
MW& /^ $-@'4.+JX@3L :.*#LG> 'CL#CSUX)##?D&&'JN5X,'C@.PA[FD<[G
M'<$*Z(Y3NNKB[&#_\KG^R@(:H%_@4LK> 50L';A^!QX! 7R^NT1C)^_NZJ("
M][G>SK>^ZP^NQRQM!Y2 ";R#RS*#J*@>3UK>$3)@Q(8@ SS>(PA4PE;T!I#*
M7ES Z__@O/QP0_RP[6+]^F>@8CZ^[,6@ )CY0111V*=,"5S>2"SMY,8["-#1
M,+2$G76V.@#B109'COI<><"C!P  CX1LJ%"DP$(#:QPL7%@E#Q$%8K1(2>>(
M")$B=VPL?' !A!<%"C8ZN<?F0T@B3DZ2X=!2@9,3$!Q@\"*RI1@14C8 0)F'
MP<4+4SJL46I!R@@*"ZGI4+H0@Y*<;Q@,H<&$(YP+&AV](7#Q15@B&:X _WC!
MDHBC&0/P1%K(0HH/.VJH7C2@)(-()@0,',+ZH]$:$!(!5/D@\4<+B63,M"32
M<:&%>!8?/&DTZP-: &14*/F 8<N> C_V&&CS02[-BX$:B31B0^(0&%BS&IEQ
M$0"U:V@?!%(S)!X3D42N5'"4DQ2%)YE@<I";P<'FY2*O_.B#]@2-*1*77.L-
M  .>N,TQ5%Q(!D+-A14RM'2T8_0/->'/'[6S1P40"(;9%2^ !\ ]4H P6G .
M/@AAA!).2"$ "P2 884:;LCA0A&$@"$1'8Y((H0L](:!%BPL4L(B6DAD@!;I
MR1@C #$0D.)%,2AU(P LZ%&"%@W&T!@+HST00?\$,EX4 5HI-F@ D$MBL,]%
M+&AA !$6!1>!7T9>=$.5&.BQR!7\9"4E!A(A.5H-+*9)9@DM+IE5#$$6]V)6
M6F 07)0E.#  FG"\B&2@>#G0Y4+\[%D#D'#L(Q$&$=1X4@0Y+E2#%@_,L<)"
M WQYT0,QQ(DED"PNHD>#*0XPYITVMEB"'D(&]^.@FI7!I)5 M@A'8S8VB%<)
M<(QFIYPJZ@%'K,!*>E*//B[YH[ E$#"JG$%6ZNN)&%0 AQX-.+AB"9 "\"FR
M5:(9I$1-ZLD/LPZRB:2O645@*  UG(L7F?B.Z6(!!2#YUYYER(NI'GKP"< -
M0VH1@:]['K5NPJ,9L,C_(GQ*BK"D!%0 V4F0^FI LG# @4$,([.HQ:QXR3@J
M'"(LU(&IUUJ),@"+GNFCL+C:Z%>,#4;0P),>[DMGL\(ZN>NCH[)X18-((BM"
MD4?C]>U",>R)[T4E#UK<OJ.J2B@+6_HIYR)'1APCJ! G"4"--2XM+)W5SGQ4
MT7@!&^]$5[3*HJT8&/MO!"]SBVIQ!LLY**4V5ATCP38.^C( $0.0:G"M9GUE
MI7_MPT^<P@:-[Y6.ET@ZB1!@R$?IJFOX(88*K Y[["76*WN)!I0P>NVZ[\[[
M V@ RWOPP@]/?/'&ZTZ[@P/4X-;QSC\/_>ZY1T]]]2-.;[V$IP>@0?84:@%B
M_P B>D]^^>:?CW[ZZJ_/?OONOP]__/+/O_KVJ;/?>@"OT\]___[_#\  "G"
M!"R@ 0]HO0ME"'_A&Q\"'PC!"$IP@A2LH 4OB$'SV:]]^=M?!C\(PA"*<(0D
M+*$)3QB[[76/@2%"H0M?",,8RG"&-*SA\#;(0OW9<(<\[*$/?PC$(/I/@0%H
M'_A:*,0D*G&)3&RB$Y\( !RNKX-0K*(5KXC%+&KQ?RKD8 .W",8PBG&,9"RC
MZ5#G1=>9<8UL;*,;W_A#(J91?/$S@".N()$.F"0]7K@"+!*0  4D@ EZ(,6:
M])B>"K!D!GQ2)"!U4AA2B  6),B ?68PA Q4,@-,F/_D)IL6G <\)P-.4%,%
MC)"!!&1@!RQP1"HS ((:2, B!O ")V54@TT.<I*:S$!F(E0#29)!D GH0S@L
MAX<9R,N1OFQ>ED!I 5>J<@<8$$@OF5 "+2UD")+$@R55Z83GJ#(!3D!+#0(C
M!AR]8&RDT,(0=E  ,EB2!&^PVP"LZ4L&L( 4#9*G*DG0 Q@I83X#> X3BD"
M!SQBGDS8@=9BX$J$ F 6>,1 !Q2P2K14X V1>X$3&L--$2C! >;DYT0" \[1
M=" S#_"F*CM2 U=N<@>SF %:#( '!M1GDQR=Q35?5$W!X-$ )@5 !:CI!0?$
M-)4*P.-$@N#48+Y,/? TJB/_Y@,822KAGTP %!]5F0%&=B _1^D (QOSDS=,
M1 (JW4$)*@G6<!1A9\%4TSE]28 "&. "3#W+ UZP FHP-0$@&&4E.]*!0*X2
M7PKMY0[V 1BF9B>QFF2"4T<Y@\@M=0<OJP$1L&)6X%WDKH'<VRR,,A&^JE(!
M2DGK7]8C!@>(LI<9X"A>MIJ!/N2I;4IH6F,KJ8 ^+$*U]D$/I@+SV+^"\JZQ
M?< -Q% ULR(,9BQ] 5EQZ@ RK):L-F&HF=YJR566P CCS(!<ER35A:J2"3*R
MKI.22A]7OG(&LQA;$+SB PS4TI=;*BMPV0L /(R3"5B)J0(>:U1^%N GX0B"
M??N[_ZW<AJ,Q@%E!H#J RD!^M 9\O24)I:@^*L+/#EF8 I\D Z,V].!'%X"!
M'LI@GM$$@@[\\((Q]1 &*U# #B/0 I#&X( A=$&?C-#""W@Q@P[HX H18 1D
MUS #+<2 !#E ZR.LT"TE]$$$CS#!(A@1@7T,X0].B,#5+ "!*\2T([.HB'D6
M$0$]/'D'6F#$:42[S<,$X@-Z,/.XJF(&%12-QWI@Q",^(*,E\,(*:!G"(<(1
M9QY@0E*/B$,XW'F+'@-@"8.@  ]V8&8AD6$-5QB5/F9@ 2. V@L?P$$O%.*C
M(ZP 0/R8 PBN!@O".*@*[(T!'CY AD9@Y0%5:(&44P8?5_^,0"(56$,X]*"$
M2#S@#CFXFI,O4A\XQ$ )+<# !7(  "VC*@Q3(( =FL"@3=&A,9RNP3P:81%J
M'$8S?[BT'D@ ',_D(=]/ #6T/R""" @(!$EZ0A9J<H\QS'H$=6CRGHQ0SP@\
M1@M5F,(BG'(%"\P; #SF!P]\L(0X^%@/"4#M/8)1"!F-62E#L(8.+$*&-(P
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M4,AQDL@&LU< 98@78X #1U%Q3 <#L  9#U -[7<"\^8>_"8$<?]  !; !BN
MB*'R&Q.A#W5 90OQ C9 @-,H>2/@<3VP!,MV%$8PBFW3C%-  4,P!@S04F]P
M <ID!\3@"#*(!U+0"#%P"':G-4:@$ ^@! KQ"(U0!X% 'L'Q"'T@D4SW% OQ
M _@(C>NW):-6!@EQ$?M1 TX''X88")FP)H^A=5L6'#\((Y1X$KEX%/=8 1S0
M&P_P T!X#SQ@ P!R4Q(0 22P1XXQ!61  _@WC[G#,5B1$C'9&%MH-X_ !"J)
M9C6A4 Z 8@\R!!^P,X>& 8"X ]EQ$3RF&VM0><+1"#323DSQ $8P'P] !DY
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M <DI'!F@!VV@%,E8 %985CZZ:8)@ NS9!Q0PE@#PIT=Q!T/X&#6@=/X)E+X
MA4/@HSJ( !]@-EO87V30!R4  5[P<LLP<Q$BHV@!FCL0@5F)!6 * 917E#9
M!B#X"!!*9QSWI1'Z!A+QC$"Y32;@%3H@ C2ZAZO!=(*0!PI:H*%R!P@  ^'
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M4_1%[G.MC6%KHFP +U"+CJ$&L5>+R<@/IR%EC[%C4-@!9NUHB] &&R@"&$
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M]. .(, 2H5SPS6O4A\**U<=&#% -[@Z!#29 J=],.Y EV),,$,C #IISCWC
M9 07@ $% D$'.^RAKW%A05LBXH(X9" !),A#':J0AP1D8)DFH88EI$P"1;I
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M(:$;':(['0R !\!9AU4@C?<J '[  VM8% S  R< B@M9+@MHD;=X@-C2.P0
M-RM@"!90DBM\!&LP Q^X-#QP!1UXC'M@LP[HO0<(A/SS#1(P@P\ I>)0 (B
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M](,0;* '.--V1(6X,.6B!P)&3%*/L<RN4@*1,9?/.6W;"L?5Q^DTSX] #XP
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MO(<>P(%BW*$6\$,,7,%HP$<)+()P#$0,E," Q, B-(!!I/\&'&3$(!*%!92
MGSQ !<"!(]9 )8H );8@ !C&%2!B)1*(79!B <2 'NC!N2SB&\:;03R &PK&
M8)2 <O!A)?)#SMR#'KBB0*BB%,VA%IR+7 3'13@C:E0 )/Y*?20C %1C)CK-
M#<!! W05)-;%&@VB) H$/\QA(+X'*083)7+B,Y8 )Y*3:QB&/&K7'28%?'#B
M(I:B;,2C.;)A0&:9\ $,\0GD02)D0BH("Q2!6)S1CL"70DKD1%(D "A< !@0
M G5617)D1WID1'R*BY  !"P$Y7WD2:+DPQ%DAJ",$-A$2L)D3"9D!VAA" C!
M&[".3.KD3GH3&@J,%CR*(_#D4!+_95$:Y5$B9<&\Q,$,7\,EY5-"951*Y51V
MY$6F80 4'U5JY59R95=Z966M9(9PTTM^95F:Y5FB95HJB$\VI1JJY5O"95S*
MY5P>1%ABB$'295[JY5[RY5-:Y96Y95\*YF 29F$BI%U>"%X:YF(R9F,ZYI2Q
M94%JI,,]9F5:YF5B9L,@9H6T)%EFYF>"9FB*)D_\9<  Y4L(Y6BJYFJR9FLR
MR%)>)66ZYFS29FU:9F1JB&+:YF[R9F_JY696R%ABI6\29W$:9UF69D$ZY7$R
M9W,Z9U$")X3HYG-29W5:IT3B9H9PEFQ>9W=ZYW=&7'0N"&?I WB:YWFBIY0E
MIX8()P*D_^=[PF=\*I (F,%+A #!U"=,2(!\\F=_^B>&2$#D!, 1$$P0S$@(
M2  &[.)_,FB#.BA*%$ $2,"W!$ )$$P!3,",\ %Q)0 $), "+, :@*B(ANB(
MFFB)HBB)JNB)KFB*LNB+NFB,MNB,PBB-RFB-XNB-ZJB-\FB.]NB.^FB0 NF0
M_FB1"JF1$NF1*FF2,BF2.NF2/FF30NF42FF51NF54BF66FF6<NF6>JF6@FF7
MANF7BFF9DNF6>JB'+H":=J@9"&@ 0 !  DP)9.B,V.F=XFF>ZNF>\FF?^NF?
M FJ@"NJ@$FJA&NJA(FJB*NJB,FJC.NJC0FJD2NJD4FJE6NJE8N=JIFKJIG)J
MITX (S@,(QQ!IY)JJ9KJJ:)JJJKJJK)JJ[KJJ\)JK,KJK-(JH&YH!$!,=$#
M#M5JK_KJKP)KL KKL!)KL1KKL2+KKX8 !)1 +#[HLT)KM$KKM%)KM5KKM6)K
MMFKKMG)KMWKKMX)KN(KKN))KN9KKN:)KNJKKNK)KN[KKN\)KO,KKO-)KO=KK
MO>)KONKKOO)KO_KKOP)LP KLP!)LP1KLP2)LPBKLPC)LPSKLPT)LQ$KLQ%)L
MQ5KLQ6)LQFKLQG)LQWKLQX)LR(KLR))LR9KLR:)LRJKLRK)LR[KLRXI$0
!.P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
